Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,A1BG,Alpha-1B-glycoprotein,17711,69,1.83 [0.44-7.50],0.4033558565893047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AAMDC,Mth938 domain-containing protein,17228,69,1.20 [0.78-1.85],0.398221058100161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AARSD1,Alanyl-tRNA editing protein Aarsd1,20178,85,0.88 [0.62-1.25],0.47260312186984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABCA2,ATP-binding cassette sub-family A member 2,17070,67,3.58 [2.29-5.60],2.1912924392087552e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABHD14B,Protein ABHD14B,20036,83,1.01 [0.71-1.43],0.9493447083179616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABL1,Tyrosine-protein kinase ABL1,20178,85,1.60 [1.24-2.07],0.0003110993702528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABO,Histo-blood group ABO system transferase,17683,68,1.09 [0.92-1.27],0.32034236143742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ABRAXAS2,BRISC complex subunit Abraxas 2,17070,67,1.16 [0.81-1.66],0.4084812570067981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",19826,80,1.82 [1.50-2.20],8.39129127005103e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",17353,70,1.00 [0.72-1.41],0.9784150498355022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",17683,70,1.09 [0.84-1.40],0.5225646952697016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACAN,Aggrecan core protein,20079,84,0.74 [0.36-1.52],0.4170831489651541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACE,Angiotensin-converting enzyme,17683,68,3.14 [1.52-6.49],0.0020359981494086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACE2,Angiotensin-converting enzyme 2,19892,84,2.01 [1.54-2.63],3.253798138924668e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACHE,Acetylcholinesterase,17300,68,1.51 [0.76-2.98],0.2398209334163764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACOT13,Acyl-coenzyme A thioesterase 13,17593,70,1.17 [0.95-1.43],0.1363010680998079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,20278,85,0.92 [0.63-1.33],0.6452632944144798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACP1,Low molecular weight phosphotyrosine protein phosphatase,17153,67,0.60 [0.34-1.07],0.0863959193140558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACP5,Tartrate-resistant acid phosphatase type 5,20388,88,2.44 [1.61-3.69],2.348568004042728e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACP6,Lysophosphatidic acid phosphatase type 6,20408,86,0.97 [0.75-1.26],0.8443478723117971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACRBP,Acrosin-binding protein,17598,68,1.28 [0.77-2.12],0.3394109684079755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACRV1,Acrosomal protein SP-10,17153,67,1.41 [1.12-1.76],0.0029660829652875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACSL1,Long-chain-fatty-acid--CoA ligase 1,17070,67,1.36 [0.82-2.26],0.2378803198529506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACTA2,"Actin, aortic smooth muscle",19892,84,2.48 [2.01-3.06],2.843872145367717e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACTN2,Alpha-actinin-2,17070,67,1.81 [1.35-2.44],8.66706256491453e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACTN4,Alpha-actinin-4,19903,84,1.32 [0.83-2.11],0.2441450413219254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACVRL1,Serine/threonine-protein kinase receptor R3,20056,84,6.83 [4.79-9.74],2.356211419710065e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACY1,Aminoacylase-1,20278,85,1.93 [1.47-2.53],2.0321932576399493e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,17070,67,2.05 [1.46-2.89],3.851840137121916e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ACYP1,Acylphosphatase-1,17232,68,0.85 [0.59-1.23],0.3954655682656638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADA,Adenosine deaminase,20478,85,1.50 [0.93-2.44],0.0998584947280219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADA2,Adenosine deaminase 2,20195,84,6.94 [5.02-9.60],1.0152349486150968e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,17153,67,6.17 [4.18-9.09],4.0453261379101605e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,19892,84,2.20 [1.19-4.07],0.0121191925082695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,20091,84,1.92 [1.16-3.19],0.0109891864784289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,20478,85,2.43 [1.32-4.49],0.0045713443624755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,20401,87,2.78 [1.88-4.11],3.1833952644939386e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,17593,70,5.99 [3.79-9.46],1.6357797888479382e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,17153,67,2.55 [1.74-3.74],1.5123801672081387e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,20528,88,1.15 [0.53-2.50],0.7242721142304336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,20178,85,2.60 [1.71-3.97],9.121665734993682e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,19892,84,1.27 [0.77-2.09],0.3537356220827021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,17153,67,2.29 [1.29-4.09],0.0049090650798906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,20360,87,0.67 [0.44-1.01],0.0574158850898893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTSL2,ADAMTS-like protein 2,17688,69,7.44 [5.12-10.81],5.774163065011578e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTSL4,ADAMTS-like protein 4,17228,69,1.40 [0.52-3.76],0.5027282627152486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADAMTSL5,ADAMTS-like protein 5,17683,70,1.92 [1.22-3.01],0.0044989583765012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,19826,80,0.81 [0.41-1.61],0.5479279856289672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADD1,Alpha-adducin,17300,68,0.91 [0.65-1.25],0.5510285398530106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRB3,Adhesion G protein-coupled receptor B3,20056,84,4.09 [2.40-6.97],2.151941452094261e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRD1,Adhesion G-protein coupled receptor D1,17300,68,3.25 [1.94-5.47],8.60718578503823e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE1,Adhesion G protein-coupled receptor E1,17593,70,1.85 [1.28-2.67],0.001152354411554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE2,Adhesion G protein-coupled receptor E2,20361,84,7.21 [4.16-12.49],1.9756532356903952e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRE5,Adhesion G protein-coupled receptor E5,20447,88,4.39 [3.33-5.79],1.2398228993336404e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRF5,Adhesion G protein-coupled receptor F5,17683,70,2.10 [0.90-4.90],0.086749366028212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRG1,Adhesion G-protein coupled receptor G1,20178,85,2.35 [2.01-2.75],1.859494121702992e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRG2,Adhesion G-protein coupled receptor G2,20278,85,0.34 [0.22-0.53],1.435997147328536e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADGRV1,Adhesion G-protein coupled receptor V1,17100,68,0.92 [0.64-1.32],0.6598042870695014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADH1B,All-trans-retinol dehydrogenase,17300,68,1.04 [0.77-1.40],0.7972610061616727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,19892,84,1.14 [0.90-1.45],0.2643837833463747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADIPOQ,Adiponectin,17711,69,0.65 [0.46-0.91],0.0119094389409266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADM,Pro-adrenomedullin,20442,86,32.92 [15.70-69.01],2.210988329545542e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ADRA2A,Alpha-2A adrenergic receptor,17070,67,1.08 [0.77-1.51],0.6627131555747172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AFAP1,Actin filament-associated protein 1,17300,68,1.12 [0.85-1.47],0.4262952898224317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AFM,Afamin,17711,69,0.66 [0.31-1.38],0.2706546701273156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AFP,Alpha-fetoprotein,20021,84,0.51 [0.37-0.70],3.6740135733418405e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGBL2,Cytosolic carboxypeptidase 2,17100,68,0.97 [0.74-1.26],0.8041724221074884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGER,Advanced glycosylation end product-specific receptor,20238,84,1.42 [0.92-2.20],0.1133803550338626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGR2,Anterior gradient protein 2 homolog,19658,82,1.98 [1.69-2.33],7.932877527365529e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGR3,Anterior gradient protein 3,19784,80,1.49 [1.12-1.98],0.0054930386923749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGRN,Agrin,20361,84,3.77 [2.99-4.76],2.743655394662236e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGRP,Agouti-related protein,20478,85,2.62 [1.91-3.60],2.090709946331441e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGT,Angiotensinogen,17683,68,2.38 [1.30-4.35],0.0047944547089446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AGXT,Serine--pyruvate aminotransferase,20278,85,1.85 [1.49-2.30],3.009174098943656e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHCY,Adenosylhomocysteinase,20278,85,1.23 [0.94-1.62],0.1300435161917262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHNAK,Neuroblast differentiation-associated protein AHNAK,17228,69,1.78 [0.93-3.39],0.0810562935308118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHNAK2,Protein AHNAK2,17228,69,2.71 [1.58-4.64],0.0002968782654231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,17598,68,1.02 [0.71-1.47],0.908718189672852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHSG,Alpha-2-HS-glycoprotein,17683,68,0.98 [0.41-2.34],0.9676735778283442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AHSP,Alpha-hemoglobin-stabilizing protein,20254,86,0.74 [0.59-0.94],0.0126412607003823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AIDA,"Axin interactor, dorsalization-associated protein",17188,68,1.26 [1.00-1.59],0.0501264211858719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AIF1,Allograft inflammatory factor 1,19826,80,1.28 [0.87-1.88],0.2139364290086357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AIF1L,Allograft inflammatory factor 1-like,17228,69,1.24 [0.88-1.76],0.2216057531883374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",20147,85,1.36 [1.15-1.62],0.0004701532395539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AK1,Adenylate kinase isoenzyme 1,20278,85,0.60 [0.43-0.82],0.0016095341993898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AK2,"Adenylate kinase 2, mitochondrial",17647,71,1.15 [0.92-1.44],0.2149179393909918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKAP12,A-kinase anchor protein 12,17300,68,0.99 [0.31-3.15],0.9865890262247328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKR1B1,Aldo-keto reductase family 1 member B1,19826,80,1.17 [0.90-1.53],0.2455134658325827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKR1B10,Aldo-keto reductase family 1 member B10,17188,68,1.63 [1.28-2.09],0.00010095275604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKR1C4,Aldo-keto reductase family 1 member C4,19892,84,1.33 [1.00-1.78],0.0499041421427034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKR7L,Aflatoxin B1 aldehyde reductase member 4,17153,67,1.56 [1.20-2.03],0.0008360429075079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKT1S1,Proline-rich AKT1 substrate 1,19826,83,1.10 [0.82-1.48],0.5292755528638927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKT2,RAC-beta serine/threonine-protein kinase,17643,68,1.00 [0.83-1.20],0.9742128455381424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AKT3,RAC-gamma serine/threonine-protein kinase,19744,79,1.02 [0.71-1.45],0.9337846294094232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALCAM,CD166 antigen,20528,88,21.64 [10.06-46.57],3.703643224961567e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALDH1A1,Retinal dehydrogenase 1,20294,86,0.92 [0.65-1.30],0.6248843837829355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALDH2,"Aldehyde dehydrogenase, mitochondrial",17598,68,1.04 [0.65-1.66],0.8699069291344097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",20184,82,1.38 [1.14-1.67],0.0011863204275329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",17643,68,2.18 [1.54-3.07],9.658441785009655e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALMS1,Alstrom syndrome protein 1,17353,70,1.51 [1.05-2.17],0.0244744523328465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALPI,Intestinal-type alkaline phosphatase,17153,67,1.15 [0.96-1.39],0.1312181339288858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ALPP,"Alkaline phosphatase, placental type",20178,85,1.14 [0.95-1.37],0.1635089015100197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMBN,Ameloblastin,19903,84,1.00 [0.55-1.80],0.9872317686680764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMBP,Protein AMBP,20406,86,24.34 [12.39-47.81],1.949028183260977e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,17688,69,1.67 [0.64-4.35],0.2902529581494568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMFR,E3 ubiquitin-protein ligase AMFR,19826,83,1.26 [0.96-1.67],0.0980089634579878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMIGO1,Amphoterin-induced protein 1,17188,68,1.12 [0.72-1.75],0.6162515076684674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMIGO2,Amphoterin-induced protein 2,20178,85,6.00 [2.84-12.69],2.649413523303153e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMN,Protein amnionless,19903,84,1.35 [0.92-1.99],0.1247125906886103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMOT,Angiomotin,17300,68,1.53 [0.86-2.73],0.1499832916666954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMOTL2,Angiomotin-like protein 2,17526,68,1.48 [1.01-2.18],0.0456581278810992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMPD3,AMP deaminase 3,17647,71,0.82 [0.59-1.12],0.2071491102633124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,16543,63,0.85 [0.53-1.38],0.5140149055473692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMY2A,Pancreatic alpha-amylase,19476,84,0.55 [0.37-0.83],0.0037791583811913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AMY2B,Alpha-amylase 2B,18892,82,0.48 [0.32-0.73],0.0005365313380493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANG,Angiogenin,20261,85,2.62 [1.62-4.24],8.564791649316971e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPT1,Angiopoietin-1,20184,84,0.92 [0.73-1.17],0.4963189912190665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPT2,Angiopoietin-2,20442,86,5.06 [3.49-7.34],1.0367630686055709e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL1,Angiopoietin-related protein 1,20001,85,6.56 [3.57-12.08],1.5055422846508635e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL2,Angiopoietin-related protein 2,20293,83,1.90 [1.19-3.05],0.007496815361708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL3,Angiopoietin-related protein 3,20319,85,0.57 [0.33-0.98],0.0413356232154722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL4,Angiopoietin-related protein 4,20325,84,5.65 [3.71-8.62],7.862956919831889e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANGPTL7,Angiopoietin-related protein 7,20442,86,3.76 [2.59-5.47],4.129275540608978e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANK2,Ankyrin-2,17070,67,0.99 [0.71-1.39],0.9732881678563622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,17153,67,1.25 [0.94-1.65],0.1228734717722987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANKRA2,Ankyrin repeat family A protein 2,17033,67,0.84 [0.54-1.31],0.4346483253350173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANKRD54,Ankyrin repeat domain-containing protein 54,19826,80,0.64 [0.42-0.97],0.0373513768461808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,17228,69,1.05 [0.58-1.90],0.8699220224836505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANPEP,Aminopeptidase N,20375,85,2.06 [1.13-3.75],0.0178423372297765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA1,Annexin A1,17200,68,1.40 [0.87-2.28],0.1692011352355226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA10,Annexin A10,19826,83,1.40 [1.15-1.71],0.0007132580794744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA11,Annexin A11,20197,82,1.18 [0.86-1.63],0.3058014173192316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA2,Annexin A2,16952,69,1.24 [0.91-1.69],0.1672775444276592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA3,Annexin A3,20401,87,1.02 [0.78-1.34],0.8902021556369359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA4,Annexin A4,20194,85,0.98 [0.75-1.29],0.897107541453989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ANXA5,Annexin A5,19762,83,2.56 [1.54-4.25],0.0002867969482195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AOC1,Amiloride-sensitive amine oxidase [copper-containing],19903,84,0.66 [0.42-1.04],0.0720332920552926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AOC3,Membrane primary amine oxidase,20401,85,26.75 [14.85-48.16],6.4757362907165585e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AP1G2,AP-1 complex subunit gamma-like 2,17598,68,1.31 [0.99-1.73],0.0580615117478392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AP2B1,AP-2 complex subunit beta,17188,68,1.37 [0.88-2.15],0.1676554277524322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AP3B1,AP-3 complex subunit beta-1,17593,70,1.37 [1.03-1.82],0.0315350605180789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AP3S2,AP-3 complex subunit sigma-2,17647,71,1.55 [1.03-2.34],0.0354794336451616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,20178,85,1.62 [1.15-2.28],0.0053180136801002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APCS,Serum amyloid P-component,17541,69,0.76 [0.50-1.15],0.1874239911767115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,20367,86,0.87 [0.61-1.22],0.4118821270804138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APLP1,Amyloid-like protein 1,20278,85,0.51 [0.35-0.76],0.0010153457193601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOA1,Apolipoprotein A-I,17711,69,0.31 [0.17-0.53],3.3543544707866066e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOA2,Apolipoprotein A-II,17683,68,1.62 [1.03-2.54],0.0361425992300042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOA4,Apolipoprotein A-IV,17711,69,3.34 [2.50-4.47],4.727137298219247e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOB,Apolipoprotein B-100,17683,68,0.96 [0.34-2.68],0.9323926562284772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOBR,Apolipoprotein B receptor,17228,69,0.58 [0.35-0.95],0.0317332105478374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOC1,Apolipoprotein C-I,17681,69,0.34 [0.23-0.50],8.841557315575815e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOD,Apolipoprotein D,16964,69,0.49 [0.33-0.73],0.0005193558155932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOE,Apolipoprotein E,17711,69,0.69 [0.44-1.09],0.1096057632244087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOF,Apolipoprotein F,17683,68,0.41 [0.29-0.59],8.867628788845279e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOH,Beta-2-glycoprotein 1,20294,86,1.20 [0.74-1.96],0.4661819474315836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOL1,Apolipoprotein L1,17683,68,0.49 [0.29-0.82],0.0065281742132087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APOM,Apolipoprotein M,20356,85,0.33 [0.23-0.48],1.278738141411804e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APP,Amyloid-beta precursor protein,20271,85,1.03 [0.77-1.38],0.8391604686330445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APPL2,DCC-interacting protein 13-beta,17300,68,1.04 [0.84-1.29],0.7166835237626537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,APRT,Adenine phosphoribosyltransferase,20043,84,1.46 [0.95-2.26],0.0858065849328524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARAF,Serine/threonine-protein kinase A-Raf,17353,70,1.02 [0.73-1.43],0.9074929434076462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AREG,Amphiregulin,20178,85,4.95 [3.95-6.21],1.7704195752268981e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARF6,ADP-ribosylation factor 6,17593,70,1.03 [0.83-1.26],0.811182545389862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARFIP1,Arfaptin-1,17643,68,1.04 [0.74-1.46],0.8002156408150243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARG1,Arginase-1,20145,84,0.57 [0.39-0.82],0.0029296322042714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARG2,"Arginase-2, mitochondrial",17598,68,1.14 [0.70-1.85],0.6092754020182551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGAP1,Rho GTPase-activating protein 1,19826,80,0.79 [0.51-1.22],0.2856278010512293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGAP25,Rho GTPase-activating protein 25,19826,80,1.16 [0.87-1.54],0.3046972468983776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGAP30,Rho GTPase-activating protein 30,17353,70,1.35 [0.83-2.21],0.2295388485516942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGAP45,Rho GTPase-activating protein 45,17300,68,1.16 [0.88-1.54],0.2948581124741842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGAP5,Rho GTPase-activating protein 5,17033,67,0.96 [0.71-1.29],0.7824183901586943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGEF1,Rho guanine nucleotide exchange factor 1,17647,71,1.11 [0.86-1.44],0.4252403531450285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGEF10,Rho guanine nucleotide exchange factor 10,17643,68,1.18 [0.93-1.50],0.1830793510903472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGEF12,Rho guanine nucleotide exchange factor 12,20224,82,1.17 [0.96-1.41],0.1137278794945139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARHGEF5,Rho guanine nucleotide exchange factor 5,17100,68,1.42 [1.10-1.84],0.006770681152493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARID3A,AT-rich interactive domain-containing protein 3A,17100,68,0.94 [0.53-1.67],0.8298477547437333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARID4B,AT-rich interactive domain-containing protein 4B,19826,83,0.60 [0.33-1.10],0.0974147649098995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARL13B,ADP-ribosylation factor-like protein 13B,17070,67,1.11 [0.80-1.55],0.5256371362398541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,17070,67,1.01 [0.55-1.86],0.9672822465618406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARMCX2,Armadillo repeat-containing X-linked protein 2,17100,68,0.88 [0.57-1.36],0.5647116489493638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARNT,Aryl hydrocarbon receptor nuclear translocator,19903,84,1.29 [0.76-2.20],0.3407882964026277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,17070,67,0.55 [0.29-1.03],0.0599246604523301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARSA,Arylsulfatase A,20294,86,1.13 [0.75-1.69],0.5567745329452927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARSB,Arylsulfatase B,20178,85,1.22 [0.87-1.69],0.2476146794712547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ART3,Ecto-ADP-ribosyltransferase 3,20401,85,2.63 [1.63-4.24],7.285626066288763e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ART5,Ecto-ADP-ribosyltransferase 5,17100,68,0.84 [0.54-1.31],0.4405038199837461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ARTN,Artemin,19903,84,1.12 [0.76-1.65],0.557326248830458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASAH1,Acid ceramidase,17497,69,1.51 [1.12-2.04],0.007586571357424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASAH2,Neutral ceramidase,20091,84,1.30 [0.88-1.92],0.1953393157073447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASGR1,Asialoglycoprotein receptor 1,20091,84,7.41 [5.24-10.47],7.521250024651094e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASGR2,Asialoglycoprotein receptor 2,17683,68,7.27 [3.70-14.28],8.356785255723665e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASPN,Asporin,17683,70,1.70 [0.97-2.99],0.0660240185045578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASPSCR1,Tether containing UBX domain for GLUT4,17643,68,0.95 [0.67-1.35],0.7774453405316881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASRGL1,Isoaspartyl peptidase/L-asparaginase,17228,69,1.03 [0.81-1.30],0.8268692821474064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ASS1,Argininosuccinate synthase,17070,67,0.92 [0.68-1.25],0.6044404366648021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATF2,Cyclic AMP-dependent transcription factor ATF-2,19826,83,1.09 [0.84-1.40],0.5304798995835546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATF4,Cyclic AMP-dependent transcription factor ATF-4,17033,67,0.69 [0.33-1.49],0.3476586801899165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATG16L1,Autophagy-related protein 16-1,17593,70,1.29 [0.99-1.69],0.0624473805412197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATG4A,Cysteine protease ATG4A,19826,80,0.87 [0.62-1.23],0.4246979170937278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATOX1,Copper transport protein ATOX1,20360,87,1.40 [1.05-1.86],0.0209603476651067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,17070,67,1.28 [0.87-1.87],0.2107278449993296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,17070,67,1.74 [1.10-2.74],0.0175174674546291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,17070,67,1.31 [0.77-2.23],0.3176253986610853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP1B4,Protein ATP1B4,17033,67,1.20 [0.70-2.06],0.5150492109365057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP2B4,Plasma membrane calcium-transporting ATPase 4,17070,67,0.86 [0.55-1.35],0.5062491556200113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP5F1D,"ATP synthase subunit delta, mitochondrial",17070,67,0.84 [0.51-1.40],0.502955148131506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP5IF1,"ATPase inhibitor, mitochondrial",20361,84,1.07 [0.89-1.27],0.4815593206276922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP5PO,"ATP synthase subunit O, mitochondrial",19826,83,0.73 [0.44-1.22],0.2291520375255764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP6AP2,Renin receptor,19826,80,1.94 [1.42-2.66],3.799883321282032e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP6V1D,V-type proton ATPase subunit D,20178,85,0.65 [0.29-1.44],0.2862426427568798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP6V1F,V-type proton ATPase subunit F,19793,82,1.07 [0.80-1.44],0.6475807506667912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP6V1G1,V-type proton ATPase subunit G 1,17228,69,1.10 [0.80-1.51],0.5589259494997603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATP6V1G2,V-type proton ATPase subunit G 2,17070,67,1.07 [0.84-1.36],0.5812571800713053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATRAID,All-trans retinoic acid-induced differentiation factor,17593,70,2.45 [1.85-3.25],4.558426162609385e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATRN,"Attractin, Isoform 2",17711,69,1.94 [0.48-7.76],0.3507800098932286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATXN10,Ataxin-10,19826,83,1.17 [0.88-1.53],0.2763305333350665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATXN2,Ataxin-2,17100,68,1.05 [0.87-1.27],0.6058220160909871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATXN2L,Ataxin-2-like protein,17643,68,1.35 [0.89-2.04],0.156904985563177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ATXN3,Ataxin-3,17647,71,0.84 [0.58-1.22],0.3630264508941846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AXIN1,Axin-1,20224,82,1.20 [0.98-1.47],0.0795224707578874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AXL,Tyrosine-protein kinase receptor UFO,20401,85,4.06 [2.16-7.63],1.3517084203655934e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AZI2,5-azacytidine-induced protein 2,17643,68,1.47 [0.99-2.18],0.0533442020640863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,AZU1,Azurocidin,19648,84,0.92 [0.71-1.20],0.545639708333487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B2M,Beta-2-microglobulin,17711,69,1.92 [1.57-2.35],2.021029359642362e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,17070,67,1.65 [0.57-4.75],0.3561153165327291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",17228,69,7.12 [3.92-12.93],1.2000638240413628e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",20361,84,9.46 [5.67-15.77],7.490047962198068e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,B4GAT1,"Beta-1,4-glucuronyltransferase 1",20294,86,1.68 [0.76-3.69],0.1999323469779625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BABAM1,BRISC and BRCA1-A complex member 1,17153,67,1.71 [0.90-3.26],0.1043446483085799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BACH1,Transcription regulator protein BACH1,20224,82,1.36 [1.05-1.76],0.017743127708208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAG3,BAG family molecular chaperone regulator 3,20056,84,1.02 [0.62-1.66],0.9413051685046836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAG4,BAG family molecular chaperone regulator 4,17153,67,1.58 [1.05-2.38],0.0288621725233412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAG6,Large proline-rich protein BAG6,19892,84,1.62 [0.96-2.72],0.0707257399136228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,19826,80,1.98 [1.58-2.48],3.895516365749226e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,19826,80,4.89 [3.36-7.11],1.1486451150947724e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BANK1,B-cell scaffold protein with ankyrin repeats,20224,82,1.17 [0.96-1.41],0.1148359652706416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAP18,Chromatin complexes subunit BAP18,17647,71,1.11 [0.80-1.54],0.5222596409449656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BATF,Basic leucine zipper transcriptional factor ATF-like,17188,68,1.15 [0.91-1.45],0.2567849961547889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BAX,Apoptosis regulator BAX,19797,83,1.20 [0.97-1.50],0.0972967855369762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAM,Basal cell adhesion molecule,20294,86,3.61 [2.36-5.51],2.747640798274236e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAN,Brevican core protein,20091,84,0.33 [0.23-0.48],2.069620085533641e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",17683,70,2.08 [1.13-3.82],0.0184762045131158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",17100,68,0.66 [0.38-1.14],0.1318359451024336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCHE,Cholinesterase,17359,68,0.53 [0.27-1.07],0.0759953438004166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL2,Apoptosis regulator Bcl-2,17593,70,1.51 [1.16-1.96],0.0021353617789031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL2L1,Bcl-2-like protein 1,17647,71,1.06 [0.84-1.34],0.6312621445970452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",20224,82,2.18 [1.26-3.79],0.0053654189156012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL2L15,Bcl-2-like protein 15,17153,67,1.46 [1.04-2.05],0.0309620770142049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL7A,B-cell CLL/lymphoma 7 protein family member A,17033,67,1.01 [0.70-1.46],0.9547695550960432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCL7B,B-cell CLL/lymphoma 7 protein family member B,17598,68,0.57 [0.29-1.11],0.0993433437897822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BCR,Breakpoint cluster region protein,20224,82,1.27 [1.02-1.57],0.0298674421214182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BDNF,Brain-derived neurotrophic factor,17688,69,0.87 [0.66-1.14],0.3182270152625859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BECN1,Beclin-1,17228,69,1.45 [1.00-2.09],0.0470510401379941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BEX3,Protein BEX3,17033,67,1.33 [0.90-1.96],0.1488522199935461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BGLAP,Osteocalcin,17688,69,0.71 [0.55-0.93],0.0110137271546277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BGN,Biglycan,19784,80,1.08 [0.91-1.28],0.3658730391395421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BHLHE40,Class E basic helix-loop-helix protein 40,17100,68,1.14 [0.85-1.53],0.3936884739678764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,17070,67,1.76 [0.75-4.14],0.1940881265840248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BID,BH3-interacting domain death agonist,20224,82,1.03 [0.77-1.38],0.8542107432755899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BIN2,Bridging integrator 2,20294,86,1.06 [0.86-1.31],0.5898024247182903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BIRC2,Baculoviral IAP repeat-containing protein 2,19826,80,1.29 [0.96-1.73],0.090023216168119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BLMH,Bleomycin hydrolase,20528,88,0.63 [0.35-1.15],0.1318412463042574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BLNK,B-cell linker protein,17153,67,1.19 [0.68-2.08],0.5399337753232033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,17100,68,0.98 [0.70-1.36],0.904712623441216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,17647,71,1.23 [0.71-2.12],0.4617348370546739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BLVRB,Flavin reductase,20294,86,0.70 [0.51-0.96],0.0262733756131137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMP10,Bone morphogenetic protein 10,17300,68,4.91 [2.10-11.46],0.000234702710549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMP4,Bone morphogenetic protein 4,20056,84,1.58 [1.10-2.28],0.0140443672963848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMP6,Bone morphogenetic protein 6,19866,84,1.73 [1.11-2.69],0.0145153033449572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BMPER,BMP-binding endothelial regulator protein,17300,68,9.88 [5.98-16.34],4.2960835946476884e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,17683,70,1.68 [0.91-3.10],0.0998508761582264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,17153,67,2.68 [1.82-3.94],6.068517097325938e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BOC,Brother of CDO,19892,84,9.41 [5.13-17.25],4.4609541838755814e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BOLA1,BolA-like protein 1,17100,68,1.38 [0.95-1.99],0.0910289577236047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BOLA2_BOLA2B,BolA-like protein 2,17228,69,0.74 [0.48-1.16],0.1909855796874593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BPIFA2,BPI fold-containing family A member 2,16623,67,0.83 [0.66-1.04],0.1045936461871696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BPIFB1,BPI fold-containing family B member 1,20229,88,0.73 [0.55-0.96],0.0246142947129594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BPIFB2,BPI fold-containing family B member 2,17642,70,0.92 [0.67-1.28],0.6337883500098537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRAP,BRCA1-associated protein,17443,70,1.07 [0.87-1.33],0.5187945467588007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRD1,Bromodomain-containing protein 1,17353,70,1.35 [0.69-2.65],0.3847457246327472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRD2,Bromodomain-containing protein 2,17100,68,1.04 [0.52-2.06],0.9180654928383362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRD3,Bromodomain-containing protein 3,17070,67,1.25 [0.81-1.94],0.3044403312233537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRDT,Bromodomain testis-specific protein,17070,67,1.07 [0.57-2.03],0.8282162523938299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRK1,Protein BRICK1,19826,83,1.14 [0.75-1.76],0.5374831711122676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRME1,Break repair meiotic recombinase recruitment factor 1,17100,68,0.48 [0.24-0.97],0.0393281647605784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BRSK2,Serine/threonine-protein kinase BRSK2,17643,68,1.68 [0.99-2.83],0.0527045265541836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BSG,Basigin,20449,85,10.06 [5.38-18.84],5.337502286350593e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BSND,Barttin,17033,67,1.10 [0.57-2.10],0.7808877977274437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,20440,87,2.87 [1.50-5.47],0.00140345615383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BST2,Bone marrow stromal antigen 2,20440,87,1.61 [1.24-2.10],0.0004398252981788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTC,Probetacellulin,19826,80,0.94 [0.70-1.25],0.6516262838989315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTD,Biotinidase,17711,69,1.90 [0.59-6.17],0.2842639787722753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTLA,B- and T-lymphocyte attenuator,17033,67,0.95 [0.70-1.29],0.7399852643697913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTN1A1,Butyrophilin subfamily 1 member A1,17560,68,1.11 [0.70-1.77],0.6555851465481333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTN2A1,Butyrophilin subfamily 2 member A1,20361,84,6.82 [4.63-10.04],2.7544435016877845e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTN3A2,Butyrophilin subfamily 3 member A2,20224,82,2.09 [1.62-2.69],1.0618371983864569e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,BTNL10,Butyrophilin-like protein 10,17033,67,1.08 [0.62-1.89],0.7766231932896815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C19orf12,Protein C19orf12,19826,83,1.19 [0.92-1.53],0.1843324009926576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1GALT1C1,C1GALT1-specific chaperone 1,17070,67,2.17 [1.37-3.44],0.0010137026669804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QA,Complement C1q subcomponent subunit A,20383,84,5.90 [3.12-11.15],4.7013493299042633e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",17643,68,0.79 [0.51-1.21],0.2761879216843876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QL2,Complement C1q-like protein 2,17153,67,0.58 [0.33-1.03],0.0615199471860809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,20401,85,2.92 [2.16-3.95],3.0926384181134968e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,17300,68,1.98 [1.04-3.76],0.0370917431444334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,17643,68,1.70 [1.05-2.77],0.0314433593935533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,17267,68,0.94 [0.59-1.51],0.8006454192084869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1R,Complement C1r subcomponent,17711,69,0.70 [0.30-1.63],0.407359243715353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1RL,Complement C1r subcomponent-like protein,17676,69,5.48 [1.60-18.71],0.0066599497516316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C1S,Complement C1s subcomponent,17711,69,0.46 [0.15-1.34],0.1544176069209288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C2,Complement C2,20356,85,2.87 [1.07-7.73],0.0368110203423013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C2CD2L,Phospholipid transfer protein C2CD2L,19793,82,1.53 [1.08-2.16],0.0159807786381525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C2orf69,UPF0565 protein C2orf69,17188,68,1.16 [0.85-1.58],0.3360295999550506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C3,Complement C3,16790,66,1.04 [0.60-1.81],0.8864533843553855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C4BPB,C4b-binding protein beta chain,20360,87,0.72 [0.44-1.17],0.1824954372984203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C5,Complement C5,17711,69,2.89 [0.66-12.70],0.159707011215495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C7,Complement component C7,17271,69,17.15 [10.25-28.69],2.5936138129974048e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C7orf50,Uncharacterized protein C7orf50,17647,71,0.68 [0.20-2.29],0.5333510074177645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C8B,Complement component C8 beta chain,17711,69,0.83 [0.39-1.77],0.6258011128118951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C9,Complement component C9,17683,68,0.94 [0.62-1.43],0.7833844188127717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,C9orf40,Uncharacterized protein C9orf40,17593,70,0.71 [0.53-0.96],0.0234716088762384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA1,Carbonic anhydrase 1,19849,83,0.54 [0.38-0.76],0.0003750218100351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA11,Carbonic anhydrase-related protein 11,19826,80,1.56 [1.01-2.39],0.0437038706716684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA12,Carbonic anhydrase 12,20178,85,7.42 [5.24-10.52],2.027208864924208e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA13,Carbonic anhydrase 13,20073,84,1.03 [0.85-1.24],0.7855170202360192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA14,Carbonic anhydrase 14,20442,86,1.44 [0.88-2.37],0.1445349113086149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA2,Carbonic anhydrase 2,20213,86,0.63 [0.47-0.85],0.0025020297128529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA3,Carbonic anhydrase 3,20494,87,1.58 [1.17-2.13],0.0025788954351582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA4,Carbonic anhydrase 4,20528,88,1.55 [0.71-3.38],0.2684197272067418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA5A,"Carbonic anhydrase 5A, mitochondrial",19892,84,1.51 [1.26-1.81],7.152366380382446e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA6,Carbonic anhydrase 6,20239,86,0.65 [0.48-0.88],0.0059751092984986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA7,Carbonic anhydrase 7,17353,70,1.67 [1.06-2.63],0.0258118428848193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA8,Carbonic anhydrase-related protein,17153,67,1.70 [0.95-3.04],0.073458687185803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CA9,Carbonic anhydrase 9,20442,86,1.86 [1.33-2.61],0.0002858631883378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CABP2,Calcium-binding protein 2,17188,68,1.31 [0.93-1.84],0.1204752516492394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,17100,68,0.60 [0.26-1.40],0.2366920795598108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,17070,67,0.70 [0.40-1.21],0.1990434420020854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,17100,68,0.81 [0.52-1.26],0.3433766809463571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,17643,68,1.28 [0.97-1.68],0.080813462475295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CACYBP,Calcyclin-binding protein,17273,68,1.13 [0.89-1.42],0.3114637420860906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CADPS,Calcium-dependent secretion activator 1,17188,68,0.94 [0.52-1.70],0.8320015557227584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALB1,Calbindin,20178,85,1.67 [1.15-2.44],0.0074986385558224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALB2,Calretinin,19826,83,1.86 [1.47-2.36],2.168036193853338e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALCA,Calcitonin,20058,83,1.63 [1.30-2.03],1.578958738388175e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALCB,Calcitonin gene-related peptide 2,17647,71,2.03 [1.49-2.76],6.3544999805762105e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,20373,86,1.17 [0.97-1.41],0.0939861901986397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,17228,69,1.28 [0.95-1.73],0.1092408062188463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CALY,Neuron-specific vesicular protein calcyon,17070,67,0.96 [0.50-1.86],0.914350189359043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,19826,80,1.60 [1.07-2.37],0.0210621193057111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,17188,68,1.37 [0.94-2.00],0.0992109777492566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,17643,68,1.20 [0.97-1.49],0.0884901217807383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CANT1,Soluble calcium-activated nucleotidase 1,20206,85,9.16 [4.02-20.85],1.3387365856074037e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAPG,Macrophage-capping protein,20098,85,1.41 [1.03-1.93],0.0322610163262832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAPN3,Calpain-3,17598,68,1.37 [0.81-2.33],0.2348027932790176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAPS,Calcyphosin,17647,71,1.07 [0.88-1.31],0.4772434703319738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CARHSP1,Calcium-regulated heat-stable protein 1,19826,83,0.45 [0.30-0.69],0.0001986158559043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASC3,Protein CASC3,17188,68,1.46 [0.87-2.44],0.1551885655503573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP1,Caspase-1,19826,83,0.91 [0.69-1.21],0.5098776207630935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP10,Caspase-10,19826,83,1.00 [0.76-1.33],0.9791133938320938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP2,Caspase-2,20224,82,1.25 [0.95-1.66],0.1171523728944668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP3,Caspase-3,20528,88,1.11 [0.89-1.38],0.350515926014745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP4,Caspase-4,17353,70,1.01 [0.88-1.16],0.8759690777488769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP7,Caspase-7,17647,71,1.04 [0.79-1.36],0.794322499942322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP8,Caspase-8,20372,86,0.77 [0.56-1.08],0.1290397221758895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASP9,Caspase-9,17153,67,0.90 [0.61-1.32],0.5837930915550911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CASQ2,Calsequestrin-2,17070,67,1.09 [0.69-1.73],0.7055181926205369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CAT,Catalase,17431,66,0.53 [0.33-0.86],0.0097606387863786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CBLIF,Cobalamin binding intrinsic factor,20237,85,1.31 [1.02-1.68],0.0315941794349058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CBLN1,Cerebellin-1,17100,68,0.93 [0.70-1.22],0.5897579429986448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CBLN4,Cerebellin-4,20442,86,1.13 [0.66-1.93],0.6577687636319127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CBS,Cystathionine beta-synthase,17228,69,1.48 [1.02-2.16],0.0394801832675209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CBX2,Chromobox protein homolog 2,17070,67,1.34 [0.90-2.01],0.1521141113880721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,20091,84,1.11 [0.85-1.44],0.4370836344259071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCAR2,Cell cycle and apoptosis regulator protein 2,17647,71,0.87 [0.52-1.45],0.5874518086172944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCDC134,Coiled-coil domain-containing protein 134,17598,68,1.35 [0.89-2.02],0.1538255118752771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCDC28A,Coiled-coil domain-containing protein 28A,17188,68,0.85 [0.38-1.92],0.7012322802591058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCDC50,Coiled-coil domain-containing protein 50,17643,68,1.15 [0.89-1.49],0.2903650466346485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCDC80,Coiled-coil domain-containing protein 80,20278,85,3.02 [2.10-4.35],2.344430366482278e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,17228,69,1.35 [0.95-1.91],0.0893711080742331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL11,Eotaxin,20478,85,3.03 [1.81-5.07],2.4573436164975577e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL13,C-C motif chemokine 13,20446,85,1.03 [0.78-1.37],0.8309014612256118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL14,C-C motif chemokine 14,20261,85,2.12 [1.52-2.95],9.761069469521736e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL15,C-C motif chemokine 15,20528,88,4.14 [2.94-5.83],3.5049744775000283e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL16,C-C motif chemokine 16,20528,88,2.64 [1.82-3.82],2.7551257282345454e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL17,C-C motif chemokine 17,20239,84,1.09 [0.89-1.35],0.4066068125300816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL18,C-C motif chemokine 18,20019,84,1.26 [1.00-1.61],0.0532507824435763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL19,C-C motif chemokine 19,20440,87,1.13 [1.00-1.28],0.0534595010923812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL2,C-C motif chemokine 2,20056,84,1.00 [0.70-1.44],0.9851643777414965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL20,C-C motif chemokine 20,20478,85,1.51 [1.30-1.75],5.2563756716324456e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL21,C-C motif chemokine 21,20361,84,2.21 [1.77-2.76],3.006094663049528e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL22,C-C motif chemokine 22,20098,84,1.46 [1.03-2.06],0.0318657044942166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL23,C-C motif chemokine 23,20361,84,1.72 [1.09-2.72],0.0196692047886401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL24,C-C motif chemokine 24,20325,84,1.06 [0.84-1.33],0.6443222168368947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL25,C-C motif chemokine 25,20478,85,2.99 [2.08-4.31],3.6693130457878927e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL26,C-C motif chemokine 26,20224,82,0.92 [0.74-1.15],0.4550985288437352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL27,C-C motif chemokine 27,20278,85,0.89 [0.65-1.23],0.4810679587980692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL28,C-C motif chemokine 28,20152,82,1.44 [1.07-1.93],0.0148356081843543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL3,C-C motif chemokine 3,20224,82,1.45 [1.21-1.74],7.021509155741556e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL4,C-C motif chemokine 4,20303,84,1.12 [0.88-1.44],0.3620736056985553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL5,C-C motif chemokine 5,20401,85,1.08 [0.89-1.31],0.41751225344839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL7,C-C motif chemokine 7,20224,82,1.79 [1.44-2.22],1.4475112517422488e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCL8,C-C motif chemokine 8,20406,86,1.12 [0.81-1.54],0.498079496674035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN1,CCN family member 1,20136,85,1.26 [0.96-1.65],0.0956792264249604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN2,CCN family member 2,20244,84,0.98 [0.68-1.40],0.905029327239246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN3,CCN family member 3,20496,88,4.02 [2.87-5.63],4.98046283876072e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN4,CCN family member 4,20442,86,4.04 [2.74-5.94],1.4152556560394632e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCN5,CCN family member 5,20294,86,4.64 [3.05-7.06],7.703824407824024e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCND2,G1/S-specific cyclin-D2,17353,70,1.12 [0.60-2.08],0.7240937216392314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCNE1,G1/S-specific cyclin-E1,17153,67,1.19 [0.96-1.47],0.1080335812196865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCS,Copper chaperone for superoxide dismutase,20091,84,0.44 [0.28-0.68],0.0002885006918233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CCT5,T-complex protein 1 subunit epsilon,19826,80,1.16 [0.75-1.78],0.5055381545632753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD101,Immunoglobulin superfamily member 2,17593,70,1.62 [0.95-2.76],0.0744403661759161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD109,CD109 antigen,20294,86,5.03 [2.82-8.95],4.1049233631647375e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD14,Monocyte differentiation antigen CD14,19912,85,3.67 [2.50-5.37],2.4909833571206927e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD160,CD160 antigen,20478,85,3.28 [2.44-4.42],5.085438456958322e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,20401,85,2.60 [1.77-3.82],1.034818108355e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD164,Sialomucin core protein 24,20294,86,1.48 [0.81-2.70],0.1974393325788737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD164L2,CD164 sialomucin-like 2 protein,17188,68,1.04 [0.55-1.96],0.9076580978594272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD177,CD177 antigen,20264,86,1.14 [0.98-1.34],0.0962955614989296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD1C,T-cell surface glycoprotein CD1c,20360,87,0.37 [0.22-0.60],6.800231648869893e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD2,T-cell surface antigen CD2,17070,67,1.54 [1.07-2.20],0.0193682469845442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD200,OX-2 membrane glycoprotein,20224,82,2.33 [1.34-4.05],0.0027623057102363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD200R1,Cell surface glycoprotein CD200 receptor 1,20164,82,1.48 [0.86-2.53],0.1551270934517529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD207,C-type lectin domain family 4 member K,19818,83,2.73 [1.69-4.42],4.008366123021544e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD209,CD209 antigen,20339,88,1.12 [0.68-1.82],0.6589359672868538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD22,B-cell receptor CD22,20478,85,1.79 [1.28-2.51],0.0006294486283346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD226,CD226 antigen,17153,67,1.49 [0.86-2.58],0.1567734485936138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD244,Natural killer cell receptor 2B4,20478,85,4.58 [2.53-8.30],5.175140682491811e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD248,Endosialin,17688,69,0.55 [0.31-1.00],0.0513234802533182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD27,CD27 antigen,20360,87,4.12 [3.25-5.22],1.240077956845764e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD274,Programmed cell death 1 ligand 1,20091,84,3.97 [2.94-5.37],2.1112606304984781e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD276,CD276 antigen,20270,84,11.97 [7.93-18.07],3.086112390421529e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD28,T-cell-specific surface glycoprotein CD28,19826,80,2.79 [2.22-3.52],2.8499082437108626e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD2AP,CD2-associated protein,20278,85,1.02 [0.76-1.37],0.8842611411601673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300A,CMRF35-like molecule 8,17300,68,6.57 [3.67-11.77],2.2865727927115663e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300C,CMRF35-like molecule 6,20440,87,4.51 [3.14-6.49],4.6307704049862425e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300E,CMRF35-like molecule 2,20374,85,4.37 [3.14-6.08],1.9752310547323097e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300LF,CMRF35-like molecule 1,20442,86,2.10 [1.47-3.00],4.879120371605174e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD300LG,CMRF35-like molecule 9,20294,86,2.15 [1.32-3.49],0.0020625266085536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD302,CD302 antigen,20178,85,6.43 [4.85-8.52],1.8996382573880115e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD33,Myeloid cell surface antigen CD33,20360,87,1.11 [0.87-1.41],0.3869544769051498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD34,Hematopoietic progenitor cell antigen CD34,20381,86,0.49 [0.22-1.07],0.0721948401102025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD36,Platelet glycoprotein 4,17153,67,1.93 [1.20-3.09],0.0063771256356428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,20178,85,6.36 [4.03-10.04],2.004516426664991e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD3D,T-cell surface glycoprotein CD3 delta chain,17100,68,0.83 [0.39-1.77],0.6249779435180925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD3E,T-cell surface glycoprotein CD3 epsilon chain,17353,70,1.12 [0.64-1.96],0.6906585709715085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD3G,T-cell surface glycoprotein CD3 gamma chain,17153,67,1.06 [0.82-1.37],0.6528404002213988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD4,T-cell surface glycoprotein CD4,20192,82,2.89 [2.18-3.83],1.244012619677627e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD40,Tumor necrosis factor receptor superfamily member 5,20267,84,2.28 [1.62-3.19],1.8486971652158708e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD40LG,CD40 ligand,20478,85,0.97 [0.76-1.24],0.8259246654251433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD46,Membrane cofactor protein,20198,85,4.50 [2.98-6.79],8.808734416999686e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD48,CD48 antigen,20325,84,5.35 [3.48-8.23],2.400735369855333e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD5,T-cell surface glycoprotein CD5,20406,86,2.12 [1.73-2.61],8.668620504980175e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD55,Complement decay-accelerating factor,19604,81,4.19 [2.88-6.09],5.92969006089512e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD58,Lymphocyte function-associated antigen 3,20244,84,0.85 [0.28-2.55],0.7728104496768209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD59,CD59 glycoprotein,19600,85,6.19 [4.26-9.00],1.4162176043221978e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD5L,CD5 antigen-like,17611,69,1.46 [0.90-2.38],0.1270835450128842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD6,T-cell differentiation antigen CD6,20449,85,0.91 [0.63-1.31],0.6186498265800098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD63,CD63 antigen,20056,84,1.67 [1.13-2.47],0.0108668597880156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD69,Early activation antigen CD69,20197,85,1.16 [0.93-1.45],0.1909446317180841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD7,T-cell antigen CD7,17114,67,2.99 [2.22-4.03],5.225506964127e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD70,CD70 antigen,20224,82,2.60 [1.89-3.57],3.528262060120853e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD72,B-cell differentiation antigen CD72,17300,68,2.46 [1.77-3.40],5.8622377998460936e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD74,HLA class II histocompatibility antigen gamma chain,20440,87,7.34 [5.00-10.76],1.9184900353035822e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,20478,85,2.91 [2.34-3.64],2.56683176445512e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD80,T-lymphocyte activation antigen CD80,17683,70,4.08 [2.82-5.92],1.1871351003865473e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD82,CD82 antigen,17353,70,1.20 [0.74-1.97],0.4579948628164422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD83,CD83 antigen,20224,82,5.10 [3.55-7.34],1.3858141762268397e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD84,SLAM family member 5,20224,82,1.63 [0.87-3.07],0.126717058983886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD86,T-lymphocyte activation antigen CD86,17593,70,0.99 [0.45-2.16],0.97153404099583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,20440,87,1.84 [1.37-2.47],5.592928915630534e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD93,Complement component C1q receptor,19536,81,3.58 [2.04-6.28],8.557821168769606e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD99,CD99 antigen,20294,86,9.65 [5.50-16.94],2.9291329337868863e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CD99L2,CD99 antigen-like protein 2,20294,86,5.43 [2.79-10.56],6.216219135014081e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDA,Cytidine deaminase,17642,70,0.74 [0.43-1.25],0.2559081906413964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDAN1,Codanin-1,17647,71,1.21 [0.55-2.65],0.642385608158053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC123,Cell division cycle protein 123 homolog,17033,67,0.99 [0.68-1.45],0.9752972032741498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC25A,M-phase inducer phosphatase 1,17033,67,0.59 [0.30-1.18],0.1383584607595409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC26,Anaphase-promoting complex subunit CDC26,17555,70,1.31 [0.95-1.80],0.100027397658141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC27,Cell division cycle protein 27 homolog,19826,80,1.51 [1.13-2.01],0.0053163279446577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC37,Hsp90 co-chaperone Cdc37,20360,87,1.06 [0.85-1.33],0.6008842055591522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDC42BPB,Serine/threonine-protein kinase MRCK beta,17593,70,1.22 [0.98-1.51],0.0722338719882316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDCP1,CUB domain-containing protein 1,20091,84,2.37 [1.81-3.11],4.9006148719647e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH1,Cadherin-1,19648,82,0.64 [0.33-1.21],0.1673232753115959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH15,Cadherin-15,20407,86,1.70 [1.37-2.11],1.590500400807145e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH17,Cadherin-17,20278,85,2.17 [1.73-2.72],2.6004971582936803e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH2,Cadherin-2,20278,85,4.47 [2.63-7.59],2.9946654873508265e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH22,Cadherin-22,17353,70,1.08 [0.50-2.32],0.8468113808555139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH23,Cadherin-23,17647,71,1.20 [0.50-2.91],0.6789531043079545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH3,Cadherin-3,20440,87,3.54 [2.38-5.25],3.484840544555594e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH4,Cadherin-4,17100,68,1.10 [0.70-1.73],0.6725428741462716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH5,Cadherin-5,20528,88,2.09 [1.15-3.80],0.0159399435842065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDH6,Cadherin-6,20278,85,3.43 [2.45-4.82],1.0362755200644418e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDHR1,Cadherin-related family member 1,19826,83,0.75 [0.47-1.22],0.2462060798295033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDHR2,Cadherin-related family member 2,20178,85,1.21 [0.89-1.65],0.2275767742801395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDHR5,Cadherin-related family member 5,20278,85,0.69 [0.42-1.12],0.1310143623426708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDK1,Cyclin-dependent kinase 1,17033,67,1.60 [0.83-3.08],0.1571989610188474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,17643,68,1.28 [0.89-1.84],0.1761786331409126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDKL5,Cyclin-dependent kinase-like 5,17100,68,0.72 [0.43-1.21],0.2131184935323744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDKN1A,Cyclin-dependent kinase inhibitor 1,20178,85,1.31 [1.10-1.57],0.0029541942913284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,20178,85,1.07 [0.87-1.32],0.5152186511178272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDNF,Cerebral dopamine neurotrophic factor,20178,85,2.19 [1.62-2.96],3.0480602616492385e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,20297,84,3.36 [1.56-7.25],0.0019934359524186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CDSN,Corneodesmosin,20421,85,2.09 [1.39-3.13],0.0003953130183575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,20330,87,2.14 [0.91-5.06],0.0826118322047474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,17593,70,0.80 [0.60-1.07],0.1389810639816699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,17353,70,1.19 [0.91-1.55],0.2039277709659157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,17593,70,2.50 [1.66-3.78],1.3131648951254486e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,17353,70,1.18 [0.79-1.76],0.4119080440063467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,20224,82,1.28 [1.04-1.58],0.0199431360833226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,19826,80,0.84 [0.54-1.31],0.4413068498062266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,19583,78,1.53 [1.15-2.02],0.002993181181315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,17688,69,1.66 [1.20-2.30],0.0021527094895094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,19892,84,2.00 [1.45-2.76],2.12489050123427e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEBPA,CCAAT/enhancer-binding protein alpha,17153,67,1.57 [0.96-2.57],0.0746119284620591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEBPB,CCAAT/enhancer-binding protein beta,19892,84,1.28 [0.84-1.96],0.2530582541982991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CELA2A,Chymotrypsin-like elastase family member 2A,17688,69,0.60 [0.43-0.85],0.0038272786745474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CELA3A,Chymotrypsin-like elastase family member 3A,20497,88,0.65 [0.48-0.89],0.0075005769321494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,17300,68,2.22 [1.06-4.65],0.035469299458676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEMIP2,Cell surface hyaluronidase,17153,67,1.49 [0.98-2.28],0.063521646672919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEND1,Cell cycle exit and neuronal differentiation protein 1,17100,68,1.06 [0.74-1.51],0.7636636452843443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CENPF,Centromere protein F,17353,70,0.88 [0.58-1.35],0.5592534458587627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CENPJ,Centromere protein J,17353,70,1.26 [0.98-1.62],0.0730380064541705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP112,Centrosomal protein of 112 kDa,17070,67,1.28 [0.84-1.96],0.2458449556030296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP152,Centrosomal protein of 152 kDa,17033,67,1.26 [0.78-2.02],0.3484661035274222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP164,Centrosomal protein of 164 kDa,19903,84,0.96 [0.71-1.30],0.8005200308228193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP170,Centrosomal protein of 170 kDa,17228,69,1.21 [0.94-1.57],0.1456270559280635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP20,Centrosomal protein 20,19826,80,1.24 [0.96-1.60],0.1013242193508462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP290,Centrosomal protein of 290 kDa,17353,70,1.19 [0.81-1.73],0.3772643786777827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP350,Centrosome-associated protein 350,17033,67,0.75 [0.39-1.41],0.3686023695694255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP43,Centrosomal protein 43,19731,83,1.23 [0.94-1.62],0.1310172464688639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CEP85,Centrosomal protein of 85 kDa,19826,80,1.33 [1.00-1.78],0.0495270275110166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CERT,Ceramide transfer protein,19826,83,1.00 [0.72-1.39],0.9850038430300369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CES1,Liver carboxylesterase 1,20344,87,1.17 [0.95-1.44],0.1420418197258713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CES2,Cocaine esterase,20178,85,1.51 [1.12-2.05],0.0072185886157719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CES3,Carboxylesterase 3,20178,85,0.89 [0.67-1.19],0.4402798820486928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CETN2,Centrin-2,19826,83,1.13 [0.85-1.49],0.3991968571870438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CETN3,Centrin-3,17593,70,1.06 [0.79-1.43],0.6820331573650658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFB,Complement factor B,17401,69,1.76 [0.84-3.68],0.1345068305534938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFC1,Cryptic protein,19826,80,2.42 [1.81-3.22],2.0765379114552584e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFD,Complement factor D,17711,69,5.39 [3.11-9.34],1.969587509752082e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFH,Complement factor H,16677,66,1.65 [0.55-4.93],0.3665651344937115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFHR2,Complement factor H-related protein 2,17580,68,1.38 [0.87-2.18],0.1663972621773349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFHR4,Complement factor H-related protein 4,17678,69,0.64 [0.48-0.85],0.0017617508579409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFHR5,Complement factor H-related protein 5,17448,68,0.66 [0.40-1.07],0.090654391908377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFI,Complement factor I,17711,69,3.64 [1.08-12.32],0.0376563189759072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CFP,Properdin,17711,69,0.33 [0.11-1.01],0.0526325403694032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGA,Glycoprotein hormones alpha chain,20294,86,1.75 [1.36-2.25],1.571638533708231e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,17683,68,1.23 [0.66-2.30],0.5155401430965908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGN,Cingulin,17188,68,0.94 [0.53-1.65],0.8233296612402486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CGREF1,Cell growth regulator with EF hand domain protein 1,20278,85,3.55 [2.37-5.30],6.54464928022599e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,19826,80,1.00 [0.72-1.39],0.9945253580311956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHAD,Chondroadherin,17300,68,0.45 [0.33-0.60],8.156162772408832e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",17647,71,2.38 [1.90-2.97],3.653294549010472e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHCHD6,MICOS complex subunit MIC25,17598,68,3.00 [2.16-4.15],4.3452154004313086e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHEK2,Serine/threonine-protein kinase Chk2,19892,84,0.72 [0.39-1.33],0.2954933649033763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHGA,Chromogranin-A,17688,69,1.76 [1.50-2.06],2.8015030810095535e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHGB,Secretogranin-1,20378,86,2.89 [2.01-4.16],8.866165931379601e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHI3L1,Chitinase-3-like protein 1,19885,82,2.08 [1.75-2.48],1.894569320541424e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHIT1,Chitotriosidase-1,20373,87,1.00 [0.89-1.12],0.988998792774212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHL1,Neural cell adhesion molecule L1-like protein,20372,85,1.41 [0.77-2.59],0.2648359852440257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHM,Rab proteins geranylgeranyltransferase component A 1,17188,68,1.02 [0.69-1.49],0.9267752986116584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHMP1A,Charged multivesicular body protein 1a,20091,84,1.00 [0.78-1.29],0.9740371662189368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHMP6,Charged multivesicular body protein 6,17683,70,1.06 [0.71-1.59],0.7765592424482087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHP1,Calcineurin B homologous protein 1,17100,68,1.04 [0.75-1.43],0.8231420043600384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHRDL1,Chordin-like protein 1,20325,84,5.66 [3.37-9.51],5.914073115668696e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHRDL2,Chordin-like protein 2,20278,85,1.11 [0.74-1.66],0.624431684583785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CHRM1,Muscarinic acetylcholine receptor M1,17188,68,1.37 [0.81-2.34],0.2427509168545775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CIAPIN1,Anamorsin,20360,87,1.19 [0.87-1.63],0.2705435878771444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CILP,Cartilage intermediate layer protein 1,17688,69,5.78 [3.92-8.51],8.170074811427131e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CINP,Cyclin-dependent kinase 2-interacting protein,17353,70,1.07 [0.67-1.70],0.7883517009436727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CIRBP,Cold-inducible RNA-binding protein,17593,70,1.09 [0.85-1.39],0.5011747298647479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CIT,Citron Rho-interacting kinase,17188,68,1.21 [0.74-1.98],0.4475080199752745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CKAP4,Cytoskeleton-associated protein 4,20391,85,5.40 [4.07-7.15],6.044659132371185e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CKB,Creatine kinase B-type,17688,69,2.06 [1.42-2.98],0.0001237571141838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",20214,84,1.57 [1.17-2.12],0.002745165808657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLASP1,CLIP-associating protein 1,17033,67,1.05 [0.76-1.46],0.7652008923302926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLC,Galectin-10,20242,85,1.27 [0.98-1.66],0.0739270850009775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC10A,C-type lectin domain family 10 member A,20091,84,2.60 [1.52-4.45],0.000516189930735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC11A,C-type lectin domain family 11 member A,20261,85,1.14 [0.77-1.69],0.5152066112792928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC12A,C-type lectin domain family 12 member A,17153,67,4.31 [2.12-8.79],5.74954292518553e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC14A,C-type lectin domain family 14 member A,20294,86,4.81 [3.07-7.53],6.682601009618466e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC1A,C-type lectin domain family 1 member A,19892,84,4.10 [2.66-6.31],1.4943351111500446e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC1B,C-type lectin domain family 1 member B,20440,87,1.12 [0.92-1.37],0.248415790638675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC2L,C-type lectin domain family 2 member L,17188,68,1.30 [0.87-1.96],0.2044052791067143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC3B,Tetranectin,17299,69,0.34 [0.19-0.59],0.0001515687349566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4A,C-type lectin domain family 4 member A,20224,82,0.32 [0.21-0.49],2.3811057405464945e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4C,C-type lectin domain family 4 member C,20224,82,0.69 [0.47-1.02],0.0613354640427619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4D,C-type lectin domain family 4 member D,20224,82,1.91 [1.44-2.54],6.909594245328485e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4G,C-type lectin domain family 4 member G,20224,82,1.29 [0.71-2.32],0.4046222793517829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC4M,C-type lectin domain family 4 member M,17655,69,0.65 [0.40-1.06],0.0844720055610928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC5A,C-type lectin domain family 5 member A,20221,85,3.78 [2.23-6.42],8.654412103838025e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC6A,C-type lectin domain family 6 member A,19826,80,2.60 [1.84-3.68],6.400382055808742e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLEC7A,C-type lectin domain family 7 member A,20478,85,2.91 [1.96-4.34],1.386411860055068e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLGN,Calmegin,17188,68,2.01 [1.52-2.66],8.492629147700906e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLIC5,Chloride intracellular channel protein 5,17188,68,1.15 [0.60-2.21],0.665161455214794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLINT1,Clathrin interactor 1,17033,67,0.94 [0.55-1.60],0.8132476377816508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLIP2,CAP-Gly domain-containing linker protein 2,20224,82,1.14 [0.96-1.36],0.1472506931676055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLMP,CXADR-like membrane protein,20442,86,9.26 [5.48-15.66],9.914716234451828e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLNS1A,Methylosome subunit pICln,17188,68,0.63 [0.30-1.29],0.2039897165172983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",20058,83,1.20 [0.98-1.47],0.0747518118568081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLPS,Colipase,20254,86,0.81 [0.62-1.05],0.1148200053683971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLSPN,Claspin,19793,82,1.15 [0.71-1.87],0.5723743582574843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLSTN1,Calsyntenin-1,19826,83,1.13 [0.78-1.63],0.5081469877220477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLSTN2,Calsyntenin-2,20478,85,3.65 [2.71-4.92],1.989952091230974e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLSTN3,Calsyntenin-3,17647,71,2.98 [1.67-5.31],0.0002250459427069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLTA,Clathrin light chain A,19892,84,1.08 [0.71-1.64],0.7161791287619342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLU,Clusterin,17711,69,1.15 [0.55-2.43],0.711908292423534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CLUL1,Clusterin-like protein 1,20246,85,0.50 [0.32-0.77],0.001799317367588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CMC1,COX assembly mitochondrial protein homolog,17683,70,1.08 [0.84-1.39],0.5322486501382674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CMIP,C-Maf-inducing protein,17598,68,1.11 [0.84-1.46],0.4594453572285061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNDP1,Beta-Ala-His dipeptidase,20401,85,0.69 [0.49-0.97],0.0304369714438204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNGB3,Cyclic nucleotide-gated cation channel beta-3,17100,68,0.78 [0.45-1.35],0.3677741836960901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",17199,69,1.05 [0.78-1.41],0.7695096837204249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNPY2,Protein canopy homolog 2,19892,84,1.03 [0.75-1.41],0.8536177254003525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNPY4,Protein canopy homolog 4,20178,85,1.32 [1.01-1.71],0.0390978453061546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNST,Consortin,20278,85,1.14 [0.95-1.35],0.1498064280370019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTF,Ciliary neurotrophic factor,17100,68,0.81 [0.41-1.58],0.5342520736735414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN1,Contactin-1,20528,88,1.58 [0.80-3.15],0.1885173750315257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN2,Contactin-2,20442,86,2.21 [1.47-3.32],0.0001265887406412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN3,Contactin-3,20294,86,1.62 [0.82-3.18],0.1643692967291607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN4,Contactin-4,20294,86,4.89 [2.31-10.33],3.252406413394158e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTN5,Contactin-5,20315,86,0.52 [0.31-0.88],0.0153332221162113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTNAP2,Contactin-associated protein-like 2,20224,82,2.53 [1.79-3.56],1.2946222388241374e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CNTNAP4,Contactin-associated protein-like 4,17188,68,1.11 [0.91-1.36],0.2900956297243282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COCH,Cochlin,17683,70,1.04 [0.64-1.70],0.8689842221618704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL15A1,Collagen alpha-1(XV) chain,17688,69,1.76 [0.82-3.77],0.1450705160710652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL18A1,Collagen alpha-1(XVIII) chain,20392,88,18.67 [9.76-35.69],8.546545209566482e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL1A1,Collagen alpha-1(I) chain,20528,88,0.63 [0.28-1.44],0.2749088445719007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL24A1,Collagen alpha-1(XXIV) chain,17593,70,1.04 [0.69-1.56],0.8568760681285853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL28A1,Collagen alpha-1(XXVIII) chain,17188,68,0.99 [0.73-1.34],0.95446014001494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL2A1,Collagen alpha-1(II) chain,17228,69,0.97 [0.72-1.29],0.8162927475948383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL3A1,Collagen alpha-1(III) chain,17688,69,5.14 [2.60-10.15],2.5362697176254266e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL4A1,Collagen alpha-1(IV) chain,20278,85,5.57 [3.84-8.08],1.275023657381506e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL4A4,Collagen alpha-4(IV) chain,17324,70,1.16 [0.73-1.82],0.531921967109795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL5A1,Collagen alpha-1(V) chain,17300,68,3.17 [2.00-5.03],8.863309807338156e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL6A3,Collagen alpha-3(VI) chain,20528,88,5.68 [4.22-7.67],4.7664652863863526e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL9A1,Collagen alpha-1(IX) chain,20224,82,0.80 [0.52-1.23],0.3101175017145363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COL9A2,Collagen alpha-2(IX) chain,17353,70,1.11 [0.76-1.62],0.5990102937371697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COLEC12,Collectin-12,20270,84,9.54 [6.12-14.86],2.118771845691905e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COMMD1,COMM domain-containing protein 1,17228,69,1.18 [0.81-1.73],0.3965241385420921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COMMD9,COMM domain-containing protein 9,17598,68,1.07 [0.61-1.88],0.8124873517453866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COMP,Cartilage oligomeric matrix protein,20094,81,0.93 [0.52-1.68],0.8213696995660373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COMT,Catechol O-methyltransferase,19678,82,1.05 [0.83-1.34],0.6658777948219277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COPB2,Coatomer subunit beta',17070,67,1.25 [0.76-2.04],0.3817749100200996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COPE,Coatomer subunit epsilon,19826,83,0.70 [0.43-1.15],0.1610178025752369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",17228,69,1.26 [0.77-2.07],0.3609439887110183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CORO1A,Coronin-1A,19863,85,1.09 [0.88-1.34],0.4178538763469487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CORO6,Coronin-6,17100,68,1.93 [1.30-2.88],0.0011786524706835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",20178,85,1.49 [1.17-1.90],0.0010922425253983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,COX6B1,Cytochrome c oxidase subunit 6B1,17683,70,2.94 [1.69-5.12],0.0001358852025928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPA1,Carboxypeptidase A1,20528,88,0.79 [0.59-1.07],0.1275156928030138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPA2,Carboxypeptidase A2,20378,86,2.07 [1.60-2.67],2.6711888294065658e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPA4,Carboxypeptidase A4,16968,67,0.86 [0.49-1.51],0.6062215499964132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPB1,Carboxypeptidase B,20528,88,0.81 [0.58-1.12],0.1950935330721407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPB2,Carboxypeptidase B2,17681,69,0.89 [0.32-2.45],0.8217425785196799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPE,Carboxypeptidase E,20272,84,0.62 [0.40-0.96],0.0313700581956211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPLX2,Complexin-2,17033,67,0.90 [0.42-1.90],0.7734978810547657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPM,Carboxypeptidase M,20331,87,5.01 [3.25-7.71],2.391120778665302e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",17153,67,0.99 [0.42-2.33],0.9856262847310708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPPED1,Serine/threonine-protein phosphatase CPPED1,20440,87,0.68 [0.50-0.92],0.0137678559275985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPQ,Carboxypeptidase Q,17649,69,2.16 [1.17-3.99],0.0132616263478469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPTP,Ceramide-1-phosphate transfer protein,17070,67,0.99 [0.52-1.87],0.96548670654714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPVL,Probable serine carboxypeptidase CPVL,20413,86,2.22 [1.36-3.65],0.0015536665762081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPXM1,Probable carboxypeptidase X1,20360,87,1.01 [0.77-1.33],0.940205554528729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CPXM2,Inactive carboxypeptidase-like protein X2,17683,70,4.57 [3.20-6.52],5.1000127343288657e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CR1,Complement receptor type 1,17615,68,4.23 [2.46-7.27],1.708899753945066e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CR2,Complement receptor type 2,20401,85,2.69 [1.91-3.79],1.5657342512290072e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,19826,80,1.28 [1.03-1.59],0.0264401220783369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRADD,Death domain-containing protein CRADD,20058,83,1.02 [0.78-1.33],0.8740722400397164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CREB3,Cyclic AMP-responsive element-binding protein 3,17033,67,0.93 [0.61-1.44],0.758077351335939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CREBZF,CREB/ATF bZIP transcription factor,17033,67,1.31 [0.54-3.17],0.5448331357648941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CREG1,Protein CREG1,20034,87,0.80 [0.49-1.30],0.3677708454692074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRELD1,Protein disulfide isomerase CRELD1,17300,68,5.52 [3.13-9.75],3.8972417406812705e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRELD2,Protein disulfide isomerase CRELD2,20325,84,2.16 [1.53-3.04],1.0098224868426806e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRH,Corticoliberin,19791,80,0.56 [0.44-0.73],9.277632769240232e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRHBP,Corticotropin-releasing factor-binding protein,20270,84,8.13 [4.18-15.80],6.522176657322363e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRHR1,Corticotropin-releasing factor receptor 1,19892,84,1.12 [0.83-1.52],0.4428121796300404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRIM1,Cysteine-rich motor neuron 1 protein,20361,84,13.74 [6.23-30.29],8.202840360458211e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRIP2,Cysteine-rich protein 2,20091,84,2.12 [1.67-2.69],6.69256261567484e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRISP2,Cysteine-rich secretory protein 2,20442,86,0.67 [0.50-0.91],0.0087459608703153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRISP3,Cysteine-rich secretory protein 3,17528,68,0.46 [0.21-1.01],0.0530044899540115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRKL,Crk-like protein,20299,84,1.09 [0.90-1.32],0.3589357653080696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRLF1,Cytokine receptor-like factor 1,20361,84,3.80 [1.80-7.99],0.0004443043552572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRNN,Cornulin,19719,82,0.87 [0.65-1.16],0.3542111830210145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRTAC1,Cartilage acidic protein 1,20528,88,0.38 [0.21-0.66],0.0007803650664216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRTAM,Cytotoxic and regulatory T-cell molecule,20091,84,2.46 [1.72-3.54],1.0668378616139482e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRTAP,Cartilage-associated protein,17188,68,1.12 [0.70-1.80],0.6272465947837165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRX,Cone-rod homeobox protein,19892,84,0.88 [0.71-1.09],0.2505645954758086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRYBB1,Beta-crystallin B1,17683,70,1.38 [0.98-1.95],0.0680431502116987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRYBB2,Beta-crystallin B2,17647,71,1.06 [0.84-1.33],0.6236635772917671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRYGD,Gamma-crystallin D,17647,71,0.91 [0.72-1.15],0.4277665577276586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRYM,Ketimine reductase mu-crystallin,17100,68,0.90 [0.64-1.27],0.5455514493753166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CRYZL1,Quinone oxidoreductase-like protein 1,17228,69,0.98 [0.75-1.26],0.8488266862202133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSDE1,Cold shock domain-containing protein E1,17070,67,1.25 [1.05-1.48],0.0139602127041416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF1,Macrophage colony-stimulating factor 1,20361,84,13.25 [7.56-23.23],1.783085658192672e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,17683,68,2.73 [1.74-4.27],1.2206219407669978e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF2,Granulocyte-macrophage colony-stimulating factor,17070,67,1.49 [0.93-2.41],0.0991361830609456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,20091,84,1.63 [1.26-2.09],0.0001595378434917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF2RB,Cytokine receptor common subunit beta,17153,67,1.04 [0.60-1.80],0.8906712579102212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF3,Granulocyte colony-stimulating factor,19903,84,1.15 [0.77-1.72],0.481037468091347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSF3R,Granulocyte colony-stimulating factor receptor,17153,67,1.58 [0.77-3.23],0.2089785978425275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSH1,Chorionic somatomammotropin hormone 1,17683,68,1.02 [0.48-2.20],0.9539230404948428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSNK1D,Casein kinase I isoform delta,17153,67,1.20 [0.87-1.66],0.2619102560978883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSNK2A1,Casein kinase II subunit alpha,17643,68,1.13 [0.67-1.90],0.6482031705382411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSPG4,Chondroitin sulfate proteoglycan 4,17688,69,2.53 [1.29-4.95],0.0066244464029841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSPG5,Chondroitin sulfate proteoglycan 5,17100,68,0.76 [0.46-1.28],0.3041162592954288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSRP3,Cysteine and glycine-rich protein 3,17070,67,1.48 [1.28-1.71],1.1376695666722961e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST1,Cystatin-SN,15373,55,1.18 [0.94-1.49],0.1565700332347651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST3,Cystatin-C,20372,85,7.87 [5.23-11.85],4.82475691321313e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST5,Cystatin-D,19870,83,1.60 [1.14-2.24],0.0062603478215761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST6,Cystatin-M,19736,85,1.40 [0.97-2.02],0.0746884146140021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CST7,Cystatin-F,20303,84,1.32 [1.14-1.52],0.0001271272156986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CSTB,Cystatin-B,20005,84,2.51 [1.75-3.58],4.323930120788151e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTAG1A_CTAG1B,Cancer/testis antigen 1,17325,70,1.03 [0.65-1.64],0.8886386521488817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTBS,Di-N-acetylchitobiase,17409,68,2.95 [1.22-7.14],0.0165271910083336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTF1,Cardiotrophin-1,19892,84,1.03 [0.83-1.29],0.7780758937472309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTHRC1,Collagen triple helix repeat-containing protein 1,17688,69,4.00 [2.36-6.79],2.6764844351044414e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTLA4,Cytotoxic T-lymphocyte protein 4,17688,69,1.73 [0.98-3.05],0.0568536697565557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTNNA1,Catenin alpha-1,17100,68,0.86 [0.41-1.77],0.676725770350566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTRB1,Chymotrypsinogen B,20294,86,0.67 [0.48-0.94],0.0214544645715783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTRC,Chymotrypsin-C,20265,84,0.56 [0.42-0.74],5.6148363686892415e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTRL,Chymotrypsin-like protease CTRL-1,17647,71,0.46 [0.34-0.63],5.972866288992425e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSB,Cathepsin B,20334,88,1.80 [1.33-2.43],0.0001410229545839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSC,Dipeptidyl peptidase 1,20228,84,1.21 [0.79-1.86],0.372634517809519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSD,Cathepsin D,19004,78,2.93 [2.27-3.77],1.0481155943119831e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSE,Cathepsin E,17300,68,1.80 [1.14-2.83],0.010923981937536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSF,Cathepsin F,20360,87,1.38 [0.86-2.23],0.1828976728555947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSH,Pro-cathepsin H,19813,84,1.29 [1.00-1.65],0.0464537255824618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSL,Cathepsin L1,20278,85,9.84 [5.19-18.65],2.4938090504786174e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSO,Cathepsin O,20478,85,4.51 [3.02-6.74],1.8122615613793637e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSS,Cathepsin S,15841,70,12.52 [5.75-27.27],1.9864677671197902e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSV,Cathepsin L2,20375,85,0.88 [0.55-1.40],0.5889982266299405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CTSZ,Cathepsin Z,20349,85,6.97 [4.12-11.80],4.49429102058993e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CUZD1,CUB and zona pellucida-like domain-containing protein 1,17188,68,1.65 [1.09-2.50],0.0182579557847919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CWC15,Spliceosome-associated protein CWC15 homolog,17481,70,1.47 [1.11-1.96],0.0079066990216459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CX3CL1,Fractalkine,20091,84,3.46 [2.21-5.40],5.05678685227722e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXADR,Coxsackievirus and adenovirus receptor,20224,82,2.42 [1.82-3.23],1.539835237234675e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL1,Growth-regulated alpha protein,20237,84,1.24 [1.05-1.48],0.0138898159134504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL10,C-X-C motif chemokine 10,20361,84,1.24 [0.94-1.63],0.1224539077289652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL11,C-X-C motif chemokine 11,20440,87,1.20 [0.98-1.48],0.0770921994530943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL12,Stromal cell-derived factor 1,19903,84,1.24 [0.76-2.05],0.3902857411026224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL13,C-X-C motif chemokine 13,20440,87,1.43 [1.25-1.64],2.647456464410414e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL14,C-X-C motif chemokine 14,19903,84,1.43 [1.14-1.81],0.0024139710620429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL16,C-X-C motif chemokine 16,20501,88,4.98 [2.48-9.97],6.1421253078166495e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL17,C-X-C motif chemokine 17,20478,85,1.78 [1.19-2.65],0.0050283966080503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL3,C-X-C motif chemokine 3,20267,84,1.01 [0.82-1.25],0.9248066275767468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL5,C-X-C motif chemokine 5,20216,84,0.96 [0.81-1.14],0.6614150490886932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL6,C-X-C motif chemokine 6,20478,85,1.26 [0.98-1.62],0.0706846302689162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL8,Interleukin-8,20136,85,1.43 [1.17-1.75],0.0004810230946012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CXCL9,C-X-C motif chemokine 9,20361,84,1.85 [1.48-2.31],8.680027353968878e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CYB5A,Cytochrome b5,17033,67,1.04 [0.75-1.43],0.8250789282189659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CYB5R2,NADH-cytochrome b5 reductase 2,17407,70,1.32 [0.89-1.94],0.1683766419539008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",17070,67,0.74 [0.52-1.06],0.1006260853121963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CYTH3,Cytohesin-3,17033,67,1.14 [0.85-1.53],0.3879522688685067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,CYTL1,Cytokine-like protein 1,17688,69,2.03 [0.82-5.04],0.1257583218166245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAAM1,Disheveled-associated activator of morphogenesis 1,17300,68,1.09 [0.83-1.45],0.5342012592648555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAB2,Disabled homolog 2,20442,86,1.14 [0.95-1.36],0.1543623917083625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAG1,Dystroglycan,20361,84,2.09 [1.38-3.15],0.0004573926909574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAND5,DAN domain family member 5,17153,67,1.35 [1.09-1.68],0.0069531573081634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAPK2,Death-associated protein kinase 2,17153,67,1.23 [0.82-1.84],0.3252509019584588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,20224,82,1.03 [0.87-1.21],0.739214362341199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DARS1,"Aspartate--tRNA ligase, cytoplasmic",20058,83,0.99 [0.75-1.29],0.9179175293447188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DBH,Dopamine beta-hydroxylase,17642,68,0.90 [0.74-1.08],0.2490590454761982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DBI,Acyl-CoA-binding protein,20208,85,1.46 [1.14-1.87],0.0028905967792583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DBN1,Drebrin,17153,67,1.73 [1.13-2.66],0.0124083346121301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DBNL,Drebrin-like protein,20361,84,1.13 [0.91-1.39],0.2755364305318608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",20360,87,6.89 [4.29-11.09],1.6863768622180577e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCC,Netrin receptor DCC,17188,68,0.53 [0.26-1.10],0.0900241798343293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCDC2C,Doublecortin domain-containing protein 2C,17033,67,0.93 [0.62-1.41],0.7408941757129361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCLRE1C,Protein artemis,17033,67,0.72 [0.34-1.56],0.407542150777159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCN,Decorin,19892,84,7.79 [4.30-14.14],1.4231602111804029e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCTD,Deoxycytidylate deaminase,17300,68,1.06 [0.83-1.36],0.6193365411457032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCTN1,Dynactin subunit 1,20442,86,1.11 [0.82-1.49],0.5058001352414785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCTN2,Dynactin subunit 2,20178,85,0.96 [0.77-1.19],0.6864619098532309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCTN6,Dynactin subunit 6,19826,83,0.96 [0.72-1.28],0.7792150853624218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCTPP1,dCTP pyrophosphatase 1,20278,85,1.69 [0.95-3.02],0.0764057666647937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCUN1D1,DCN1-like protein 1,17100,68,0.89 [0.62-1.29],0.543474091677127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCUN1D2,DCN1-like protein 2,17033,67,1.17 [0.91-1.51],0.2289353798329752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DCXR,L-xylulose reductase,20360,87,0.91 [0.64-1.30],0.6093661681113698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDA1,DET1- and DDB1-associated protein 1,17070,67,1.04 [0.57-1.88],0.906943331852497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",20178,85,2.76 [1.98-3.84],1.883649503006855e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDC,Aromatic-L-amino-acid decarboxylase,20237,85,1.19 [0.80-1.77],0.3955565270617083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDHD2,Phospholipase DDHD2,17643,68,1.18 [0.83-1.69],0.3515541489143489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDI2,Protein DDI1 homolog 2,17300,68,0.72 [0.53-0.97],0.033346733282424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDR1,Epithelial discoidin domain-containing receptor 1,20440,87,7.95 [4.50-14.04],9.247422115491585e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDT,D-dopachrome decarboxylase,17688,69,0.84 [0.47-1.48],0.5399258608768625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX1,ATP-dependent RNA helicase DDX1,17593,70,1.38 [0.96-1.98],0.0851006592310844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX25,ATP-dependent RNA helicase DDX25,17188,68,0.91 [0.48-1.75],0.7839596040012063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX39A,ATP-dependent RNA helicase DDX39A,17153,67,0.91 [0.31-2.66],0.8654902169448186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX4,Probable ATP-dependent RNA helicase DDX4,17153,67,1.02 [0.66-1.57],0.9371440709043376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX53,Probable ATP-dependent RNA helicase DDX53,17188,68,1.01 [0.51-1.98],0.9810166991822444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DDX58,Antiviral innate immune response receptor RIG-I,19826,80,0.96 [0.66-1.38],0.8084942884947913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",20224,82,1.27 [1.03-1.56],0.0229561652564784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFA1_DEFA1B,Neutrophil defensin 1,19903,85,1.94 [1.56-2.41],2.256933839331528e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB103A_DEFB103B,Beta-defensin 103,17009,67,1.59 [1.20-2.11],0.0014311706438779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB104A_DEFB104B,Beta-defensin 104,17100,68,0.55 [0.32-0.95],0.031410853161039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB116,Beta-defensin 116,17100,68,0.69 [0.45-1.05],0.0845905138589766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB118,Beta-defensin 118,17100,68,0.84 [0.49-1.45],0.5360900089040818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DEFB4A_DEFB4B,Beta-defensin 4A,19999,85,1.19 [1.05-1.36],0.0084025759601675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DENND2B,DENN domain-containing protein 2B,17070,67,1.05 [0.67-1.65],0.8261859676000991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DENR,Density-regulated protein,17153,67,0.96 [0.62-1.48],0.844873274320698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DFFA,DNA fragmentation factor subunit alpha,20478,85,1.09 [0.82-1.45],0.5478338656629644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DGCR6,Protein DGCR6,17100,68,1.18 [0.72-1.93],0.5047858296809397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DGKA,Diacylglycerol kinase alpha,17153,67,1.25 [0.82-1.91],0.2992324373491586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DGKZ,Diacylglycerol kinase zeta,19903,84,1.17 [0.68-2.00],0.5696533133178664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DHODH,Dihydroorotate dehydrogenase,17070,67,1.07 [0.65-1.78],0.7840217143897155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DHPS,Deoxyhypusine synthase,17598,68,1.41 [0.96-2.07],0.0824469480097694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,17647,71,1.37 [0.92-2.03],0.1187980926912731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DIABLO,"Diablo homolog, mitochondrial",20221,85,0.99 [0.83-1.17],0.8740697172350356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DIPK1C,Divergent protein kinase domain 1C,17188,68,1.13 [0.67-1.91],0.64333292604223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DIPK2B,Divergent protein kinase domain 2B,17300,68,0.99 [0.41-2.39],0.9908504891927542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKK1,Dickkopf-related protein 1,20440,87,1.10 [0.79-1.52],0.5704454771099252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKK3,Dickkopf-related protein 3,20528,88,2.78 [1.49-5.17],0.0012683353806956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKK4,Dickkopf-related protein 4,20062,84,3.20 [2.54-4.02],5.2383900615778424e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DKKL1,Dickkopf-like protein 1,20178,85,1.25 [0.98-1.61],0.0749859307677145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLG4,Disks large homolog 4,17647,71,1.21 [0.88-1.66],0.2396905661006344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLGAP5,Disks large-associated protein 5,17643,68,1.28 [0.92-1.78],0.1351079297049521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLK1,Protein delta homolog 1,20528,88,1.16 [0.84-1.61],0.3577509798864954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLL1,Delta-like protein 1,20360,87,10.70 [7.12-16.06],3.2057621982449424e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DLL4,Delta-like protein 4,17228,69,0.84 [0.58-1.22],0.3646107354138768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DMD,Dystrophin,17228,69,1.97 [1.55-2.50],2.6753023405502653e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DMP1,Dentin matrix acidic phosphoprotein 1,17228,69,0.37 [0.29-0.46],1.285690271542777e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJA1,DnaJ homolog subfamily A member 1,17033,67,0.92 [0.55-1.53],0.7481626448751934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJA2,DnaJ homolog subfamily A member 2,20420,85,1.16 [0.91-1.47],0.232493766108902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJA4,DnaJ homolog subfamily A member 4,17647,71,0.81 [0.58-1.11],0.1921698777839887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJB1,DnaJ homolog subfamily B member 1,20178,85,1.10 [0.88-1.37],0.4200464800954681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJB14,DnaJ homolog subfamily B member 14,17593,70,1.29 [0.91-1.83],0.1525361581841559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJB2,DnaJ homolog subfamily B member 2,17300,68,0.65 [0.41-1.03],0.0649529425575978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJB6,DnaJ homolog subfamily B member 6,17136,68,1.17 [0.88-1.54],0.2728040288486793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJB8,DnaJ homolog subfamily B member 8,19892,84,1.04 [0.74-1.48],0.8097049770870883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJC21,DnaJ homolog subfamily C member 21,17647,71,1.46 [0.83-2.56],0.1906048151852105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJC6,Putative tyrosine-protein phosphatase auxilin,17228,69,1.14 [0.86-1.50],0.3620979366697536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNAJC9,DnaJ homolog subfamily C member 9,17593,70,0.97 [0.72-1.30],0.8223622257176314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNER,Delta and Notch-like epidermal growth factor-related receptor,20225,84,0.46 [0.28-0.76],0.0022882859204001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNLZ,DNL-type zinc finger protein,17100,68,0.79 [0.56-1.12],0.1844588845105385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNM1,Dynamin-1,17593,70,1.08 [0.88-1.32],0.4635707643257724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNM3,Dynamin-3,17643,68,1.85 [1.43-2.39],3.149438426423672e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNMBP,Dynamin-binding protein,20091,84,1.62 [1.22-2.14],0.0007153416405218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNPEP,Aspartyl aminopeptidase,17647,71,1.06 [0.70-1.60],0.7848936368369546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,20335,84,0.65 [0.44-0.95],0.0262959258884555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DOC2B,Double C2-like domain-containing protein beta,17188,68,1.11 [0.62-2.01],0.7180579555254161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DOCK9,Dedicator of cytokinesis protein 9,17100,68,0.88 [0.70-1.12],0.3020154755332909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DOK1,Docking protein 1,17647,71,1.04 [0.88-1.23],0.6322059749335793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DOK2,Docking protein 2,20278,85,1.10 [0.94-1.28],0.2433559663665436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPEP1,Dipeptidase 1,20058,83,0.95 [0.64-1.40],0.7832084835019995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPEP2,Dipeptidase 2,20178,85,1.74 [0.95-3.20],0.0751360294994126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP10,Inactive dipeptidyl peptidase 10,20224,82,1.97 [1.25-3.10],0.0032738270688366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP4,Dipeptidyl peptidase 4,19946,85,0.39 [0.20-0.74],0.0044726066863521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,20178,85,3.61 [2.13-6.12],1.9213715240794923e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPP7,Dipeptidyl peptidase 2,20123,85,1.45 [1.08-1.95],0.0134799695076147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPT,Dermatopontin,20528,88,10.71 [4.62-24.83],3.1895577267744915e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DPY30,Protein dpy-30 homolog,20367,86,2.03 [1.66-2.49],1.1049634642697928e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DRAXIN,Draxin,20091,84,2.52 [1.82-3.49],2.658838162913073e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DRG2,Developmentally-regulated GTP-binding protein 2,20178,85,1.21 [0.87-1.69],0.2498221953110638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSC2,Desmocollin-2,20087,86,5.45 [4.10-7.25],2.74344916861022e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSCAM,Down syndrome cell adhesion molecule,17643,68,2.59 [1.37-4.88],0.003364248748555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSG2,Desmoglein-2,20294,86,3.07 [1.69-5.59],0.000231437105661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSG3,Desmoglein-3,20366,86,1.46 [0.87-2.46],0.1543941909282626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DSG4,Desmoglein-4,20117,84,0.40 [0.27-0.58],2.2651509668368704e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTD1,D-aminoacyl-tRNA deacylase 1,17300,68,1.05 [0.80-1.38],0.7045242635873183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTNB,Dystrobrevin beta,17560,68,4.03 [3.05-5.33],1.1994839526599177e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTX2,Probable E3 ubiquitin-protein ligase DTX2,17188,68,0.78 [0.50-1.22],0.2779906418669913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,20178,85,2.96 [1.89-4.62],1.9406902127481007e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DTYMK,Thymidylate kinase,17683,70,0.95 [0.67-1.33],0.7480197742904245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DUOX2,Dual oxidase 2,19892,84,0.86 [0.63-1.19],0.3671834734178424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DUSP13,Dual specificity protein phosphatase 13 isoform A,17598,68,1.05 [0.62-1.78],0.8502689456413834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DUSP29,Dual specificity phosphatase 29,17188,68,1.09 [0.80-1.48],0.6004774951609624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DUSP3,Dual specificity protein phosphatase 3,19826,83,0.88 [0.68-1.13],0.3069873147420956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",17593,70,1.28 [1.03-1.59],0.0230537845673663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DXO,Decapping and exoribonuclease protein,17647,71,1.00 [0.60-1.67],0.9934574674285728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,17598,68,1.15 [0.75-1.77],0.5324564546645107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DYNLT1,Dynein light chain Tctex-type 1,17188,68,1.36 [1.04-1.76],0.0226994246905836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,DYNLT3,Dynein light chain Tctex-type 3,17598,68,1.01 [0.60-1.72],0.9572217311992844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,20091,84,1.19 [0.97-1.46],0.1016188634137569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EBI3_IL27,Interleukin-27,20408,86,5.20 [2.99-9.07],5.844151112041964e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECE1,Endothelin-converting enzyme 1,19826,83,1.00 [0.59-1.70],0.9989274075805916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",17683,70,1.55 [1.20-1.99],0.0007525435026861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECHS1,"Enoyl-CoA hydratase, mitochondrial",17228,69,1.52 [1.21-1.91],0.000335851490681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECI2,Enoyl-CoA delta isomerase 2,17070,67,1.47 [1.05-2.06],0.0262280689721745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECM1,Extracellular matrix protein 1,17254,69,1.47 [0.75-2.86],0.2577822600699251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ECSCR,Endothelial cell-specific chemotaxis regulator,17100,68,1.23 [0.85-1.77],0.2774344226760858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,20442,86,5.58 [4.36-7.14],8.599330069304133e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDAR,Tumor necrosis factor receptor superfamily member EDAR,20224,82,0.95 [0.76-1.18],0.6210628698874339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDDM3B,Epididymal secretory protein E3-beta,17598,68,0.68 [0.44-1.07],0.0952483554635394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,17070,67,1.01 [0.54-1.91],0.9637047263313984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDF1,Endothelial differentiation-related factor 1,17643,68,1.14 [0.83-1.56],0.4260281441390703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,19892,84,2.76 [1.72-4.43],2.66795898119518e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDN1,Endothelin-1,17228,69,8.43 [4.73-15.03],4.89534155743452e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EDNRB,Endothelin receptor type B,17153,67,1.38 [0.90-2.11],0.1350765255245486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EEF1D,Elongation factor 1-delta,17683,70,1.30 [1.02-1.65],0.0365327855065276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,17593,70,2.16 [1.64-2.86],5.33206435582113e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFCAB2,Dynein regulatory complex protein 8,17353,70,1.44 [0.76-2.71],0.2606893275491191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,20374,85,10.75 [6.61-17.49],1.159606297869736e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFHD1,EF-hand domain-containing protein D1,17643,68,2.02 [1.34-3.05],0.0007938833266316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFNA1,Ephrin-A1,20262,85,7.43 [5.33-10.35],2.024818330516872e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFNA4,Ephrin-A4,20056,84,0.59 [0.29-1.20],0.1440079496959358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EFNB2,Ephrin-B2,17188,68,1.48 [1.10-1.98],0.0091557638970541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGF,Pro-epidermal growth factor,20234,84,1.02 [0.84-1.23],0.8734052932702087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGFL7,Epidermal growth factor-like protein 7,19826,80,2.01 [1.39-2.89],0.0001955211324761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGFLAM,Pikachurin,17593,70,2.30 [1.37-3.87],0.0015819902562686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGFR,Epidermal growth factor receptor,20528,88,0.35 [0.16-0.75],0.0064616445018658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EGLN1,Egl nine homolog 1,20224,82,1.34 [1.06-1.69],0.0145467372480136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EHBP1,EH domain-binding protein 1,17683,70,1.34 [0.99-1.79],0.0543402973772535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EHD3,EH domain-containing protein 3,17228,69,1.00 [0.82-1.21],0.9964685060579048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",17647,71,1.06 [0.70-1.61],0.7861668032727857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",17520,69,1.16 [0.94-1.42],0.177490712558513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,17070,67,1.19 [0.85-1.67],0.301624658368153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,17228,69,1.15 [0.66-2.02],0.6183403677356255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF4B,Eukaryotic translation initiation factor 4B,20091,84,0.92 [0.65-1.28],0.6070759862504638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF4E,Eukaryotic translation initiation factor 4E,17153,67,0.98 [0.75-1.28],0.90429567967005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,20278,85,1.13 [0.85-1.51],0.3869038433758336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,20478,85,1.27 [1.03-1.56],0.0222585072779318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,17643,68,1.26 [0.90-1.77],0.1719334581504263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF5,Eukaryotic translation initiation factor 5,17070,67,1.27 [0.77-2.11],0.3547299432482477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EIF5A,Eukaryotic translation initiation factor 5A-1,19903,84,1.22 [0.65-2.27],0.531409333355189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELAC1,Zinc phosphodiesterase ELAC protein 1,17643,68,1.11 [0.84-1.46],0.4823428027857372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELAVL4,ELAV-like protein 4,17100,68,1.16 [0.89-1.51],0.2788819411058217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELN,Elastin,17683,70,3.95 [2.18-7.15],5.80263143810892e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELOA,Elongin-A,20178,85,1.05 [0.75-1.47],0.7671831324753351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ELOB,Elongin-B,17070,67,1.66 [1.12-2.47],0.0119695780865809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENAH,Protein enabled homolog,19903,84,2.06 [1.50-2.82],7.914935419948088e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENDOU,Poly(U)-specific endoribonuclease,16299,68,1.71 [1.18-2.49],0.004968469177997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENG,Endoglin,20528,88,6.44 [3.02-13.76],1.493747642066524e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENO1,Alpha-enolase,20251,85,1.05 [0.82-1.34],0.7016038360580068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENO2,Gamma-enolase,20440,87,1.04 [0.78-1.40],0.7766634541295748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENO3,Beta-enolase,17228,69,0.67 [0.43-1.03],0.067063030565272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENOPH1,Enolase-phosphatase E1,17598,68,0.77 [0.44-1.35],0.3584975361724051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,17070,67,1.76 [0.87-3.56],0.1136182794355196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPEP,Glutamyl aminopeptidase,17070,67,0.87 [0.50-1.53],0.6393654918299272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,20528,88,4.46 [2.50-7.97],4.445614721989186e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,20361,84,0.77 [0.52-1.15],0.2038732972024378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,17228,69,1.09 [0.57-2.11],0.7920985424588733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,19614,82,1.28 [1.02-1.60],0.0360054049464217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENSA,Alpha-endosulfine,17598,68,0.85 [0.53-1.35],0.4802983906509274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,19826,80,1.34 [0.89-2.02],0.1592650251060454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,19892,84,0.38 [0.16-0.88],0.0232032042199206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,19892,84,2.64 [1.19-5.85],0.0168356880973109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ENTR1,Endosome-associated-trafficking regulator 1,17228,69,1.14 [0.79-1.65],0.4817213893288963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EP300,Histone acetyltransferase p300,17153,67,1.99 [1.37-2.88],0.0002948339386153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPB41L5,Band 4.1-like protein 5,17188,68,1.04 [0.74-1.48],0.8069803516139028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPCAM,Epithelial cell adhesion molecule,20259,83,0.94 [0.77-1.15],0.5299532759668639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPGN,Epigen,17598,68,0.81 [0.45-1.47],0.4936055115347507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA1,Ephrin type-A receptor 1,20335,84,4.14 [2.24-7.64],5.6563476415523365e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA10,Ephrin type-A receptor 10,19826,83,1.02 [0.78-1.35],0.8744710433477658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA2,Ephrin type-A receptor 2,19546,83,3.89 [3.18-4.76],2.291518723273829e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHA4,Ephrin type-A receptor 4,17300,68,3.67 [1.70-7.91],0.0009345877603882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHB4,Ephrin type-B receptor 4,20528,88,9.32 [5.89-14.73],1.2572142297624377e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHB6,Ephrin type-B receptor 6,20058,83,4.60 [3.01-7.03],1.7533183046880125e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPHX2,Bifunctional epoxide hydrolase 2,19892,84,0.94 [0.68-1.32],0.732044457241532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPN1,Epsin-1,17353,70,1.10 [0.65-1.86],0.7232351620160393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPO,Erythropoietin,20224,82,1.55 [1.32-1.82],1.0959245239796433e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPPK1,Epiplakin,17228,69,1.27 [0.94-1.71],0.1220498570722185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,20401,86,3.72 [2.66-5.21],1.5265378830515512e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERBB2,Receptor tyrosine-protein kinase erbB-2,20360,87,1.58 [0.74-3.39],0.2377133649094504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERBB3,Receptor tyrosine-protein kinase erbB-3,20213,84,2.18 [0.85-5.61],0.1066406626554309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,20360,87,2.76 [1.26-6.03],0.0109356817298716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERBIN,Erbin,20178,85,1.16 [0.96-1.41],0.1247765774109626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERC2,ERC protein 2,17188,68,0.85 [0.59-1.22],0.3682608056025412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERCC1,DNA excision repair protein ERCC-1,17033,67,1.07 [0.53-2.17],0.8533257079501567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EREG,Proepiregulin,20058,83,0.98 [0.77-1.25],0.8676908331860168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERI1,3'-5' exoribonuclease 1,17353,70,1.30 [0.69-2.46],0.4158017389953514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERMAP,Erythroid membrane-associated protein,17153,67,3.58 [2.24-5.71],8.827237533990088e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,17598,68,0.92 [0.48-1.78],0.8084262318545793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERP29,Endoplasmic reticulum resident protein 29,17300,68,1.12 [0.92-1.36],0.273442110238514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERP44,Endoplasmic reticulum resident protein 44,20136,85,1.35 [0.64-2.84],0.4365195399723107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,17070,67,1.06 [0.61-1.83],0.8463698945445672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESAM,Endothelial cell-selective adhesion molecule,20528,88,4.59 [2.85-7.38],3.5448401738841743e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESM1,Endothelial cell-specific molecule 1,20270,84,0.92 [0.52-1.63],0.7826725068216481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESPL1,Separin,17033,67,1.18 [0.82-1.68],0.3779039128197243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESR1,Estrogen receptor,17153,67,1.29 [0.91-1.83],0.152682029755412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ESYT2,Extended synaptotagmin-2,17647,71,1.39 [1.06-1.82],0.0172954640927358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EVI2B,Protein EVI2B,17033,67,1.01 [0.59-1.72],0.9710372647565352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EVI5,Ecotropic viral integration site 5 protein homolog,17153,67,1.35 [1.05-1.74],0.0209632182496234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EVPL,Envoplakin,17353,70,1.48 [0.80-2.74],0.2077101067808021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EXOSC10,Exosome component 10,17070,67,1.00 [0.68-1.48],0.9897146186476432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EXTL1,Exostosin-like 1,17070,67,0.69 [0.38-1.28],0.2442215441961081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,EZR,Ezrin,20440,87,1.47 [0.72-3.03],0.2911154644433047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F10,Coagulation factor X,17683,68,0.55 [0.27-1.11],0.0927346744427059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F11,Coagulation factor XI,17458,69,1.22 [0.60-2.50],0.5875527587023821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F11R,Junctional adhesion molecule A,20294,86,1.70 [1.24-2.34],0.0010425142807457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F12,Coagulation factor XII,17711,69,0.86 [0.50-1.49],0.5970623108413038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F13B,Coagulation factor XIII B chain,17611,69,0.58 [0.24-1.45],0.2467004513135489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F2,Prothrombin,17711,69,0.49 [0.18-1.34],0.1672525381758086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F2R,Proteinase-activated receptor 1,20325,84,2.19 [1.56-3.07],6.395619949331523e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F3,Tissue factor,20318,86,3.27 [1.68-6.35],0.0004750108799113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F7,Coagulation factor VII,20370,85,1.07 [0.59-1.91],0.8284775922092947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,F9,Coagulation factor IX,20356,85,5.39 [2.00-14.49],0.0008503560334685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP1,"Fatty acid-binding protein, liver",20270,84,1.80 [1.53-2.11],6.754891923104863e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP2,"Fatty acid-binding protein, intestinal",20278,85,1.21 [0.97-1.50],0.0869336857407262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP3,"Fatty acid-binding protein, heart",17683,70,3.58 [2.83-4.54],3.678471257979025e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP4,"Fatty acid-binding protein, adipocyte",20528,88,3.51 [2.76-4.48],2.358177777799781e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP5,Fatty acid-binding protein 5,20362,87,1.52 [1.17-1.97],0.0015837943813876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP6,Gastrotropin,19853,83,1.29 [0.96-1.73],0.089895839150939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FABP9,Fatty acid-binding protein 9,20224,82,0.90 [0.64-1.26],0.5305964439646886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FADD,FAS-associated death domain protein,20278,85,1.00 [0.78-1.30],0.9829563808010228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM13A,Protein FAM13A,17593,70,1.19 [0.85-1.67],0.3095179063863824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM171A2,Protein FAM171A2,17643,68,0.96 [0.82-1.11],0.5701860163592123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM171B,Protein FAM171B,17598,68,1.37 [0.69-2.72],0.361268186117642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM172A,Cotranscriptional regulator FAM172A,17228,69,1.01 [0.69-1.48],0.9653346944954492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM20A,Pseudokinase FAM20A,17683,70,2.85 [1.84-4.41],2.97821589562442e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3B,Protein FAM3B,20178,85,14.68 [7.91-27.26],1.7803766601586256e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3C,Protein FAM3C,20237,85,13.45 [8.84-20.46],6.48133425920717e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAM3D,Protein FAM3D,17593,70,2.91 [2.21-3.83],2.7576728141119072e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAP,Prolyl endopeptidase FAP,20528,88,1.72 [0.88-3.39],0.1131871690611769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FARSA,Phenylalanine--tRNA ligase alpha subunit,17188,68,1.18 [0.88-1.59],0.2724726427807981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FAS,Tumor necrosis factor receptor superfamily member 6,20470,88,2.03 [1.56-2.63],9.905399939914408e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FASLG,Tumor necrosis factor ligand superfamily member 6,20478,85,0.92 [0.53-1.59],0.7742651819191992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FBLN2,Fibulin-2,17688,69,5.94 [3.81-9.28],4.6084955359412206e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FBN2,Fibrillin-2,17188,68,1.32 [0.90-1.94],0.1574284625207714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FBP1,"Fructose-1,6-bisphosphatase 1",20278,85,1.14 [0.89-1.47],0.3041885865783428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,17683,70,1.86 [1.39-2.50],3.7640691118966254e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCAR,Immunoglobulin alpha Fc receptor,20224,82,2.18 [1.46-3.24],0.0001389021166968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,17643,68,2.13 [0.85-5.32],0.1071269656908383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,20294,86,1.63 [1.33-2.01],3.1330424482973053e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,20224,85,2.31 [1.50-3.56],0.0001352855796812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,19826,80,1.12 [0.80-1.56],0.5142634405441135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,20333,85,1.04 [0.70-1.55],0.82830354946834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCN1,Ficolin-1,17642,68,3.92 [2.39-6.42],5.742302215422121e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCN2,Ficolin-2,20228,84,0.52 [0.37-0.74],0.0002558817361884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL1,Fc receptor-like protein 1,20278,85,1.56 [1.12-2.17],0.008065472908515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL2,Fc receptor-like protein 2,20366,83,1.67 [1.26-2.20],0.000365069383045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL3,Fc receptor-like protein 3,19903,84,1.01 [0.71-1.43],0.958606032625442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL5,Fc receptor-like protein 5,20294,86,1.36 [1.00-1.86],0.048690875748653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRL6,Fc receptor-like protein 6,20224,82,1.43 [1.08-1.89],0.0112957564309296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FCRLB,Fc receptor-like B,19826,80,1.45 [1.22-1.72],2.4815104486061383e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FDX1,"Adrenodoxin, mitochondrial",17070,67,1.77 [1.41-2.23],1.0102758128464036e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FDX2,"Ferredoxin-2, mitochondrial",17070,67,1.40 [0.98-2.01],0.0614924999834399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FEN1,Flap endonuclease 1,19826,80,0.82 [0.57-1.17],0.271584561367495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FES,Tyrosine-protein kinase Fes/Fps,19826,80,1.05 [0.68-1.63],0.8099737971689931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FETUB,Fetuin-B,20356,85,1.39 [0.72-2.69],0.3270185020362968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGA,Fibrinogen alpha chain,17307,69,2.60 [1.25-5.40],0.0104232234037014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",17643,68,1.11 [0.83-1.49],0.4886519192327213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF12,Fibroblast growth factor 12,17153,67,0.86 [0.47-1.57],0.6218789483913685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF16,Fibroblast growth factor 16,17153,67,1.22 [0.76-1.95],0.4105156315703256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF19,Fibroblast growth factor 19,20361,84,1.07 [0.84-1.37],0.5662145927233058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF2,Fibroblast growth factor 2,20224,82,1.44 [1.11-1.86],0.0056656952688168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF20,Fibroblast growth factor 20,17153,67,1.00 [0.59-1.71],0.9911152627547736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF21,Fibroblast growth factor 21,20408,86,1.64 [1.44-1.88],4.667863960506056e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF23,Fibroblast growth factor 23,20416,86,1.98 [1.67-2.35],8.356833073597295e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF3,Fibroblast growth factor 3,17153,67,1.07 [0.55-2.09],0.8428291835063644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF5,Fibroblast growth factor 5,19903,84,4.67 [3.47-6.30],3.910304505298022e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF6,Fibroblast growth factor 6,17153,67,1.22 [0.79-1.88],0.3703148381308339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF7,Fibroblast growth factor 7,17033,67,1.14 [0.89-1.46],0.3023988441161359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGF9,Fibroblast growth factor 9,17007,67,0.92 [0.52-1.64],0.7774877429368681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFBP1,Fibroblast growth factor-binding protein 1,20360,87,0.36 [0.27-0.49],4.950401287252233e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFBP2,Fibroblast growth factor-binding protein 2,17688,69,0.56 [0.41-0.77],0.0002713538241859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFBP3,Fibroblast growth factor-binding protein 3,17647,71,0.41 [0.21-0.77],0.0057327257503602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFR2,Fibroblast growth factor receptor 2,20360,87,11.72 [6.90-19.89],7.800561649729367e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGFR4,Fibroblast growth factor receptor 4,17300,68,0.68 [0.43-1.06],0.0880170368746749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGL1,Fibrinogen-like protein 1,17683,68,2.62 [1.99-3.44],5.1679630146274026e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FGR,Tyrosine-protein kinase Fgr,19826,83,1.08 [0.80-1.46],0.6232802503077051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FH,"Fumarate hydratase, mitochondrial",17100,68,1.06 [0.82-1.38],0.6609478662380353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FHIP2A,FHF complex subunit HOOK interacting protein 2A,17070,67,1.07 [0.67-1.71],0.7764931932506164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FHIT,Bis(5'-adenosyl)-triphosphatase,19826,83,0.88 [0.67-1.14],0.3301623453421717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FIS1,Mitochondrial fission 1 protein,20277,84,1.06 [0.83-1.37],0.6317787407001341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,17643,68,1.15 [0.91-1.46],0.2285472175386287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,20315,83,0.99 [0.83-1.18],0.904945173929256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,20091,84,1.79 [1.13-2.84],0.0130616224958113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,20091,84,1.21 [0.97-1.50],0.0847694267325007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,19793,82,1.18 [0.82-1.71],0.3684195360137768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FKBPL,FK506-binding protein-like,17593,70,1.06 [0.72-1.57],0.7601882254849133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLI1,Friend leukemia integration 1 transcription factor,19826,80,1.18 [1.00-1.40],0.0520174139561329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,20091,84,5.97 [3.71-9.59],1.6704380604439494e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLT1,Vascular endothelial growth factor receptor 1,20143,85,2.21 [1.46-3.36],0.0001957640056184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLT3,Receptor-type tyrosine-protein kinase FLT3,19826,80,0.89 [0.46-1.71],0.7222531807728454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLT3LG,Fms-related tyrosine kinase 3 ligand,20478,85,2.90 [1.69-4.95],0.0001010950537034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FLT4,Vascular endothelial growth factor receptor 3,20360,87,0.82 [0.47-1.44],0.4868162843235026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FMNL1,Formin-like protein 1,19826,83,1.03 [0.76-1.38],0.8574792931444613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FMR1,Synaptic functional regulator FMR1,19826,80,1.03 [0.59-1.80],0.9128522194486736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FN1,Fibronectin,17711,69,0.48 [0.21-1.13],0.0932768316884965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FNDC1,Fibronectin type III domain-containing protein 1,17647,71,1.52 [0.93-2.47],0.0938136820773358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,17598,68,1.29 [0.69-2.42],0.4289735241212148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLH1,Glutamate carboxypeptidase 2,17153,67,1.27 [1.08-1.50],0.0041551237704504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLR1,Folate receptor alpha,20275,87,3.19 [2.26-4.52],5.443689764816671e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLR2,Folate receptor beta,20440,87,2.87 [1.58-5.22],0.0005557865842051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOLR3,Folate receptor gamma,20300,87,1.06 [0.96-1.15],0.2403723664104118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOS,Proto-oncogene c-Fos,17007,67,0.88 [0.46-1.67],0.686151085712921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOSB,Protein fosB,19826,83,1.16 [0.71-1.89],0.5600473833065136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOXJ3,Forkhead box protein J3,17153,67,1.40 [0.86-2.28],0.1811694422260723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOXO1,Forkhead box protein O1,20224,82,1.28 [1.02-1.61],0.0313620331588778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FOXO3,Forkhead box protein O3,19826,80,1.22 [1.00-1.48],0.0475805950884231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FRMD4B,FERM domain-containing protein 4B,17070,67,1.21 [0.87-1.68],0.2584161334369471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FRMD7,FERM domain-containing protein 7,17188,68,0.97 [0.49-1.93],0.9356735017656644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FRZB,Secreted frizzled-related protein 3,20022,84,0.93 [0.42-2.04],0.8534517378932577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FSHB,Follitropin subunit beta,17228,69,1.09 [0.67-1.77],0.726835588765012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FST,Follistatin,20325,84,0.76 [0.49-1.16],0.1990894157214902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FSTL1,Follistatin-related protein 1,17228,69,6.95 [4.20-11.49],4.0938671251749e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FSTL3,Follistatin-related protein 3,20230,84,8.38 [5.90-11.90],1.343868742870825e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FTCD,Formimidoyltransferase-cyclodeaminase,17609,71,1.25 [0.98-1.60],0.0677283433406447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUCA1,Tissue alpha-L-fucosidase,20413,88,1.08 [0.86-1.36],0.5137721994340323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUOM,Fucose mutarotase,17300,68,1.38 [0.98-1.96],0.0670656570469721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FURIN,Furin,20360,87,1.33 [0.73-2.39],0.3497987213375563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUS,RNA-binding protein FUS,19801,80,1.15 [0.72-1.83],0.5698359946565426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",17317,70,1.00 [0.68-1.47],0.999711619590714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,20440,87,1.93 [1.31-2.85],0.0009808600912975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FUT8,"Alpha-(1,6)-fucosyltransferase",20091,84,1.17 [0.84-1.62],0.3535624268474022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FXN,"Frataxin, mitochondrial",20442,86,1.12 [0.87-1.46],0.3815249438784006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FXYD5,FXYD domain-containing ion transport regulator 5,19903,84,1.18 [0.88-1.57],0.2622143728650494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FYB1,FYN-binding protein 1,20254,86,1.05 [0.85-1.28],0.6718028846895256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FZD10,Frizzled-10,17188,68,0.88 [0.56-1.38],0.5838186153668987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,FZD8,Frizzled-8,17100,68,1.28 [0.88-1.86],0.1907034099682214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GABARAP,Gamma-aminobutyric acid receptor-associated protein,17598,68,1.26 [0.84-1.90],0.2700505343740477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,17353,70,1.00 [0.69-1.46],0.9909600222585384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,17100,68,1.15 [0.82-1.60],0.4138085214868632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAD1,Glutamate decarboxylase 1,17033,67,1.64 [0.68-3.94],0.2706882572165969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAD2,Glutamate decarboxylase 2,17153,67,1.22 [0.85-1.75],0.2826468356915981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,17353,70,0.51 [0.25-1.05],0.0688778257036713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,17228,69,1.41 [0.95-2.10],0.0860891202179574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAGE2A,G antigen 2A,17033,67,1.20 [0.90-1.60],0.2247162682808474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAL,Galanin peptides,20361,84,0.83 [0.62-1.11],0.2074086910722236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,20178,85,5.14 [2.91-9.09],1.718075610380685e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,20442,86,0.44 [0.22-0.87],0.0185525204562026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,19903,84,1.80 [1.30-2.50],0.0004052467311812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,17683,70,1.62 [0.80-3.26],0.1794991344197806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GALNT7,N-acetylgalactosaminyltransferase 7,20178,85,3.59 [1.41-9.09],0.0071471227706311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAMT,Guanidinoacetate N-methyltransferase,17070,67,1.08 [0.56-2.05],0.8255246817185121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,16919,67,1.10 [0.50-2.43],0.805938628292393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GART,Trifunctional purine biosynthetic protein adenosine-3,17643,68,1.19 [0.55-2.57],0.6517557867213318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAS2,Growth arrest-specific protein 2,17353,70,1.14 [0.80-1.63],0.456233455384086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAS6,Growth arrest-specific protein 6,20415,87,3.79 [1.79-8.06],0.0005212472186474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GASK1A,Golgi-associated kinase 1A,17070,67,0.46 [0.27-0.80],0.0060043136243353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GAST,Gastrin,17647,71,1.45 [1.28-1.64],4.201249884685136e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,17033,67,0.83 [0.35-1.97],0.6717572482142833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",17228,69,1.24 [0.92-1.66],0.1541532109471839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GBA,Lysosomal acid glucosylceramidase,17188,68,1.32 [0.91-1.93],0.1456202151871043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GBP1,Guanylate-binding protein 1,17613,70,1.17 [0.82-1.67],0.388078058168557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GBP2,Guanylate-binding protein 2,19903,84,0.95 [0.68-1.32],0.7438535474091278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GBP4,Guanylate-binding protein 4,19826,83,1.07 [0.72-1.59],0.7523044173009585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GBP6,Guanylate-binding protein 6,17070,67,0.93 [0.54-1.62],0.8043942029407809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GC,Vitamin D-binding protein,17711,69,1.18 [0.48-2.93],0.7200305135586533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCC1,GRIP and coiled-coil domain-containing protein 1,17647,71,1.15 [0.93-1.43],0.1914232082894591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCG,Pro-glucagon,19826,80,2.01 [1.72-2.35],4.767291816756649e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,16885,67,1.92 [1.42-2.59],1.92567328782996e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCLM,Glutamate--cysteine ligase regulatory subunit,17070,67,0.95 [0.56-1.63],0.8568424515322222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",20178,85,4.36 [2.66-7.15],4.837488425358686e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GDF15,Growth/differentiation factor 15,20528,88,7.09 [5.76-8.74],1.6076496328052476e-75
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GDF2,Growth/differentiation factor 2,20278,85,1.67 [0.99-2.83],0.0553879623511211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GDNF,Glial cell line-derived neurotrophic factor,19826,83,2.75 [1.97-3.86],3.6481346768579318e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GET3,ATPase GET3,17683,70,1.17 [0.78-1.75],0.4586928213552342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFAP,Glial fibrillary acidic protein,19791,80,0.74 [0.48-1.14],0.173951869352399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFER,FAD-linked sulfhydryl oxidase ALR,19826,80,1.68 [1.26-2.24],0.0003600378396802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,19826,80,0.93 [0.77-1.12],0.4200573664918231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRA1,GDNF family receptor alpha-1,20408,86,15.73 [10.18-24.31],2.521439749196104e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRA2,GDNF family receptor alpha-2,20178,85,3.69 [1.94-7.02],6.967472336400498e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRA3,GDNF family receptor alpha-3,20036,84,2.80 [1.52-5.15],0.0009691162240142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GFRAL,GDNF family receptor alpha-like,17110,68,0.67 [0.45-1.01],0.05406853221394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGA1,ADP-ribosylation factor-binding protein GGA1,19826,83,0.97 [0.70-1.34],0.8606742241735499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGACT,Gamma-glutamylaminecyclotransferase,17683,70,1.04 [0.75-1.44],0.8233952626761932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGCT,Gamma-glutamylcyclotransferase,17644,70,0.94 [0.57-1.54],0.8037324475214169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGH,Gamma-glutamyl hydrolase,19989,84,1.54 [0.91-2.59],0.1068003006480151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGT1,Glutathione hydrolase 1 proenzyme,20262,85,1.87 [1.36-2.56],9.648879897855652e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GGT5,Glutathione hydrolase 5 proenzyme,20091,84,12.55 [8.82-17.87],7.960080696067441e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GH1,Somatotropin,20237,85,1.18 [1.06-1.32],0.0021225479699124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GH2,Growth hormone variant,19826,80,0.99 [0.88-1.12],0.8876248675127579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GHR,Growth hormone receptor,17300,68,0.35 [0.15-0.84],0.0193658826718033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GHRHR,Growth hormone-releasing hormone receptor,19826,83,1.13 [0.83-1.53],0.4480410057441042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GHRL,Appetite-regulating hormone,20278,85,1.07 [0.85-1.33],0.5641287822601944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GID8,Glucose-induced degradation protein 8 homolog,17643,68,0.47 [0.18-1.24],0.128226737499209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIGYF2,GRB10-interacting GYF protein 2,17643,68,1.63 [1.22-2.17],0.0008577811988062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIMAP7,GTPase IMAP family member 7,17300,68,0.58 [0.35-0.97],0.0360298082545787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIMAP8,GTPase IMAP family member 8,17033,67,0.78 [0.46-1.34],0.3725692026707365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIP,Gastric inhibitory polypeptide,17228,69,1.89 [1.39-2.59],6.366159913989727e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIPC2,PDZ domain-containing protein GIPC2,17647,71,4.93 [3.27-7.44],2.9266752308918494e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIPC3,PDZ domain-containing protein GIPC3,17593,70,1.07 [0.84-1.35],0.6033643795795813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIPR,Gastric inhibitory polypeptide receptor,17153,67,0.92 [0.55-1.55],0.7554846622399721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GIT1,ARF GTPase-activating protein GIT1,17153,67,1.14 [0.89-1.45],0.2956258074098852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GJA8,Gap junction alpha-8 protein,17033,67,0.66 [0.41-1.06],0.0851757943695067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GKN1,Gastrokine-1,19444,82,2.20 [1.28-3.76],0.0041756697560419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLA,Alpha-galactosidase A,17273,68,2.34 [1.37-3.99],0.0019179461849264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLB1,Beta-galactosidase,20091,84,1.57 [1.00-2.45],0.0480353025935361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLI2,Zinc finger protein GLI2,17153,67,2.11 [1.26-3.53],0.0043992117996998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLO1,Lactoylglutathione lyase,19892,84,0.96 [0.69-1.34],0.8277737546747603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLOD4,Glyoxalase domain-containing protein 4,20241,84,0.84 [0.47-1.48],0.5423635975212527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLP1R,Glucagon-like peptide 1 receptor,17100,68,1.24 [0.73-2.08],0.4260816782253624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLRX,Glutaredoxin-1,20137,85,0.93 [0.66-1.30],0.6583731891846698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",17300,68,1.22 [0.94-1.57],0.1337468348802132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,19826,83,0.90 [0.57-1.43],0.6513928994815376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GLYR1,Putative oxidoreductase GLYR1,17598,68,1.18 [0.82-1.71],0.3733645766881865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GM2A,Ganglioside GM2 activator,17234,68,1.83 [1.48-2.25],2.2041522295596337e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GMFG,Glia maturation factor gamma,17683,70,1.07 [0.77-1.47],0.6972376918088468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GMPR,GMP reductase 1,20478,85,0.68 [0.48-0.98],0.0377087198228176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GMPR2,GMP reductase 2,17300,68,0.95 [0.67-1.36],0.790714702861606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNAS,Neuroendocrine secretory protein 55,17643,68,1.24 [0.97-1.57],0.0808311581770075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,19826,80,0.97 [0.72-1.32],0.8704598011376312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,17188,68,0.80 [0.47-1.37],0.417800066221449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNLY,Granulysin,20294,86,1.16 [0.82-1.63],0.4138480693721565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNPDA1,Glucosamine-6-phosphate isomerase 1,17228,69,0.83 [0.39-1.74],0.6154716954347885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GNPDA2,Glucosamine-6-phosphate isomerase 2,17300,68,0.44 [0.23-0.85],0.0139404628874892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GOLGA3,Golgin subfamily A member 3,17643,68,1.40 [1.05-1.85],0.0204459295579073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GOLM2,Protein GOLM2,20440,87,5.38 [3.27-8.86],3.775851868007164e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,20224,82,1.09 [0.90-1.32],0.3809671592825721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GORASP2,Golgi reassembly-stacking protein 2,17593,70,1.42 [0.91-2.22],0.1228847316462498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GOT1,"Aspartate aminotransferase, cytoplasmic",17688,69,0.89 [0.51-1.56],0.6821752225738678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GP1BA,Platelet glycoprotein Ib alpha chain,20219,84,1.02 [0.58-1.82],0.9371492119727576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GP1BB,Platelet glycoprotein Ib beta chain,17070,67,1.26 [0.89-1.78],0.1918357367302454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,19634,82,1.12 [0.89-1.40],0.3307163966868407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GP5,Platelet glycoprotein V,17300,68,0.89 [0.47-1.68],0.7127610770877892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GP6,Platelet glycoprotein VI,20254,86,1.09 [0.87-1.36],0.443516154658375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPA33,Cell surface A33 antigen,20178,85,0.83 [0.72-0.95],0.00889651533068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPC1,Glypican-1,20442,86,2.72 [1.46-5.06],0.0016415823872625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPC5,Glypican-5,20091,84,0.49 [0.34-0.70],8.149730266552587e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPD1,Glycerol-3-phosphate dehydrogenase,17598,68,2.03 [1.44-2.86],5.582014532308353e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPHA2,Glycoprotein hormone alpha-2,17593,70,1.14 [0.72-1.82],0.566845401229974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPI,Glucose-6-phosphate isomerase,17683,68,1.37 [0.85-2.21],0.1983395072121736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,17593,70,1.27 [0.89-1.83],0.1914864772828161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPKOW,G-patch domain and KOW motifs-containing protein,19826,83,1.36 [0.90-2.08],0.1480231635990985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPNMB,Transmembrane glycoprotein NMB,19718,84,8.59 [4.80-15.35],4.0410151830236214e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR101,Probable G-protein coupled receptor 101,17100,68,0.66 [0.38-1.14],0.1326064284720698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR158,Probable G-protein coupled receptor 158,17643,68,1.41 [0.84-2.36],0.1893594173086339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR15L,Protein GPR15L,17593,70,2.11 [1.54-2.89],2.868711307381728e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPR37,Prosaposin receptor GPR37,19892,84,3.60 [2.82-4.58],4.751197423799775e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GPRC5C,G-protein coupled receptor family C group 5 member C,17598,68,2.14 [1.68-2.73],6.06963784845876e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRAP2,GRB2-related adapter protein 2,20278,85,1.04 [0.90-1.21],0.6090204276664433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,17683,70,1.11 [0.77-1.60],0.5814502194015072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRIK2,"Glutamate receptor ionotropic, kainate 2",17643,68,0.98 [0.57-1.70],0.9548859280205094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",17100,68,1.33 [1.00-1.77],0.0517993400944035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRK5,G protein-coupled receptor kinase 5,19892,84,0.84 [0.55-1.28],0.4090321351409851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRN,Progranulin,20196,85,6.16 [3.86-9.83],2.6713078242079105e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRP,Gastrin-releasing peptide,17228,69,0.96 [0.64-1.46],0.8573755689558819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",20178,85,2.43 [2.00-2.95],3.438182845571607e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GRSF1,G-rich sequence factor 1,16949,67,1.38 [1.05-1.80],0.0206661335491539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSAP,Gamma-secretase-activating protein,19826,80,0.91 [0.70-1.19],0.5019113469889244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSN,Gelsolin,17622,68,0.46 [0.30-0.71],0.0004900808278496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSR,"Glutathione reductase, mitochondrial",17575,68,1.12 [0.38-3.30],0.8399123711331864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSTA1,Glutathione S-transferase A1,20242,85,1.00 [0.80-1.26],0.9814834735369484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSTA3,Glutathione S-transferase A3,19826,80,1.04 [0.81-1.34],0.7442365468700463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSTM4,Glutathione S-transferase Mu 4,17070,67,0.94 [0.67-1.32],0.7225210172270833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSTP1,Glutathione S-transferase P,19703,83,0.68 [0.49-0.95],0.0236475999088626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GSTT2B,Glutathione S-transferase theta-2B,17647,71,0.99 [0.90-1.08],0.7552993623471664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,17353,70,0.95 [0.67-1.34],0.7715800626275485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GTPBP2,GTP-binding protein 2,17188,68,1.07 [0.80-1.44],0.6352350555007935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GUCA2A,Guanylin,20184,86,3.76 [2.64-5.35],1.86380593487093e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GUCY2C,Heat-stable enterotoxin receptor,17353,70,0.97 [0.71-1.32],0.8416705416144707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GUK1,Guanylate kinase,17070,67,1.44 [0.88-2.36],0.1496730953364712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GUSB,Beta-glucuronidase,20388,88,1.15 [0.86-1.53],0.355157172709593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GYS1,"Glycogen [starch] synthase, muscle",19892,84,1.02 [0.83-1.26],0.8292099788904219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GZMA,Granzyme A,20478,85,1.98 [1.21-3.24],0.0062077155254176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GZMB,Granzyme B,20224,82,0.82 [0.59-1.14],0.2362039241131234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,GZMH,Granzyme H,19892,84,1.05 [0.85-1.30],0.6268758138869535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,H2AP,Huntingtin-interacting protein M,17033,67,1.07 [0.68-1.68],0.7793013170651417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",17070,67,0.98 [0.68-1.42],0.92922306920461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",20372,86,0.61 [0.46-0.81],0.0006271698707617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAO1,Hydroxyacid oxidase 1,20442,86,1.46 [1.26-1.68],2.412993565162693e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HARS1,"Histidine--tRNA ligase, cytoplasmic",20294,86,1.12 [0.87-1.43],0.3879257697145413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAVCR1,Hepatitis A virus cellular receptor 1,20406,86,3.22 [2.67-3.88],1.1073615806002976e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HAVCR2,Hepatitis A virus cellular receptor 2,20294,86,5.18 [3.60-7.44],6.988701447366492e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HBEGF,Proheparin-binding EGF-like growth factor,20372,86,0.83 [0.64-1.09],0.1762900820285681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HBQ1,Hemoglobin subunit theta-1,20442,86,0.50 [0.35-0.71],9.095081743276848e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HBZ,Hemoglobin subunit zeta,17683,70,0.81 [0.64-1.01],0.0654793769763936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HCG22,Protein PBMUCL2,17070,67,1.12 [0.76-1.65],0.5642822085389143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HCLS1,Hematopoietic lineage cell-specific protein,20478,85,1.05 [0.73-1.52],0.7756138529426168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HDAC8,Histone deacetylase 8,17153,67,1.09 [0.76-1.56],0.6525725995534486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HDAC9,Histone deacetylase 9,17100,68,0.73 [0.46-1.16],0.1862234913165316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HDDC2,5'-deoxynucleotidase HDDC2,17593,70,0.72 [0.42-1.24],0.231361864214368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HDGF,Hepatoma-derived growth factor,20403,86,1.04 [0.85-1.28],0.6988655979945468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HDGFL2,Hepatoma-derived growth factor-related protein 2,17647,71,1.18 [0.82-1.68],0.372581852547283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEBP1,Heme-binding protein 1,19892,84,0.81 [0.54-1.21],0.2971265268033342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEG1,Protein HEG homolog 1,17300,68,4.53 [2.10-9.78],0.0001208112540475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEPACAM2,HEPACAM family member 2,17647,71,1.42 [0.84-2.40],0.194242000834391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEPH,Hephaestin,17683,70,18.88 [8.26-43.16],3.225897654341808e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HEXIM1,Protein HEXIM1,20224,82,1.34 [1.05-1.71],0.0187961172734812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HGF,Hepatocyte growth factor,20478,85,4.18 [2.72-6.41],5.853530907706184e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HGFAC,Hepatocyte growth factor activator,17515,68,1.53 [0.63-3.71],0.3423818848892497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,19826,80,1.19 [0.92-1.53],0.1907649883429841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HHEX,Hematopoietically-expressed homeobox protein HHEX,17647,71,1.48 [1.11-1.99],0.0083531662741126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HIF1A,Hypoxia-inducible factor 1-alpha,17153,67,1.22 [0.89-1.67],0.2120437425739958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HIP1,Huntingtin-interacting protein 1,17070,67,1.28 [0.71-2.31],0.4064777758130451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HIP1R,Huntingtin-interacting protein 1-related protein,17606,70,2.13 [1.72-2.62],1.7172225319928565e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HJV,Hemojuvelin,17643,68,1.45 [1.02-2.07],0.0366818128606359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HK2,Hexokinase-2,19892,84,1.34 [0.67-2.69],0.4126481241568306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",17643,68,2.84 [1.41-5.73],0.0035776244900026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",20168,82,1.81 [1.11-2.96],0.018025572192079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",20224,82,5.40 [3.64-8.00],4.59013714808372e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMBS,Porphobilinogen deaminase,20442,86,0.42 [0.27-0.64],6.946605663982552e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMCN2,Hemicentin-2,17272,68,1.61 [1.05-2.47],0.0279805822487804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",17228,69,1.34 [0.86-2.10],0.1939509738522016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",17070,67,0.77 [0.43-1.37],0.3659528428416707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMMR,Hyaluronan mediated motility receptor,16996,67,0.96 [0.58-1.59],0.870967536308927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMOX1,Heme oxygenase 1,20043,85,0.55 [0.36-0.85],0.0063062229067601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HMOX2,Heme oxygenase 2,19826,83,1.53 [1.12-2.09],0.0070797314377937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HNF1A,Hepatocyte nuclear factor 1-alpha,17188,68,0.82 [0.56-1.22],0.3342240609776923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HNMT,Histamine N-methyltransferase,19989,83,2.21 [1.59-3.07],2.239045311042e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,19835,84,1.14 [0.89-1.46],0.2867957752847744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,17643,68,1.31 [0.86-2.00],0.2092749812584282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HPCAL1,Hippocalcin-like protein 1,20478,85,1.28 [0.97-1.69],0.0794327095356406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HPGDS,Hematopoietic prostaglandin D synthase,19826,80,0.30 [0.18-0.52],1.3034619638325033e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HPSE,Heparanase,17446,68,1.13 [0.88-1.46],0.3337596569223418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HRAS,GTPase Hras,17313,69,1.25 [1.07-1.46],0.0039417543094104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,17228,69,1.91 [1.27-2.87],0.0018563103874271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HRG,Histidine-rich glycoprotein,17611,69,1.83 [0.89-3.79],0.1025115695948809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HS1BP3,HCLS1-binding protein 3,17228,69,1.18 [0.91-1.54],0.2124399052733162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,20178,85,2.32 [1.42-3.77],0.0007265057625124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,20442,86,1.34 [0.80-2.24],0.2631883344492434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,17153,67,4.05 [2.54-6.45],4.052259511743739e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSBP1,Heat shock factor-binding protein 1,17228,69,1.23 [0.96-1.57],0.1085316345812809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,20224,82,0.78 [0.49-1.26],0.3088283229621276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,17647,71,1.45 [1.01-2.08],0.0414044800130274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSD17B3,Testosterone 17-beta-dehydrogenase 3,17070,67,1.11 [0.70-1.78],0.6472005170509012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,17228,69,1.35 [0.86-2.14],0.1943402138223351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSP90B1,Endoplasmin,19724,83,0.90 [0.64-1.26],0.535677446238044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPA1A,Heat shock 70 kDa protein 1A,20335,84,1.22 [0.93-1.59],0.1461346729176043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPA2,Heat shock-related 70 kDa protein 2,17598,68,2.76 [1.94-3.91],1.5006920433938414e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPB1,Heat shock protein beta-1,19976,84,1.33 [0.98-1.81],0.068977680827289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPB6,Heat shock protein beta-6,20442,86,6.57 [4.66-9.26],7.482374761608822e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,20161,83,5.29 [3.71-7.54],3.1361696106127307e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HTR1A,5-hydroxytryptamine receptor 1A,17100,68,1.02 [0.74-1.40],0.9197173516344972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HTR1B,5-hydroxytryptamine receptor 1B,17100,68,0.78 [0.43-1.44],0.4341529297908097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HTRA2,"Serine protease HTRA2, mitochondrial",20360,87,1.25 [0.92-1.69],0.1479934159364272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HYAL1,Hyaluronidase-1,20207,83,10.16 [5.29-19.52],3.4765470572322773e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,HYOU1,Hypoxia up-regulated protein 1,20528,88,8.78 [4.32-17.81],1.787587357821756e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICA1,Islet cell autoantigen 1,19903,84,1.09 [0.85-1.39],0.5086482630734095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM1,Intercellular adhesion molecule 1,20221,84,3.75 [2.11-6.65],6.621840894810274e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM2,Intercellular adhesion molecule 2,20528,88,3.58 [1.97-6.49],2.788169918377025e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM3,Intercellular adhesion molecule 3,20528,88,3.06 [1.67-5.61],0.0002843427544893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM4,Intercellular adhesion molecule 4,20224,82,0.65 [0.45-0.93],0.0194850879300634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICAM5,Intercellular adhesion molecule 5,20278,85,1.87 [1.25-2.79],0.0021372022351024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ICOSLG,ICOS ligand,20178,85,4.95 [1.92-12.75],0.0009401494042205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ID4,DNA-binding protein inhibitor ID-4,17353,70,1.24 [0.77-2.01],0.3792444206875712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IDI2,Isopentenyl-diphosphate delta-isomerase 2,19826,83,1.40 [0.98-2.01],0.0633271031390723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IDO1,"Indoleamine 2,3-dioxygenase 1",17228,69,1.08 [0.74-1.56],0.699896634514958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IDS,Iduronate 2-sulfatase,20478,85,0.35 [0.05-2.53],0.2955811263080025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IDUA,Alpha-L-iduronidase,20442,86,2.93 [1.87-4.59],2.657387221073536e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,17149,68,3.18 [2.06-4.90],1.648234450887219e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,17353,70,0.88 [0.55-1.40],0.5773339158025117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,17353,70,1.43 [0.85-2.39],0.1773610758289455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNAR1,Interferon alpha/beta receptor 1,17593,70,1.26 [0.53-3.01],0.5947399055616938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNG,Interferon gamma,19903,84,1.21 [1.01-1.44],0.0378241574050914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNGR1,Interferon gamma receptor 1,20361,84,5.76 [3.50-9.50],6.294937377257894e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNGR2,Interferon gamma receptor 2,20091,84,1.90 [1.36-2.66],0.0001822998189166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNL1,Interferon lambda-1,19826,83,1.92 [1.38-2.69],0.0001261405473396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNL2,Interferon lambda-2,17100,68,0.80 [0.50-1.27],0.3436064491076019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNLR1,Interferon lambda receptor 1,20224,82,1.94 [1.36-2.75],0.0002247384161545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFNW1,Interferon omega-1,17070,67,0.87 [0.42-1.82],0.7157272059791802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IFT20,Intraflagellar transport protein 20 homolog,17188,68,1.55 [0.95-2.52],0.077243497042173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGBP1,Immunoglobulin-binding protein 1,17643,68,0.86 [0.58-1.27],0.4447953916608356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,17100,68,0.93 [0.56-1.54],0.7763302173012163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,17688,69,0.69 [0.29-1.64],0.3967155384183277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGF1R,Insulin-like growth factor 1 receptor,20178,85,6.15 [3.90-9.72],6.714099133333714e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,17070,67,1.31 [0.80-2.14],0.2796314048890048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGF2R,Cation-independent mannose-6-phosphate receptor,20294,86,7.85 [3.70-16.65],7.771321576130514e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP1,Insulin-like growth factor-binding protein 1,20494,87,1.08 [0.93-1.26],0.3287859306103038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP2,Insulin-like growth factor-binding protein 2,20505,88,2.25 [1.66-3.06],2.112118449560154e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP3,Insulin-like growth factor-binding protein 3,20401,85,0.31 [0.22-0.44],3.396279808671136e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP4,Insulin-like growth factor-binding protein 4,20025,84,3.82 [3.11-4.69],2.734024984018275e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP6,Insulin-like growth factor-binding protein 6,20213,84,4.57 [3.14-6.64],2.081711469816018e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBP7,Insulin-like growth factor-binding protein 7,20528,88,2.68 [2.13-3.37],2.6049412276350002e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,20278,85,6.91 [4.67-10.23],4.796839174321517e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGFL4,Insulin growth factor-like family member 4,17153,67,1.22 [0.96-1.55],0.1074027667836877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGHMBP2,DNA-binding protein SMUBP-2,17070,67,1.28 [0.85-1.92],0.2379763534169271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGLC2,Immunoglobulin lambda constant 2,17678,69,2.56 [1.80-3.63],1.4157895984260321e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGLON5,IgLON family member 5,17033,67,1.15 [0.93-1.40],0.1909688069697094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF21,Immunoglobulin superfamily member 21,17228,69,0.63 [0.32-1.25],0.190882910509769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF3,Immunoglobulin superfamily member 3,20178,85,2.36 [1.84-3.04],1.6778734600648053e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF8,Immunoglobulin superfamily member 8,20278,85,4.74 [3.44-6.53],1.883789841889085e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IGSF9,Protein turtle homolog A,17683,70,1.53 [1.18-1.98],0.0015083713491722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IKBKG,NF-kappa-B essential modulator,20224,82,1.20 [0.97-1.49],0.0955117104278307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IKZF2,Zinc finger protein Helios,19826,80,1.01 [0.79-1.28],0.9419336978767424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL10,Interleukin-10,19903,84,1.41 [1.19-1.67],8.211822391070926e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL10RA,Interleukin-10 receptor subunit alpha,19903,84,1.13 [0.86-1.49],0.3663444580676527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL10RB,Interleukin-10 receptor subunit beta,20361,84,3.85 [2.92-5.06],7.138873907326339e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL11,Interleukin-11,19903,84,0.98 [0.72-1.34],0.9187493119432564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12A_IL12B,Interleukin-12,20178,85,2.14 [1.77-2.59],7.168898681484888e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12B,Interleukin-12 subunit beta,20478,85,2.79 [2.02-3.85],3.8001029878780094e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12RB1,Interleukin-12 receptor subunit beta-1,19903,84,3.07 [2.47-3.82],5.849669957878739e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL12RB2,Interleukin-12 receptor subunit beta-2,17153,67,2.25 [1.54-3.29],2.726447989017884e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL13,Interleukin-13,19903,84,0.93 [0.60-1.44],0.737615042293905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL13RA1,Interleukin-13 receptor subunit alpha-1,20049,86,0.41 [0.17-0.96],0.0406210041870661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL13RA2,Interleukin-13 receptor subunit alpha-2,17100,68,1.01 [0.45-2.23],0.9893532742837476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL15,Interleukin-15,20224,82,2.69 [1.55-4.65],0.0004059027698848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL15RA,Interleukin-15 receptor subunit alpha,19903,84,4.14 [2.50-6.84],3.0911958156632385e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL16,Pro-interleukin-16,20478,85,1.71 [1.18-2.46],0.0041641674176846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17A,Interleukin-17A,19874,83,1.24 [0.82-1.88],0.3138870341840692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17C,Interleukin-17C,19903,84,1.50 [1.26-1.79],5.7299113982572405e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17D,Interleukin-17D,19903,84,1.49 [1.00-2.21],0.0500529379065451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17F,Interleukin-17F,19903,84,1.05 [0.82-1.35],0.704848091093475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17RA,Interleukin-17 receptor A,20294,86,1.41 [0.92-2.17],0.1141582803738151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL17RB,Interleukin-17 receptor B,19975,82,1.30 [0.91-1.87],0.1522045484516236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18,Interleukin-18,20207,84,2.57 [1.82-3.63],8.108884289905698e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18BP,Interleukin-18-binding protein,20401,85,8.18 [5.42-12.35],1.250671771132129e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18R1,Interleukin-18 receptor 1,20478,85,7.07 [4.31-11.60],9.217637542523288e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL18RAP,Interleukin-18 receptor accessory protein,19961,83,1.01 [0.90-1.14],0.8393370835080998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL19,Interleukin-19,19748,81,1.82 [1.51-2.19],3.6773329655693096e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1A,Interleukin-1 alpha,19903,84,1.02 [0.76-1.36],0.915850079519532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1B,Interleukin-1 beta,19819,83,1.11 [0.81-1.53],0.5141619561720518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1R1,Interleukin-1 receptor type 1,20262,85,27.43 [17.11-43.98],5.362805638923238e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1R2,Interleukin-1 receptor type 2,20239,84,4.94 [1.82-13.40],0.0016931647513232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RAP,Interleukin-1 receptor accessory protein,20294,86,1.36 [0.91-2.04],0.1392658362803016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RL1,Interleukin-1 receptor-like 1,20470,88,4.24 [2.84-6.32],1.329256636283137e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RL2,Interleukin-1 receptor-like 2,19903,84,0.90 [0.54-1.50],0.6952874851394912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL1RN,Interleukin-1 receptor antagonist protein,20237,84,2.09 [1.63-2.67],4.497593215090572e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL2,Interleukin-2,19903,84,1.00 [0.54-1.86],0.991021287049508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL20,Interleukin-20,19903,84,1.10 [0.76-1.59],0.612937937157748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL20RA,Interleukin-20 receptor subunit alpha,19903,84,0.96 [0.59-1.55],0.8679080982984888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL20RB,Interleukin-20 receptor subunit beta,17153,67,1.12 [0.66-1.90],0.666527161572813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL21R,Interleukin-21 receptor,17153,67,1.01 [0.70-1.46],0.9419050501706606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL22,Interleukin-22,17598,68,1.58 [1.22-2.05],0.0004931538873613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL22RA1,Interleukin-22 receptor subunit alpha-1,19903,84,1.27 [0.91-1.77],0.1538968454341668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL24,Interleukin-24,19903,84,0.57 [0.35-0.92],0.020542567395842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL25,Interleukin-25,16974,67,1.10 [0.55-2.19],0.7839288457522837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL2RA,Interleukin-2 receptor subunit alpha,20123,87,2.73 [2.22-3.36],1.893517072262059e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL2RB,Interleukin-2 receptor subunit beta,19903,84,1.51 [1.02-2.24],0.0417449790933244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL2RG,Cytokine receptor common subunit gamma,17598,68,1.44 [0.93-2.22],0.0991049973422527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL3,Interleukin-3,17033,67,1.25 [0.83-1.89],0.287681930559995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL31,Interleukin-31,17153,67,0.95 [0.61-1.50],0.8381886702863743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL31RA,Interleukin-31 receptor subunit alpha,17083,67,1.20 [0.65-2.22],0.5672040312228896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL32,Interleukin-32,20224,82,1.80 [1.28-2.55],0.0008429094022929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL33,Interleukin-33,19903,84,1.88 [1.18-2.99],0.0077004747728776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL34,Interleukin-34,19797,83,1.10 [0.65-1.88],0.7169849049525878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL36A,Interleukin-36 alpha,17153,67,0.91 [0.58-1.43],0.6882880461709997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL36G,Interleukin-36 gamma,17071,67,1.37 [1.10-1.71],0.0045914793705163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL3RA,Interleukin-3 receptor subunit alpha,19903,84,1.94 [1.13-3.33],0.0157714945593687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL4,Interleukin-4,19903,84,1.17 [0.90-1.50],0.2365986623403215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL4R,Interleukin-4 receptor subunit alpha,20224,82,3.38 [2.45-4.65],9.039942982119734e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL5,Interleukin-5,19903,84,0.82 [0.70-0.98],0.025429609286775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL5RA,Interleukin-5 receptor subunit alpha,20224,82,1.70 [1.28-2.25],0.0002648240810162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL6,Interleukin-6,20178,85,1.62 [1.38-1.89],1.856657108509251e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL6R,Interleukin-6 receptor subunit alpha,20196,84,1.63 [0.92-2.87],0.0940141503853679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL6ST,Interleukin-6 receptor subunit beta,20278,85,10.23 [5.89-17.74],1.3451157632689183e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL7,Interleukin-7,20224,82,0.92 [0.67-1.26],0.5933263424950809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL7R,Interleukin-7 receptor subunit alpha,20294,86,0.84 [0.59-1.20],0.3422445093285625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IL9,Interleukin-9,17353,70,1.28 [0.96-1.71],0.0937590886148649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,19793,83,1.31 [0.99-1.73],0.0625924256160447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IMMT,MICOS complex subunit MIC60,17598,68,2.61 [1.97-3.44],1.3804486774607254e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IMPA1,Inositol monophosphatase 1,20091,84,1.02 [0.74-1.42],0.8862470422415466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IMPACT,Protein IMPACT,17647,71,0.81 [0.53-1.23],0.3161451358576906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IMPG1,Interphotoreceptor matrix proteoglycan 1,17100,68,0.55 [0.22-1.33],0.1813216094498051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ING1,Inhibitor of growth protein 1,19793,82,1.08 [0.74-1.57],0.6928814205349889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INHBB,Inhibin beta B chain,17300,68,2.32 [1.61-3.37],7.936436735388842e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INHBC,Inhibin beta C chain,20294,86,4.29 [2.53-7.29],6.713942854608146e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INPP1,Inositol polyphosphate 1-phosphatase,20178,85,1.32 [0.93-1.87],0.1231703238310448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",17228,69,1.35 [0.91-2.02],0.137835432587922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",17643,68,1.05 [0.60-1.82],0.8693008641883133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",20178,85,1.24 [1.02-1.51],0.0312642306581377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSL3,Insulin-like 3,17647,71,0.77 [0.59-0.99],0.041578454526041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSL4,Early placenta insulin-like peptide,17598,68,1.66 [1.30-2.12],5.08074701707226e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSL5,Insulin-like peptide INSL5,17593,70,1.67 [1.36-2.05],9.197693377364508e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,INSR,Insulin receptor,17153,67,5.89 [2.56-13.53],2.941106715252381e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IPCEF1,Interactor protein for cytohesin exchange factors 1,20056,84,1.15 [0.92-1.43],0.2086881687023622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IQGAP2,Ras GTPase-activating-like protein IQGAP2,20178,85,1.78 [1.30-2.44],0.0003252690030895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",19892,84,1.24 [1.02-1.52],0.0329063766735954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IRAK1,Interleukin-1 receptor-associated kinase 1,19903,84,1.33 [1.01-1.75],0.0421186813824499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IRAK4,Interleukin-1 receptor-associated kinase 4,20224,82,1.14 [0.94-1.39],0.1793582838707766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,19561,81,1.02 [0.62-1.67],0.9434968514957968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ISM1,Isthmin-1,20224,82,1.25 [0.75-2.10],0.393912940408152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ISM2,Isthmin-2,17688,69,0.93 [0.53-1.64],0.7945368091574081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IST1,IST1 homolog,17465,69,1.07 [0.84-1.36],0.5804966111647758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA11,Integrin alpha-11,20224,82,0.33 [0.19-0.55],2.807767770552089e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA2,Integrin alpha-2,17300,68,0.52 [0.27-1.01],0.052450751463506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA5,Integrin alpha-5,20294,86,9.74 [4.97-19.07],3.192241878397253e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGA6,Integrin alpha-6,20224,82,0.74 [0.48-1.14],0.1716620049121844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGAL,Integrin alpha-L,17153,67,1.79 [1.00-3.21],0.0501357305372664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGAM,Integrin alpha-M,20294,86,1.64 [0.90-2.99],0.1063474143990712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGAV,Integrin alpha-V,20442,86,0.34 [0.19-0.64],0.0006580187062682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGAX,Integrin alpha-X,17353,70,1.05 [0.70-1.56],0.8291697143901704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB1,Integrin beta-1,20302,85,2.78 [1.20-6.48],0.0175976314732984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB1BP1,Integrin beta-1-binding protein 1,19826,80,1.07 [0.65-1.76],0.8038730762983333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB1BP2,Integrin beta-1-binding protein 2,19892,84,1.11 [0.93-1.32],0.236029517796624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB2,Integrin beta-2,20162,86,3.34 [1.83-6.10],8.990792217987531e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB5,Integrin beta-5,20360,87,1.13 [0.70-1.83],0.6119533923942468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB6,Integrin beta-6,19903,84,3.09 [1.65-5.79],0.000446269054165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGB7,Integrin beta-7,20442,86,2.13 [1.50-3.02],2.167030901657852e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITGBL1,Integrin beta-like protein 1,17688,69,3.65 [2.79-4.76],2.055709523586804e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,17711,69,1.79 [0.50-6.34],0.3673452020232182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,20401,85,5.16 [3.20-8.30],1.4074477445965148e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,17711,69,1.56 [0.64-3.81],0.3256504963850558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,17598,68,1.49 [1.05-2.13],0.0257537901309898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITM2A,Integral membrane protein 2A,20224,82,1.05 [0.76-1.43],0.7808888657645447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITPA,Inosine triphosphate pyrophosphatase,17070,67,0.97 [0.69-1.37],0.8786173920828398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",17228,69,1.18 [0.87-1.60],0.2915899292180615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",17100,68,1.18 [0.71-1.96],0.5248296862562832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",19826,83,0.81 [0.53-1.22],0.3162439867499085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,IZUMO1,Izumo sperm-egg fusion protein 1,17033,67,1.12 [0.70-1.78],0.6347522204536881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JAM2,Junctional adhesion molecule B,20440,87,5.45 [3.63-8.19],3.3892101204930307e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JAM3,Junctional adhesion molecule C,17300,68,2.14 [1.45-3.14],0.0001190324242825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JCHAIN,Immunoglobulin J chain,19903,84,1.53 [1.12-2.07],0.0069497944956275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,17033,67,1.01 [0.69-1.47],0.9554770777744755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JPT2,Jupiter microtubule associated homolog 2,17593,70,1.16 [0.89-1.51],0.2836509178370066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,JUN,Transcription factor AP-1,19903,84,1.69 [1.31-2.18],6.268726782518102e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,20178,85,3.23 [2.02-5.15],9.195744234595762e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KAZN,Kazrin,17593,70,1.18 [0.95-1.47],0.1372713889493676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KCNC4,Potassium voltage-gated channel subfamily C member 4,17100,68,1.31 [0.96-1.80],0.0932307957100102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KCNH2,Potassium voltage-gated channel subfamily H member 2,17188,68,1.19 [0.92-1.54],0.1754675630677612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KCNIP4,Kv channel-interacting protein 4,19826,83,0.77 [0.48-1.24],0.2769242989183108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KCTD5,BTB/POZ domain-containing protein KCTD5,17330,70,1.76 [1.24-2.52],0.0017747761664642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KDM3A,Lysine-specific demethylase 3A,17153,67,1.27 [1.04-1.56],0.0207549782523341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KDR,Vascular endothelial growth factor receptor 2,20360,87,0.54 [0.26-1.14],0.1065497805430036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KEL,Kell blood group glycoprotein,19826,83,1.29 [0.76-2.19],0.3520784140703543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KHDC3L,KH domain-containing protein 3,17033,67,0.87 [0.59-1.29],0.5031167360976558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KHK,Ketohexokinase,17228,69,1.34 [0.92-1.94],0.1221337881898229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIAA0319,Dyslexia-associated protein KIAA0319,17647,71,1.29 [0.67-2.47],0.4455597851505842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIAA1549,UPF0606 protein KIAA1549,17353,70,1.08 [0.77-1.53],0.6418537827670031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIAA1549L,UPF0606 protein KIAA1549L,17353,70,1.19 [0.57-2.45],0.6448063065523261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIAA2013,Uncharacterized protein KIAA2013,17598,68,0.80 [0.47-1.35],0.3962120757288624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIF1C,Kinesin-like protein KIF1C,17070,67,2.43 [1.84-3.20],3.605258805906949e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIF20B,Kinesin-like protein KIF20B,17100,68,0.95 [0.70-1.30],0.7518605361196015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIF22,Kinesin-like protein KIF22,17070,67,1.17 [0.96-1.43],0.1282004628822932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIFBP,KIF-binding protein,20178,85,1.27 [1.00-1.62],0.0480786406562335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,17598,68,1.39 [1.08-1.78],0.009375412463822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,19826,80,1.34 [1.07-1.69],0.0112206838155063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,17593,70,1.03 [0.91-1.18],0.6102063994994706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,19826,80,1.05 [0.90-1.23],0.4946530083620116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,17033,67,0.94 [0.68-1.29],0.6920449149449959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIRREL1,Kin of IRRE-like protein 1,17100,68,0.94 [0.59-1.49],0.7848299467573505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIRREL2,Kin of IRRE-like protein 2,19826,83,1.12 [0.71-1.76],0.6374281601284705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KIT,Mast/stem cell growth factor receptor Kit,20356,85,0.34 [0.18-0.64],0.0007946754280691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KITLG,Kit ligand,20278,85,0.83 [0.51-1.35],0.4461650303005169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLB,Beta-klotho,19826,83,1.19 [0.92-1.53],0.1889439816702778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLF4,Krueppel-like factor 4,17100,68,1.30 [0.75-2.23],0.3490630273185731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLHL41,Kelch-like protein 41,17643,68,1.62 [1.10-2.39],0.0147065987022343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK1,Kallikrein-1,20093,86,0.90 [0.77-1.04],0.1598072403279499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK10,Kallikrein-10,20299,87,1.00 [0.64-1.57],0.9982248640502188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK11,Kallikrein-11,20174,87,2.41 [1.91-3.04],1.525818207537767e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK12,Kallikrein-12,19826,80,0.95 [0.83-1.10],0.511587845026406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK13,Kallikrein-13,19840,84,0.60 [0.40-0.90],0.0135840383218788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK14,Kallikrein-14,20442,86,1.09 [0.72-1.64],0.6855369382165649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK15,Kallikrein-15,17562,68,1.31 [0.86-2.01],0.21130307479192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK3,Prostate-specific antigen,17688,69,0.77 [0.62-0.95],0.0160689970950184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK4,Kallikrein-4,20442,86,2.47 [2.12-2.88],1.323340934658377e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK6,Kallikrein-6,20319,86,1.80 [0.98-3.31],0.0598920098561915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK7,Kallikrein-7,16864,67,0.38 [0.20-0.72],0.003139580074852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLK8,Kallikrein-8,19610,86,1.64 [1.02-2.63],0.0413359980973329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLKB1,Plasma kallikrein,17330,69,0.58 [0.23-1.46],0.2487782850145615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,20478,85,6.89 [4.70-10.09],4.256222841001497e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,17100,68,1.06 [0.72-1.57],0.7640714094122907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRD1,Natural killer cells antigen CD94,20478,85,2.67 [1.80-3.95],1.0473237638199243e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRF1,Killer cell lectin-like receptor subfamily F member 1,17153,67,1.55 [1.11-2.17],0.0100509916158373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KLRK1,NKG2-D type II integral membrane protein,17647,71,2.38 [1.82-3.12],3.69454658380933e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT14,"Keratin, type I cytoskeletal 14",19202,80,0.58 [0.26-1.27],0.1713980051453023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT17,"Keratin, type I cytoskeletal 17",17070,67,0.58 [0.30-1.11],0.1011125861808595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT18,"Keratin, type I cytoskeletal 18",20178,85,1.79 [1.51-2.13],2.7548252307270197e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT19,"Keratin, type I cytoskeletal 19",20184,82,2.50 [2.02-3.10],5.426417177581133e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT5,"Keratin, type II cytoskeletal 5",19826,83,1.04 [0.71-1.52],0.8341952860584754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT6C,"Keratin, type II cytoskeletal 6C",17070,67,1.26 [0.70-2.29],0.4393334564459834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KRT8,"Keratin, type II cytoskeletal 8",17100,68,1.53 [1.35-1.74],2.3608261357911232e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KYAT1,Kynurenine--oxoglutarate transaminase 1,20251,85,0.96 [0.68-1.35],0.8061816504268948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,KYNU,Kynureninase,20478,85,1.19 [0.79-1.79],0.3955315564505579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,L1CAM,Neural cell adhesion molecule L1,20360,87,0.90 [0.47-1.73],0.7619752982297467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,17683,70,1.13 [0.88-1.47],0.3438003670390984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LACRT,Extracellular glycoprotein lacritin,17567,68,0.57 [0.28-1.15],0.1157538457427955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LACTB2,Endoribonuclease LACTB2,20278,85,1.10 [0.83-1.47],0.5045782252633575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAG3,Lymphocyte activation gene 3 protein,20178,85,3.45 [2.61-4.56],4.218752299107737e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,20270,84,3.91 [3.00-5.09],4.123157173674663e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,20091,84,1.56 [1.29-1.89],4.901780707836432e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMA1,Laminin subunit alpha-1,17070,67,1.07 [0.69-1.68],0.7538892654154558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMA4,Laminin subunit alpha-4,20361,84,1.61 [0.93-2.79],0.0914118560603289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMB1,Laminin subunit beta-1,17228,69,4.15 [1.93-8.93],0.0002780379148391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMP1,Lysosome-associated membrane glycoprotein 1,17175,67,1.22 [0.74-2.00],0.4442683115305083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMP2,Lysosome-associated membrane glycoprotein 2,19643,81,0.81 [0.32-2.05],0.6605251178914515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMP3,Lysosome-associated membrane glycoprotein 3,20449,85,1.66 [1.17-2.35],0.0046058252426757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAMTOR5,Ragulator complex protein LAMTOR5,17598,68,1.06 [0.59-1.91],0.8498305308479315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAP3,Cytosol aminopeptidase,19903,84,1.25 [0.87-1.78],0.2237746651407535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LARP1,La-related protein 1,17598,68,1.24 [0.91-1.68],0.170445136771515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAT,Linker for activation of T-cells family member 1,20478,85,1.23 [0.94-1.61],0.1288419264597872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAT2,Linker for activation of T-cells family member 2,20178,85,1.21 [1.04-1.41],0.0148772331217045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LATS1,Serine/threonine-protein kinase LATS1,17153,67,1.20 [0.91-1.58],0.2001675492983157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LAYN,Layilin,20058,83,6.00 [4.54-7.94],4.022163379576918e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LBP,Lipopolysaccharide-binding protein,20401,85,1.88 [1.39-2.54],4.686322760464958e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LBR,Delta(14)-sterol reductase LBR,20440,87,1.31 [1.05-1.64],0.0183242496460264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCAT,Phosphatidylcholine-sterol acyltransferase,17683,68,0.43 [0.20-0.91],0.0272343484569128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCN15,Lipocalin-15,17643,68,1.75 [1.44-2.12],1.6383129712424867e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCN2,Neutrophil gelatinase-associated lipocalin,19725,82,2.99 [2.12-4.21],3.436341040481589e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LCP1,Plastin-2,17688,69,0.62 [0.37-1.05],0.0779440330633923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LDLR,Low-density lipoprotein receptor,20329,87,0.91 [0.63-1.33],0.6362440661242457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LDLRAP1,Low density lipoprotein receptor adapter protein 1,17643,68,1.17 [0.93-1.48],0.1813205012218619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LECT2,Leukocyte cell-derived chemotaxin-2,17683,70,2.05 [1.48-2.84],1.672847870944669e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEFTY2,Left-right determination factor 2,20408,86,1.99 [1.36-2.90],0.0003681144095153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEG1,Protein LEG1 homolog,16737,65,1.02 [0.72-1.43],0.9200296355193204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LELP1,Late cornified envelope-like proline-rich protein 1,17100,68,1.03 [0.77-1.39],0.8225059224405719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEO1,RNA polymerase-associated protein LEO1,17643,68,1.62 [1.05-2.49],0.0287143250271787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEP,Leptin,20278,85,1.45 [1.06-1.98],0.0184267831077539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LEPR,Leptin receptor,20278,85,1.77 [1.09-2.88],0.0207161043826631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LETM1,Mitochondrial proton/calcium exchanger protein,17643,68,2.06 [1.56-2.72],3.304957154456473e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS1,Galectin-1,20278,85,2.82 [1.86-4.26],1.0304943175356185e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS3,Galectin-3,20340,87,4.35 [2.67-7.10],4.027152694240581e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS3BP,Galectin-3-binding protein,17711,69,2.88 [1.88-4.42],1.1163802817802734e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS4,Galectin-4,20270,84,4.22 [3.35-5.33],6.059436790343487e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS7_LGALS7B,Galectin-7,20198,85,1.75 [1.28-2.38],0.0004039461883363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS8,Galectin-8,20440,87,1.30 [0.97-1.75],0.0839622001894766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGALS9,Galectin-9,20267,84,8.04 [5.07-12.75],7.462444173591594e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LGMN,Legumain,20361,84,1.63 [0.96-2.76],0.0704130630408265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LHB,Lutropin subunit beta,19826,80,1.11 [0.91-1.36],0.2865896791383381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,20295,84,0.61 [0.45-0.82],0.0011779762086089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LIF,Leukemia inhibitory factor,19826,83,0.98 [0.65-1.46],0.9054362075864932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LIFR,Leukemia inhibitory factor receptor,20224,82,9.51 [6.27-14.41],2.655587646059028e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,20294,86,1.70 [0.97-2.96],0.0626184788364673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,17688,69,0.93 [0.81-1.07],0.2984829165344984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,17070,67,1.16 [0.75-1.80],0.4999495972006443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,20237,85,3.02 [1.69-5.42],0.000198585710416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,17683,70,1.90 [1.36-2.66],0.0001787751359798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,20528,88,3.80 [2.04-7.05],2.4428900165227867e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,20447,88,3.20 [1.77-5.77],0.0001105774393231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,19903,84,3.70 [2.63-5.21],6.739014218846305e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,20528,88,0.98 [0.75-1.29],0.900707456837837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LIPF,Gastric triacylglycerol lipase,17228,69,0.70 [0.48-1.02],0.0621647063061884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LMNB1,Lamin-B1,17564,70,1.03 [0.70-1.51],0.8726506858405128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LMNB2,Lamin-B2,17647,71,4.03 [2.44-6.65],4.741290772610453e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LMOD1,Leiomodin-1,17643,68,3.18 [2.35-4.30],7.499215832563877e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LMOD2,Leiomodin-2,17100,68,0.87 [0.57-1.33],0.5227087703964202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LONP1,"Lon protease homolog, mitochondrial",17228,69,1.43 [1.11-1.84],0.0059670252870471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPA,Apolipoprotein(a),17311,68,1.11 [0.98-1.26],0.1097192071192547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPCAT2,Lysophosphatidylcholine acyltransferase 2,20178,85,1.20 [0.85-1.70],0.2932367319288774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPL,Lipoprotein lipase,20278,85,0.67 [0.46-0.97],0.0339632295316575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPO,Lactoperoxidase,19573,83,1.73 [1.27-2.36],0.0004812916804287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LPP,Lipoma-preferred partner,17070,67,1.03 [0.72-1.47],0.8804802315018692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,17070,67,1.45 [1.06-1.99],0.020145197520055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,17188,68,0.75 [0.41-1.37],0.343248998345065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRG1,Leucine-rich alpha-2-glycoprotein,17711,69,2.92 [1.32-6.50],0.0084331959923641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,20372,86,3.19 [1.97-5.15],2.207545377190604e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,17093,67,2.70 [1.58-4.59],0.0002554475103782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRP1,Prolow-density lipoprotein receptor-related protein 1,20178,85,2.14 [1.11-4.10],0.0226201707914534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRP11,Low-density lipoprotein receptor-related protein 11,20278,85,5.31 [3.47-8.12],1.407144986814562e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRP2,Low-density lipoprotein receptor-related protein 2,17188,68,1.01 [0.55-1.86],0.9667508739587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRP2BP,LRP2-binding protein,17188,68,1.35 [1.12-1.63],0.0018088088702778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,20440,87,1.24 [0.93-1.64],0.1374148745389373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRC25,Leucine-rich repeat-containing protein 25,20178,85,3.06 [2.07-4.52],2.1872887112048626e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRC37A2,Leucine-rich repeat-containing protein 37A2,17593,70,2.42 [1.45-4.05],0.0007692452229015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRC38,Leucine-rich repeat-containing protein 38,17188,68,1.19 [0.75-1.87],0.4608937785536205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRC59,Leucine-rich repeat-containing protein 59,17683,70,1.55 [1.03-2.33],0.0370945696786401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,17598,68,1.57 [1.02-2.42],0.0422424553557481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRRN1,Leucine-rich repeat neuronal protein 1,19903,84,0.60 [0.37-0.96],0.0347096094263971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,17188,68,1.28 [0.78-2.12],0.3324767167578932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,17643,68,0.36 [0.13-0.95],0.0398012356050296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LSM1,U6 snRNA-associated Sm-like protein LSm1,19826,80,1.03 [0.74-1.45],0.8488994885535878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LSM8,U6 snRNA-associated Sm-like protein LSm8,17353,70,0.96 [0.73-1.27],0.7870308619199802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LSP1,Lymphocyte-specific protein 1,20224,82,1.90 [1.21-2.97],0.0051104921975041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTA,Lymphotoxin-alpha,20224,82,1.83 [1.26-2.65],0.0015601222396622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTA4H,Leukotriene A-4 hydrolase,20442,86,0.65 [0.46-0.93],0.0183958876149019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTB,Lymphotoxin-beta,17598,68,1.20 [0.68-2.11],0.5384229385289596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,20528,88,6.88 [4.72-10.03],1.1081513645572733e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,19826,80,1.94 [1.56-2.41],3.099461094487255e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTBR,Tumor necrosis factor receptor superfamily member 3,20186,84,6.50 [4.32-9.78],2.953968639910152e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LTO1,Protein LTO1 homolog,19903,84,1.29 [0.93-1.80],0.1264417928276092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LUZP2,Leucine zipper protein 2,17598,68,1.78 [1.28-2.48],0.0006360515273837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LXN,Latexin,20012,84,0.60 [0.43-0.84],0.0024759040015598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY6D,Lymphocyte antigen 6D,20176,84,2.30 [1.66-3.18],5.677421211205151e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY75,Lymphocyte antigen 75,20224,82,2.34 [1.36-4.02],0.002016570009197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY9,T-lymphocyte surface antigen Ly-9,20010,82,4.82 [2.98-7.82],1.6889839119635318e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LY96,Lymphocyte antigen 96,20091,84,2.51 [1.68-3.74],7.348721402742656e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYAR,Cell growth-regulating nucleolar protein,19826,80,0.80 [0.51-1.24],0.3190423184978884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYN,Tyrosine-protein kinase Lyn,20178,85,1.20 [0.95-1.51],0.1289193495209627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYPD1,Ly6/PLAUR domain-containing protein 1,19826,83,0.92 [0.65-1.30],0.6378980830297245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYPD3,Ly6/PLAUR domain-containing protein 3,20193,87,0.98 [0.55-1.75],0.948563018330378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYPD8,Ly6/PLAUR domain-containing protein 8,19826,80,1.63 [1.20-2.22],0.0019490969417697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYPLA2,Acyl-protein thioesterase 2,17100,68,1.11 [0.92-1.33],0.2627060509461461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,17188,68,0.95 [0.76-1.20],0.6846665056594572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,17711,69,6.21 [2.13-18.11],0.0008204193227527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LYZL2,Lysozyme-like protein 2,17033,67,1.40 [0.79-2.51],0.2508468437447568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,LZTFL1,Leucine zipper transcription factor-like protein 1,17300,68,1.10 [0.79-1.53],0.5758862142646612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,M6PR,Cation-dependent mannose-6-phosphate receptor,17228,69,0.99 [0.52-1.88],0.9859203153262036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,20020,83,1.59 [1.28-1.97],3.0830786896834274e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAEA,E3 ubiquitin-protein transferase MAEA,19826,80,1.14 [0.67-1.94],0.6309941754884005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAG,Myelin-associated glycoprotein,17188,68,0.76 [0.48-1.20],0.2370825479324023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAGEA3,Melanoma-associated antigen 3,17353,70,1.11 [0.84-1.48],0.4706246376762277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAGED1,Melanoma-associated antigen D1,19826,80,1.49 [1.04-2.14],0.0311067615048313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAMDC2,MAM domain-containing protein 2,17683,70,3.45 [2.11-5.65],8.082371108653432e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAMDC4,Apical endosomal glycoprotein,17598,68,1.35 [0.91-2.00],0.1320718530551445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",17228,69,2.13 [0.86-5.27],0.102372243780619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAN2B2,Epididymis-specific alpha-mannosidase,17683,70,1.28 [0.87-1.87],0.2116580184209843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",17033,67,1.05 [0.67-1.63],0.8405988015551678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MANF,Mesencephalic astrocyte-derived neurotrophic factor,20361,84,1.10 [0.93-1.31],0.2557414548580824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MANSC1,MANSC domain-containing protein 1,20360,87,5.05 [2.96-8.61],2.806308849064724e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MANSC4,MANSC domain-containing protein 4,17070,67,1.01 [0.73-1.41],0.9323283952084188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,17100,68,1.05 [0.50-2.20],0.8943415326440245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,17070,67,0.89 [0.58-1.38],0.602029683400743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP2,Microtubule-associated protein 2,17647,71,1.76 [1.29-2.41],0.0003528982186174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,17593,70,1.36 [0.95-1.95],0.0902648325927531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,20224,82,1.06 [0.87-1.29],0.5761587770772136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,19826,80,1.24 [1.02-1.50],0.0315010838833893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,20058,83,1.13 [0.95-1.35],0.1788062430865449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAPK13,Mitogen-activated protein kinase 13,17033,67,1.35 [0.81-2.22],0.2471188759116114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAPK9,Mitogen-activated protein kinase 9,20224,82,1.24 [0.77-2.00],0.3715274159047365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAPKAPK2,MAP kinase-activated protein kinase 2,17353,70,1.12 [0.83-1.53],0.4574380450146434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAPRE3,Microtubule-associated protein RP/EB family member 3,17033,67,1.11 [0.96-1.29],0.1714272275338354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAPT,Microtubule-associated protein tau,19826,83,1.20 [0.81-1.77],0.3653195934528117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MARCO,Macrophage receptor MARCO,20278,85,2.60 [1.24-5.43],0.0110689203551716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MARS1,"Methionine--tRNA ligase, cytoplasmic",17273,68,1.15 [0.87-1.52],0.3179735083907665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MASP1,Mannan-binding lectin serine protease 1,20058,83,1.84 [0.80-4.22],0.1511405654363111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MATN2,Matrilin-2,20297,84,3.05 [1.64-5.66],0.000412316473575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MATN3,Matrilin-3,20056,84,0.61 [0.33-1.13],0.1161316802065793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAVS,Mitochondrial antiviral-signaling protein,19826,80,1.30 [1.05-1.61],0.014652903289038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MAX,Protein max,19826,83,1.11 [0.92-1.33],0.2823877872247121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MB,Myoglobin,20528,88,2.51 [1.91-3.31],5.498911636729369e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MBL2,Mannose-binding protein C,17467,69,1.16 [0.94-1.44],0.1770214326258067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCAM,Cell surface glycoprotein MUC18,20401,85,1.82 [1.02-3.23],0.041163846959949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",17643,68,1.59 [1.06-2.39],0.0263071701291739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCEMP1,Mast cell-expressed membrane protein 1,17153,67,1.16 [0.90-1.50],0.2376123056465436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCFD2,Multiple coagulation factor deficiency protein 2,20174,85,2.44 [1.62-3.67],2.0601755804388345e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MCTS1,Malignant T-cell-amplified sequence 1,17593,70,1.22 [0.62-2.40],0.5634734531214556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,20091,84,1.88 [1.40-2.54],3.492866060879898e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDH1,"Malate dehydrogenase, cytoplasmic",17585,68,0.93 [0.51-1.70],0.8086654370505522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDK,Midkine,20303,87,2.17 [1.79-2.63],2.6317461344951654e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MDM1,Nuclear protein MDM1,17188,68,1.21 [0.58-2.54],0.6083953175347112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",17228,69,1.33 [1.04-1.71],0.0239990666250201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MED18,Mediator of RNA polymerase II transcription subunit 18,19826,80,1.13 [0.87-1.47],0.3581311547257113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MED21,Mediator of RNA polymerase II transcription subunit 21,17070,67,1.18 [0.75-1.85],0.4805465264234191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEGF10,Multiple epidermal growth factor-like domains protein 10,20270,84,2.31 [1.42-3.75],0.0007804199278096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEGF11,Multiple epidermal growth factor-like domains protein 11,17070,67,1.33 [0.71-2.49],0.3726529128895165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEGF9,Multiple epidermal growth factor-like domains protein 9,20470,88,2.41 [0.93-6.27],0.0705670479790396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MELTF,Melanotransferrin,17683,70,1.62 [0.86-3.04],0.1369843376953243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MENT,Protein MENT,17300,68,0.30 [0.18-0.50],3.14778416378019e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEP1A,Meprin A subunit alpha,17593,70,1.10 [0.81-1.50],0.5336007002755394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEP1B,Meprin A subunit beta,20278,85,0.86 [0.74-1.01],0.0617753713045476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MEPE,Matrix extracellular phosphoglycoprotein,20270,84,0.39 [0.20-0.74],0.0042240835447318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MERTK,Tyrosine-protein kinase Mer,20478,85,2.38 [1.18-4.79],0.0153035410632292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MESD,LRP chaperone MESD,20294,86,1.09 [0.94-1.28],0.2555417662614637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MET,Hepatocyte growth factor receptor,20323,86,0.55 [0.21-1.47],0.235812484404797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,METAP1,Methionine aminopeptidase 1,19826,83,1.45 [0.75-2.78],0.2683814306603606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",20224,82,1.29 [1.02-1.63],0.0369935527403255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,METAP2,Methionine aminopeptidase 2,20408,86,1.24 [0.88-1.76],0.2226886466709085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFAP3,Microfibril-associated glycoprotein 3,19892,84,1.02 [0.68-1.52],0.9349469486353084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFAP3L,Microfibrillar-associated protein 3-like,17188,68,0.94 [0.65-1.37],0.7452840909622602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFAP4,Microfibril-associated glycoprotein 4,17300,68,9.36 [4.81-18.22],4.583151000859918e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFAP5,Microfibrillar-associated protein 5,20528,88,1.76 [1.10-2.81],0.0176455028425174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MFGE8,Lactadherin,20294,86,4.23 [2.89-6.18],9.215696648950537e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MGLL,Monoglyceride lipase,20325,84,1.06 [0.85-1.33],0.593775291736224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MGMT,Methylated-DNA--protein-cysteine methyltransferase,20224,82,1.05 [0.89-1.24],0.5441564673362244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MIA,Melanoma-derived growth regulatory protein,20360,87,0.96 [0.57-1.62],0.8697252916904822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MICALL2,MICAL-like protein 2,17188,68,1.29 [0.95-1.76],0.1024106616362224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,20224,82,1.31 [1.07-1.61],0.0097685299692556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MIF,Macrophage migration inhibitory factor,20263,86,0.96 [0.72-1.28],0.7695535139416301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MILR1,Allergin-1,19903,84,2.76 [2.02-3.78],2.534476780469876e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,17598,68,1.12 [0.89-1.39],0.3291376377236382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MINK1,Misshapen-like kinase 1,17647,71,1.09 [0.85-1.40],0.492964646845172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MITD1,MIT domain-containing protein 1,20091,84,1.09 [0.89-1.34],0.4091945490182013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MKI67,Proliferation marker protein Ki-67,17153,67,1.59 [1.01-2.50],0.0458607896902054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MLLT1,Protein ENL,17033,67,1.38 [1.09-1.75],0.0073281008716989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MLN,Promotilin,20224,82,1.90 [1.50-2.41],9.527674882049953e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MME,Neprilysin,20178,85,1.79 [1.44-2.22],1.1500795206154877e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP1,Interstitial collagenase,19523,80,1.25 [0.99-1.57],0.0611951490470561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP10,Stromelysin-2,20216,84,1.93 [1.47-2.53],2.0050486452346472e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP12,Macrophage metalloelastase,20273,86,2.59 [1.96-3.43],2.8779465791895325e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP13,Collagenase 3,19826,83,1.06 [0.59-1.92],0.8411282029900565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP15,Matrix metalloproteinase-15,17683,70,1.34 [0.97-1.85],0.0737421217006989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP3,Stromelysin-1,20294,86,1.86 [1.34-2.59],0.0001989701710545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP7,Matrilysin,19861,84,4.39 [3.02-6.38],9.95866656497506e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP8,Neutrophil collagenase,20401,87,1.27 [0.99-1.63],0.0648080769975181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMP9,Matrix metalloproteinase-9,20253,86,1.31 [0.95-1.81],0.1031028366973165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",17070,67,1.39 [0.93-2.07],0.1054025544059975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MN1,Transcriptional activator MN1,17188,68,1.45 [1.10-1.90],0.0088288587014389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MNAT1,CDK-activating kinase assembly factor MAT1,17353,70,0.91 [0.51-1.65],0.7665483257697471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MNDA,Myeloid cell nuclear differentiation antigen,20242,85,0.93 [0.76-1.14],0.4841291743457807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MOCS2,Molybdopterin synthase catalytic subunit,17300,68,1.41 [1.01-1.97],0.0412283827151465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MOG,Myelin-oligodendrocyte glycoprotein,20442,86,1.48 [0.86-2.55],0.1580921736671295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MORC3,MORC family CW-type zinc finger protein 3,17647,71,1.62 [0.76-3.46],0.2104786918349777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MORF4L1,Mortality factor 4-like protein 1,17353,70,0.91 [0.48-1.74],0.7735485229939927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MORF4L2,Mortality factor 4-like protein 2,17033,67,1.00 [0.52-1.92],0.9997581732565668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MORN4,MORN repeat-containing protein 4,17033,67,1.00 [0.73-1.37],0.999361428124707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MPHOSPH8,M-phase phosphoprotein 8,19892,84,1.14 [0.89-1.46],0.3084551415968062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MPI,Mannose-6-phosphate isomerase,20178,85,1.21 [0.97-1.51],0.0980873972640098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,20325,84,1.08 [0.83-1.41],0.5778634695101541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MPO,Myeloperoxidase,20294,86,1.33 [0.92-1.93],0.1269479858628162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MPRIP,Myosin phosphatase Rho-interacting protein,17562,68,0.73 [0.41-1.27],0.2625796635229712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRC1,Macrophage mannose receptor 1,17683,68,8.20 [4.32-15.57],1.2402449701675995e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRI1,Methylthioribose-1-phosphate isomerase,17188,68,0.74 [0.53-1.03],0.0764267179034197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPL24,"39S ribosomal protein L24, mitochondrial",17070,67,1.36 [0.88-2.11],0.1719207343443148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPL28,"39S ribosomal protein L28, mitochondrial",17643,68,1.08 [0.60-1.95],0.7935095943100656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPL46,"39S ribosomal protein L46, mitochondrial",19826,83,1.20 [0.64-2.27],0.5735948560502421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPL52,"39S ribosomal protein L52, mitochondrial",16996,67,0.94 [0.39-2.31],0.8998317507851186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",17643,68,1.10 [0.81-1.48],0.5495140176960666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MRPS16,"28S ribosomal protein S16, mitochondrial",17153,67,0.67 [0.24-1.87],0.4470384488559326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSLN,Mesothelin,20145,85,1.77 [1.34-2.34],5.713027993938763e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSLNL,Mesothelin-like protein,17188,68,0.86 [0.48-1.53],0.6052730532521116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSMB,Beta-microseminoprotein,20239,88,1.44 [1.12-1.87],0.0053068231030362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSR1,Macrophage scavenger receptor types I and II,20440,87,3.88 [2.77-5.43],3.0151306106117364e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSRA,Mitochondrial peptide methionine sulfoxide reductase,20360,87,1.08 [0.83-1.41],0.5611850366897626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MST1,Hepatocyte growth factor-like protein,17405,68,1.70 [0.97-2.96],0.0636593702819239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MSTN,Growth/differentiation factor 8,19892,84,0.79 [0.56-1.13],0.1987611332215655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTDH,Protein LYRIC,17153,67,1.35 [1.06-1.72],0.0161702649307345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",17647,71,1.89 [1.06-3.37],0.031055757005448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,17353,70,1.05 [0.86-1.29],0.6115821541526989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTIF3,"Translation initiation factor IF-3, mitochondrial",17593,70,1.22 [0.95-1.57],0.1239392373660908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTPN,Myotrophin,19892,84,0.81 [0.42-1.54],0.5125250507627581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTR,Methionine synthase,17070,67,1.32 [0.99-1.76],0.0564806641863959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTSS1,Protein MTSS 1,17593,70,1.18 [0.96-1.45],0.1187617003369988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTSS2,Protein MTSS 2,17598,68,1.20 [0.95-1.50],0.1242103659204062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MTUS1,Microtubule-associated tumor suppressor 1,17353,70,1.73 [1.28-2.34],0.000331521678219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MUC13,Mucin-13,19826,83,4.37 [3.53-5.40],2.694882151953827e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MUC16,Mucin-16,20178,85,1.10 [0.98-1.23],0.0913999285552094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MUC2,Mucin-2,17688,69,1.08 [0.84-1.37],0.5551097344859528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MUCL3,Mucin-like protein 3,17033,67,1.60 [1.18-2.18],0.0023973752838392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MVK,Mevalonate kinase,19903,84,1.70 [1.39-2.09],3.799522193181081e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MXRA8,Matrix remodeling-associated protein 8,17300,68,0.49 [0.30-0.78],0.0032170225362106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYBPC1,"Myosin-binding protein C, slow-type",17683,70,2.27 [1.80-2.85],2.7390639953114665e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYBPC2,"Myosin-binding protein C, fast-type",17228,69,1.46 [1.23-1.73],1.2554473167784792e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,17643,68,1.13 [0.81-1.59],0.4640096030707314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYDGF,Myeloid-derived growth factor,17683,70,1.31 [1.04-1.65],0.0219479105226705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYH4,Myosin-4,17070,67,0.88 [0.51-1.52],0.6433991017340992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYH7B,Myosin-7B,17033,67,1.12 [0.69-1.81],0.6433767351622679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYH9,Myosin-9,17688,69,1.08 [0.89-1.32],0.440741883042519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",17070,67,1.92 [1.40-2.64],5.342878712637478e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYL3,Myosin light chain 3,17228,69,2.07 [1.57-2.74],3.218576989267161e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYL4,Myosin light chain 4,17228,69,1.21 [0.84-1.75],0.3006016115820591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYL6B,Myosin light chain 6B,17188,68,1.09 [0.87-1.38],0.4510533711789659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",17188,68,2.06 [1.68-2.54],1.0535322007326965e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYO6,Unconventional myosin-VI,17643,68,1.49 [0.92-2.40],0.1032667965583662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYO9B,Unconventional myosin-IXb,19903,84,1.11 [0.83-1.48],0.4793257667163656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYOC,Myocilin,20294,86,0.93 [0.60-1.43],0.7263247173720078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYOM1,Myomesin-1,17100,68,1.11 [0.70-1.76],0.6492162631246134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYOM2,Myomesin-2,17070,67,1.66 [1.19-2.32],0.0027182397687331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MYOM3,Myomesin-3,17300,68,1.55 [1.23-1.97],0.0002709164423819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MZB1,Marginal zone B- and B1-cell-specific protein,20333,84,1.89 [1.37-2.62],0.0001270573946131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,MZT1,Mitotic-spindle organizing protein 1,19826,80,1.24 [0.85-1.81],0.2667035738335728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAA10,N-alpha-acetyltransferase 10,17070,67,0.88 [0.56-1.41],0.6040712372372175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAA80,N-alpha-acetyltransferase 80,17188,68,1.14 [0.94-1.38],0.1737177884469974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAAA,N-acylethanolamine-hydrolyzing acid amidase,20002,83,1.04 [0.75-1.45],0.8050579151593207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NACC1,Nucleus accumbens-associated protein 1,17598,68,1.36 [0.97-1.92],0.0768146095359402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NADK,NAD kinase,20278,85,1.16 [0.85-1.59],0.3367186720645505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAGA,Alpha-N-acetylgalactosaminidase,17114,67,1.52 [1.14-2.03],0.0042735918170159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAGK,N-acetyl-D-glucosamine kinase,17199,69,0.59 [0.38-0.92],0.0191246491099748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,17300,68,3.78 [1.33-10.75],0.0128630655932692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAMPT,Nicotinamide phosphoribosyltransferase,19826,80,1.03 [0.71-1.47],0.892807603749441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAP1L4,Nucleosome assembly protein 1-like 4,17555,70,0.83 [0.47-1.46],0.525877251209589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NAPRT,Nicotinate phosphoribosyltransferase,17647,71,0.78 [0.38-1.60],0.4927612269484026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NARS1,"Asparagine--tRNA ligase, cytoplasmic",17643,68,1.27 [0.75-2.13],0.3776528420791045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,20360,87,12.58 [7.64-20.71],2.437162556867999e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NBN,Nibrin,19903,84,0.85 [0.56-1.29],0.4435974292869159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCAM1,Neural cell adhesion molecule 1,20401,85,1.42 [0.77-2.62],0.2634337786754838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCAM2,Neural cell adhesion molecule 2,20294,86,1.14 [0.55-2.36],0.7201892125486842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCAN,Neurocan core protein,20440,87,0.41 [0.30-0.56],9.352524426308721e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCF2,Neutrophil cytosol factor 2,20196,82,1.00 [0.79-1.27],0.9939801465329032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCK2,Cytoplasmic protein NCK2,20361,84,1.08 [0.90-1.30],0.3929433117087312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCLN,Nicalin,19903,84,1.28 [0.93-1.77],0.1312292736520783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCR1,Natural cytotoxicity triggering receptor 1,20192,82,5.35 [3.58-8.00],2.9835408092158923e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,17593,70,5.45 [3.60-8.27],1.3684875434700188e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NCS1,Neuronal calcium sensor 1,20442,86,7.40 [4.29-12.77],6.76410340402097e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDRG1,Protein NDRG1,19826,83,0.92 [0.66-1.30],0.6483372102992354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,17598,68,0.83 [0.54-1.28],0.3965482794850136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,17134,67,2.11 [1.14-3.93],0.0181973920195836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,17593,70,1.19 [0.92-1.53],0.1820284668632488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",19826,80,1.34 [1.14-1.57],0.0002718998103588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEB,Nebulin,17070,67,1.67 [1.07-2.60],0.0226931242826408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECAP2,Adaptin ear-binding coat-associated protein 2,17070,67,1.09 [0.78-1.53],0.6208139166286206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECTIN1,Nectin-1,17153,67,1.16 [0.56-2.39],0.6916510240788976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECTIN2,Nectin-2,20237,85,8.97 [6.22-12.95],1.0790118333197852e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NECTIN4,Nectin-4,20360,87,3.63 [2.68-4.92],1.1167294618872302e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,17153,67,0.86 [0.53-1.39],0.548336682682278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEDD9,Enhancer of filamentation 1,17153,67,1.60 [0.90-2.86],0.1092448585440259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEFL,Neurofilament light polypeptide,19765,83,3.23 [2.55-4.09],2.3145073779116493e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEK7,Serine/threonine-protein kinase Nek7,17353,70,0.95 [0.68-1.32],0.7637846142367269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NELL1,Protein kinase C-binding protein NELL1,20360,87,0.44 [0.33-0.59],5.963369181149202e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NELL2,Protein kinase C-binding protein NELL2,20361,84,1.31 [0.67-2.55],0.4282465158755634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NENF,Neudesin,17598,68,1.04 [0.84-1.29],0.7063663050887456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEO1,Neogenin,17643,68,1.93 [0.90-4.13],0.0908542127054787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NEXN,Nexilin,17683,68,1.21 [0.88-1.67],0.2476228191304256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFASC,Neurofascin,20478,85,27.32 [16.43-45.41],2.9206644153178408e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFAT5,Nuclear factor of activated T-cells 5,17153,67,1.22 [0.95-1.57],0.1133088331306848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",20224,82,1.21 [0.99-1.47],0.0596825729263738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",19903,84,1.83 [1.44-2.32],8.787289252351036e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFE2,Transcription factor NF-E2 45 kDa subunit,17228,69,1.26 [0.92-1.71],0.1463936412106556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFIC,Nuclear factor 1 C-type,17643,68,1.05 [0.65-1.69],0.8380875521778455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFKB1,Nuclear factor NF-kappa-B p105 subunit,17070,67,1.23 [0.90-1.69],0.1990397230830266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFKB2,Nuclear factor NF-kappa-B p100 subunit,17353,70,1.05 [0.70-1.57],0.8293072639160297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFKBIE,NF-kappa-B inhibitor epsilon,19826,80,1.43 [1.02-2.01],0.0377341939454063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",17593,70,1.21 [0.97-1.52],0.089712764420326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFX1,Transcriptional repressor NF-X1,17070,67,1.21 [0.86-1.70],0.2654042728206517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NFYA,Nuclear transcription factor Y subunit alpha,17070,67,1.40 [0.88-2.23],0.1579993813669675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NGF,Beta-nerve growth factor,20091,84,3.84 [0.99-14.97],0.052208764855927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NGFR,Tumor necrosis factor receptor superfamily member 16,17683,70,2.52 [1.83-3.47],1.437733827082148e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NGRN,Neugrin,17647,71,3.82 [2.44-5.98],4.753704679517841e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NHLRC3,NHL repeat-containing protein 3,16865,68,7.28 [3.60-14.72],3.3751293700863323e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NID1,Nidogen-1,20319,85,1.28 [0.76-2.14],0.3552182169208449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NID2,Nidogen-2,20294,86,1.02 [0.79-1.32],0.8819292063912595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NINJ1,Ninjurin-1,19826,80,1.40 [1.07-1.83],0.0150278834882902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NIT1,Deaminated glutathione amidase,17228,69,0.69 [0.43-1.11],0.1268740772463817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NIT2,Omega-amidase NIT2,17621,70,1.17 [0.85-1.60],0.3374233398083249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NLGN1,Neuroligin-1,17188,68,0.84 [0.54-1.30],0.4285520107519744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NLGN2,Neuroligin-2,17100,68,0.80 [0.45-1.40],0.4343033002504212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NME1,Nucleoside diphosphate kinase A,17153,67,2.73 [1.00-7.44],0.0499170456004434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NME3,Nucleoside diphosphate kinase 3,20297,84,0.71 [0.29-1.73],0.4461406234913277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NMI,N-myc-interactor,17542,68,1.18 [0.87-1.62],0.290129657737069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,20091,84,0.98 [0.75-1.28],0.8751171391821486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NMRK2,Nicotinamide riboside kinase 2,17033,67,1.15 [0.68-1.96],0.598522216974642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,17643,68,0.97 [0.69-1.36],0.8529299137800463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOMO1,Nodal modulator 1,20294,86,2.58 [1.14-5.83],0.0227522027520085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOP56,Nucleolar protein 56,17070,67,1.24 [1.06-1.46],0.0084251244939281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOS1,"Nitric oxide synthase, brain",19826,83,2.29 [1.88-2.78],1.8953564156230364e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOS2,"Nitric oxide synthase, inducible",17070,67,0.85 [0.45-1.61],0.6101559080476013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOS3,"Nitric oxide synthase, endothelial",19826,83,1.69 [1.41-2.02],1.1736420675069584e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOTCH1,Neurogenic locus notch homolog protein 1,20528,88,13.28 [4.87-36.20],4.275033170320253e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOTCH2,Neurogenic locus notch homolog protein 2,17688,69,4.59 [2.06-10.20],0.0001849535696529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NOTCH3,Neurogenic locus notch homolog protein 3,20528,88,2.02 [1.16-3.54],0.0133876168472941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPC2,NPC intracellular cholesterol transporter 2,17379,69,2.56 [1.96-3.33],3.561869315906003e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPDC1,Neural proliferation differentiation and control protein 1,20278,85,4.05 [3.08-5.31],8.145520962169034e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPHS1,Nephrin,17153,67,1.05 [0.51-2.16],0.8878162216211136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPHS2,Podocin,17153,67,1.11 [0.90-1.37],0.3430689355015837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPL,N-acetylneuraminate lyase,17683,70,1.40 [0.87-2.27],0.1692506458867954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPPB,Natriuretic peptides B,19892,84,1.41 [1.24-1.60],8.73551520713519e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPPC,C-type natriuretic peptide,20224,82,1.29 [0.94-1.77],0.120861389509442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPR1,Atrial natriuretic peptide receptor 1,17070,67,0.71 [0.36-1.41],0.3266282907644434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPTN,Neuroplastin,19826,80,1.20 [0.98-1.47],0.0761866038180587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPTX1,Neuronal pentraxin-1,20294,86,1.94 [1.28-2.95],0.0017905970875519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPTX2,Neuronal pentraxin-2,17688,69,3.20 [1.66-6.16],0.0004997784714927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPTXR,Neuronal pentraxin receptor,20278,85,0.95 [0.54-1.68],0.8679761110114922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NPY,Pro-neuropeptide Y,20442,86,3.87 [2.74-5.45],1.1852133649157794e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRCAM,Neuronal cell adhesion molecule,20278,85,4.86 [3.20-7.37],1.0252978475836277e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRGN,Neurogranin,17683,68,1.14 [0.89-1.47],0.3065918920431014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRN1,Neuritin,17643,68,1.29 [0.74-2.23],0.3686955144358652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRP1,Neuropilin-1,20427,85,10.59 [5.62-19.95],2.7203570496840053e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRP2,Neuropilin-2,20294,86,2.12 [1.19-3.76],0.0107518085862893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRTN,Neurturin,19903,84,1.51 [1.10-2.07],0.0112716531440206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NRXN3,Neurexin-3,17188,68,1.13 [0.60-2.13],0.6968247973232353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NSFL1C,NSFL1 cofactor p47,20440,87,0.84 [0.62-1.13],0.2423632236119261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",17683,70,1.12 [0.82-1.54],0.4734462243686306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,17647,71,2.79 [2.17-3.60],2.0135886486546544e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NT5C3A,Cytosolic 5'-nucleotidase 3A,20197,82,0.94 [0.75-1.17],0.563279887150747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NT5E,5'-nucleotidase,20360,87,1.20 [0.85-1.68],0.3074217895619792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTF3,Neurotrophin-3,20224,82,2.93 [2.05-4.18],3.0944623570569078e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTF4,Neurotrophin-4,19826,80,0.87 [0.47-1.60],0.6559669605654933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTRK2,BDNF/NT-3 growth factors receptor,20278,85,2.07 [0.98-4.38],0.0563778539871038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTRK3,NT-3 growth factor receptor,20440,87,0.32 [0.14-0.74],0.0078730345481127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,20278,85,1.61 [1.42-1.81],2.7824527448346382e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUB1,NEDD8 ultimate buster 1,20224,82,1.10 [0.87-1.38],0.4335905750979476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,17598,68,1.21 [0.98-1.50],0.0767164519886579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUCB2,Nucleobindin-2,20400,86,2.94 [1.82-4.74],1.02754137695063e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDC,Nuclear migration protein nudC,20478,85,1.43 [1.04-1.96],0.0281478013051407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,17228,69,0.72 [0.26-2.05],0.5424869436548725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,17070,67,0.85 [0.51-1.43],0.5473173083993534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDT16,U8 snoRNA-decapping enzyme,17557,70,1.31 [1.01-1.69],0.0442789336887722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],20178,85,0.80 [0.56-1.15],0.2238237513696467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUDT5,ADP-sugar pyrophosphatase,20294,86,1.32 [0.92-1.90],0.1346757312085355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUMB,Protein numb homolog,17153,67,1.22 [0.92-1.63],0.1730114434574464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NUP50,Nuclear pore complex protein Nup50,17070,67,1.34 [0.76-2.35],0.3103253197333613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NXPE4,NXPE family member 4,17070,67,1.06 [0.51-2.22],0.8729961749327316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NXPH1,Neurexophilin-1,19826,83,1.41 [0.99-2.00],0.0592483802772638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,NXPH3,Neurexophilin-3,17153,67,1.98 [0.90-4.36],0.0882453706849391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OBP2B,Odorant-binding protein 2b,20027,84,0.88 [0.64-1.22],0.4475489928462932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OCLN,Occludin,17643,68,3.31 [2.52-4.35],6.8738817680089e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ODAM,Odontogenic ameloblast-associated protein,19797,83,0.64 [0.43-0.94],0.0248001387398513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OFD1,Oral-facial-digital syndrome 1 protein,17353,70,1.06 [0.75-1.51],0.727022907975451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OGA,Protein O-GlcNAcase,17593,70,1.18 [0.86-1.64],0.3104317928141606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OGFR,Opioid growth factor receptor,20178,85,1.92 [1.11-3.32],0.01941826198099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OGN,Mimecan,20294,86,3.73 [2.72-5.11],2.708714509069822e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,17353,70,0.94 [0.62-1.41],0.7540656753065903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OLFM4,Olfactomedin-4,16654,67,1.36 [1.10-1.67],0.0041885850789208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OLR1,Oxidized low-density lipoprotein receptor 1,20078,84,1.17 [0.86-1.60],0.3033488969100686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OMD,Osteomodulin,20361,84,0.38 [0.25-0.58],5.085771994369453e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OMG,Oligodendrocyte-myelin glycoprotein,20178,85,0.55 [0.42-0.73],4.094554065787812e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OMP,Olfactory marker protein,17100,68,0.73 [0.42-1.27],0.2679554226142339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OPHN1,Oligophrenin-1,17647,71,1.10 [0.89-1.36],0.3856112161496591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OPLAH,5-oxoprolinase,17228,69,1.48 [1.06-2.06],0.0203026070705339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OPTC,Opticin,20178,85,1.24 [0.86-1.78],0.2401600831872679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ORM1,Alpha-1-acid glycoprotein 1,17644,69,1.97 [0.67-5.84],0.2208785929295375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSBPL2,Oxysterol-binding protein-related protein 2,17647,71,0.84 [0.43-1.68],0.62917515509584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,20297,84,4.47 [2.59-7.74],8.293193421996363e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSM,Oncostatin-M,20136,81,1.27 [0.96-1.69],0.0949709572595574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSMR,Oncostatin-M-specific receptor subunit beta,20427,85,10.42 [4.05-26.79],1.1468459598206457e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OSTN,Osteocrin,17188,68,1.00 [0.57-1.74],0.9908845510930238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OTOA,Otoancorin,17100,68,0.71 [0.40-1.26],0.2425060532934122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OTUD6B,Deubiquitinase OTUD6B,17593,70,1.07 [0.73-1.58],0.7191676764190467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OTUD7B,OTU domain-containing protein 7B,17643,68,1.53 [1.07-2.20],0.0200144454489296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",17228,69,1.24 [0.91-1.71],0.1751521922408311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,OXT,Oxytocin-neurophysin 1,20440,87,1.18 [1.03-1.36],0.0162727304627203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,P4HB,Protein disulfide-isomerase,20198,87,2.11 [1.31-3.39],0.0020470688292196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PACS2,Phosphofurin acidic cluster sorting protein 2,17070,67,1.49 [1.04-2.15],0.0298773498206706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PADI2,Protein-arginine deiminase type-2,19903,84,1.28 [0.98-1.67],0.0750452527938031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PADI4,Protein-arginine deiminase type-4,19797,83,0.84 [0.62-1.12],0.2300454075355503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAEP,Glycodelin,20091,84,1.12 [0.93-1.33],0.2260025895836585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,17643,68,1.19 [1.00-1.41],0.0512555805789431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",17353,70,1.20 [0.76-1.88],0.4295973708553784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,19892,84,1.55 [1.15-2.09],0.0042107820167394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAGR1,PAXIP1-associated glutamate-rich protein 1,17228,69,1.27 [0.77-2.08],0.3503462771971064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,17007,67,1.15 [0.72-1.84],0.5631906295643805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAK4,Serine/threonine-protein kinase PAK 4,19826,83,1.06 [0.78-1.44],0.7227705737040236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALLD,Palladin,17153,67,1.45 [0.93-2.26],0.1003228534468485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALM,Paralemmin-1,17493,70,3.27 [2.39-4.47],1.4164008131182618e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALM2,Paralemmin-2,17647,71,3.80 [2.91-4.98],1.858800575116972e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PALM3,Paralemmin-3,17070,67,1.23 [0.92-1.63],0.1570665782171115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAM,Peptidyl-glycine alpha-amidating monooxygenase,20431,87,1.65 [0.81-3.36],0.169084235974368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAMR1,Inactive serine protease PAMR1,20294,86,1.39 [0.68-2.84],0.3715943567619053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAPPA,Pappalysin-1,19903,84,0.81 [0.54-1.23],0.327485949269434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PARD3,Partitioning defective 3 homolog,17353,70,1.01 [0.75-1.38],0.9293727307366744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PARK7,Parkinson disease protein 7,20294,86,0.94 [0.65-1.38],0.7653460471155965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PARP1,Poly [ADP-ribose] polymerase 1,20224,82,1.17 [0.89-1.53],0.2528238745155713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PAXX,Protein PAXX,17300,68,1.36 [0.82-2.23],0.2293839049680883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PBK,Lymphokine-activated killer T-cell-originated protein kinase,17033,67,1.19 [0.58-2.43],0.641875078667905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PBLD,Phenazine biosynthesis-like domain-containing protein,19826,83,0.72 [0.49-1.05],0.086720752946027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,17593,70,2.31 [1.43-3.73],0.0005783180079506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCARE,Photoreceptor cilium actin regulator,17100,68,1.10 [0.86-1.40],0.4497893917780973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,17273,68,1.54 [1.00-2.38],0.051995320859293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCBP2,Poly(rC)-binding protein 2,17643,68,1.09 [0.79-1.51],0.5985514957046523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH1,Protocadherin-1,20415,85,2.91 [1.54-5.51],0.0010425922982041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH12,Protocadherin-12,17643,68,1.99 [0.82-4.82],0.1292339191291429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH17,Protocadherin-17,20278,85,3.31 [2.49-4.40],1.3040746049313914e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH7,Protocadherin-7,17593,70,2.08 [1.50-2.88],1.1224196837389868e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDH9,Protocadherin-9,17593,70,1.98 [1.02-3.87],0.0447416095754198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCDHB15,Protocadherin beta-15,17598,68,1.79 [1.10-2.92],0.0188011304411793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCNA,Proliferating cell nuclear antigen,17033,67,1.24 [0.93-1.65],0.14602324519143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCSK7,Proprotein convertase subtilisin/kexin type 7,17598,68,1.14 [0.73-1.77],0.5700102409592955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,20528,88,2.24 [1.42-3.53],0.0005163121926873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PCYT2,Ethanolamine-phosphate cytidylyltransferase,17593,70,1.12 [0.82-1.52],0.4701157276561877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDAP1,28 kDa heat- and acid-stable phosphoprotein,17683,70,1.15 [0.91-1.46],0.2419292418134678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD1,Programmed cell death protein 1,20405,86,2.61 [1.99-3.42],5.270087594933083e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD1LG2,Programmed cell death 1 ligand 2,20178,85,3.11 [2.30-4.21],2.4053935388284495e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD5,Programmed cell death protein 5,20440,87,1.09 [0.79-1.52],0.594247700164794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCD6,Programmed cell death protein 6,20278,85,1.48 [1.03-2.11],0.0319753712382083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDCL2,Phosducin-like protein 2,17033,67,0.89 [0.55-1.45],0.6391271741393136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",17033,67,1.05 [0.68-1.61],0.8291115182156876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",17070,67,1.13 [0.77-1.65],0.5430018084684642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",17300,68,1.06 [0.84-1.33],0.615937256634743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFA,Platelet-derived growth factor subunit A,20528,88,0.91 [0.70-1.19],0.5022298454773334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFB,Platelet-derived growth factor subunit B,20361,84,0.91 [0.72-1.14],0.394406968242132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFC,Platelet-derived growth factor C,19826,80,1.54 [0.77-3.10],0.2208980920471565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFRA,Platelet-derived growth factor receptor alpha,20278,85,7.64 [4.65-12.55],9.934565068532861e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDGFRB,Platelet-derived growth factor receptor beta,20528,88,1.17 [0.67-2.02],0.581149488526121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDIA2,Protein disulfide-isomerase A2,17033,67,0.94 [0.54-1.66],0.8387967040594477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDIA3,Protein disulfide-isomerase A3,17300,68,3.94 [2.40-6.46],5.3147786590334906e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDIA4,Protein disulfide-isomerase A4,17688,69,1.42 [0.99-2.02],0.0562823209874554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDIA5,Protein disulfide-isomerase A5,17033,67,0.90 [0.59-1.37],0.6172998407032577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDLIM5,PDZ and LIM domain protein 5,17643,68,1.05 [0.86-1.29],0.6158119991423889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDLIM7,PDZ and LIM domain protein 7,20361,84,1.12 [0.96-1.31],0.1450311427378153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",19826,80,1.01 [0.66-1.55],0.9509129673725872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDRG1,p53 and DNA damage-regulated protein 1,17188,68,0.89 [0.53-1.46],0.6347995465216127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,17033,67,0.47 [0.22-1.01],0.0533502753815322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDZD2,PDZ domain-containing protein 2,17070,67,1.58 [1.15-2.16],0.0050026027511332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,17153,67,2.95 [2.15-4.06],2.3978368082266507e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PEAR1,Platelet endothelial aggregation receptor 1,20528,88,4.72 [2.07-10.72],0.0002142502346593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PEBP1,Phosphatidylethanolamine-binding protein 1,20294,86,1.00 [0.72-1.41],0.979442631701574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PECAM1,Platelet endothelial cell adhesion molecule,20294,86,1.69 [0.93-3.08],0.0852474983171264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PECR,Peroxisomal trans-2-enoyl-CoA reductase,17228,69,0.57 [0.22-1.49],0.2551603218473055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PENK,Proenkephalin-A,17300,68,2.31 [1.61-3.33],6.427078976117959e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PEPD,Xaa-Pro dipeptidase,17683,68,0.48 [0.27-0.86],0.0129128091746685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PER3,Period circadian protein homolog 3,17153,67,1.00 [0.82-1.21],0.9934960188462792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PF4,Platelet factor 4,17576,68,1.09 [0.85-1.39],0.4980627444209702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PFDN2,Prefoldin subunit 2,19826,83,1.17 [0.81-1.68],0.4026444903954748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PFDN4,Prefoldin subunit 4,17033,67,1.12 [0.72-1.74],0.6104406805570176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PFDN6,Prefoldin subunit 6,17188,68,0.82 [0.53-1.28],0.3806842152651399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",20136,85,1.13 [0.88-1.44],0.3483789948728066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGA4,Pepsin A-4,17683,68,1.07 [0.81-1.41],0.6458251883899924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",17683,70,1.12 [0.71-1.75],0.6297994261786275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGF,Placenta growth factor,20478,85,5.76 [4.05-8.21],2.580389717822853e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGLYRP1,Peptidoglycan recognition protein 1,20447,88,2.18 [1.55-3.06],6.361444555953192e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,17493,69,1.30 [0.59-2.88],0.5172741941550005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGLYRP4,Peptidoglycan recognition protein 4,17070,67,1.33 [0.98-1.79],0.0640990445747174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGM2,Phosphoglucomutase-2,17188,68,1.07 [0.75-1.53],0.714929541799746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PGR,Progesterone receptor,17153,67,1.29 [1.09-1.54],0.0032673350657462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHACTR2,Phosphatase and actin regulator 2,17643,68,1.07 [0.87-1.31],0.5150411346168223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHLDB1,Pleckstrin homology-like domain family B member 1,17593,70,2.24 [1.52-3.29],4.072086049420467e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHLDB2,Pleckstrin homology-like domain family B member 2,17033,67,1.13 [0.90-1.40],0.2926934016551742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,20091,84,4.58 [3.35-6.26],1.4107183724825285e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,17300,68,1.24 [0.71-2.17],0.4529079032722966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PI16,Peptidase inhibitor 16,17683,68,1.96 [0.77-4.98],0.158621394186379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PI3,Elafin,20030,87,2.09 [1.67-2.62],1.1265639558942791e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",17643,68,1.13 [0.83-1.52],0.4380372534197141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIGR,Polymeric immunoglobulin receptor,20025,86,9.25 [6.38-13.41],9.238063433885672e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,20224,82,0.85 [0.62-1.18],0.3373752383176595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,20294,86,7.00 [5.06-9.70],1.023726085603489e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,17153,67,1.28 [0.87-1.88],0.2105978633169135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,20294,86,5.34 [3.50-8.17],1.010141446367765e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,20278,85,3.27 [2.21-4.82],2.5498721394441127e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,17300,68,0.59 [0.44-0.79],0.0003363086390405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PITHD1,PITH domain-containing protein 1,17007,67,1.12 [0.84-1.49],0.4298085123868388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKD1,Polycystin-1,17683,70,15.06 [6.79-33.37],2.41312526646408e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKD2,Polycystin-2,17070,67,1.78 [1.34-2.36],6.464141120609045e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKLR,Pyruvate kinase PKLR,20299,84,0.63 [0.46-0.87],0.0045804270141633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PKN3,Serine/threonine-protein kinase N3,17353,70,1.29 [0.98-1.70],0.0728257346462046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G10,Group 10 secretory phospholipase A2,20091,84,2.19 [1.56-3.08],5.502034178199239e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G15,Phospholipase A2 group XV,20360,87,6.57 [3.69-11.69],1.4751314756459802e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G1B,Phospholipase A2,20499,88,0.53 [0.35-0.80],0.0022924186599062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G2A,"Phospholipase A2, membrane associated",20242,86,1.49 [1.19-1.86],0.0005865696025612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G4A,Cytosolic phospholipase A2,20361,84,1.14 [0.92-1.42],0.2390247792992968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLA2G7,Platelet-activating factor acetylhydrolase,20294,86,0.40 [0.28-0.59],2.604387248007836e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLAT,Tissue-type plasminogen activator,20470,88,1.02 [0.70-1.49],0.902823418962634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLAU,Urokinase-type plasminogen activator,20294,86,1.63 [1.10-2.42],0.0158969867266002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLAUR,Urokinase plasminogen activator surface receptor,20141,84,13.66 [8.55-21.83],7.341230953432063e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLB1,"Phospholipase B1, membrane-associated",17647,71,0.50 [0.34-0.71],0.0001649267504923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",17153,67,1.54 [1.00-2.36],0.0488480418727278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",17647,71,1.19 [0.94-1.51],0.15077554130763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLEKHO1,Pleckstrin homology domain-containing family O member 1,17647,71,1.44 [1.06-1.95],0.0197522247557773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLG,Plasminogen,17281,68,1.13 [0.36-3.51],0.8341427529462051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLIN1,Perilipin-1,19826,83,1.81 [1.23-2.66],0.0027238928600328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLIN3,Perilipin-3,20278,85,2.19 [1.48-3.24],8.713813674316327e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLPBP,Pyridoxal phosphate homeostasis protein,20278,85,0.93 [0.70-1.24],0.6314926465242319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLSCR3,Phospholipid scramblase 3,17613,71,1.88 [1.28-2.77],0.0014179254956752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLTP,Phospholipid transfer protein,20472,87,0.95 [0.56-1.59],0.841207527851441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXDC1,Plexin domain-containing protein 1,19826,80,1.44 [0.90-2.31],0.1251445944471672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXDC2,Plexin domain-containing protein 2,17647,71,2.08 [1.38-3.16],0.0005328953568496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXNA4,Plexin-A4,20224,82,1.14 [0.89-1.44],0.3004798886411508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXNB2,Plexin-B2,20426,88,30.92 [19.34-49.44],1.4248077505817571e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PLXNB3,Plexin-B3,20224,85,1.10 [0.74-1.66],0.6308997454918825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,20158,85,1.00 [0.90-1.10],0.931712391765826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PMCH,Pro-MCH,17070,67,0.97 [0.72-1.32],0.8674745682046838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PMM2,Phosphomannomutase 2,17070,67,1.27 [0.86-1.87],0.2269975206954529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PMS1,PMS1 protein homolog 1,17188,68,1.41 [0.96-2.07],0.0779321192378049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PMVK,Phosphomevalonate kinase,19790,83,1.04 [0.86-1.25],0.7074743448683578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNLIP,Pancreatic triacylglycerol lipase,17683,68,0.86 [0.60-1.24],0.4265136587890997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNLIPRP1,Inactive pancreatic lipase-related protein 1,17647,71,1.22 [0.93-1.60],0.1478861343390053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNLIPRP2,Pancreatic lipase-related protein 2,20270,84,1.05 [0.98-1.13],0.1635528075070633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNMA1,Paraneoplastic antigen Ma1,17228,69,1.03 [0.68-1.56],0.9009072210368008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNMA2,Paraneoplastic antigen Ma2,17100,68,0.93 [0.55-1.59],0.7946795309849823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",19903,84,1.09 [0.93-1.27],0.2998049792605669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PODXL,Podocalyxin,20178,85,2.09 [0.61-7.19],0.2436044964569945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PODXL2,Podocalyxin-like protein 2,20360,87,1.31 [0.68-2.50],0.4215378132481945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POF1B,Protein POF1B,17153,67,2.42 [1.94-3.03],8.334487712462746e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POLR2A,DNA-directed RNA polymerase II subunit RPB1,17153,67,1.55 [0.76-3.20],0.2309911070608881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",20178,85,1.94 [1.43-2.63],1.855046283395151e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POMC,Pro-opiomelanocortin,17228,69,1.00 [0.72-1.38],0.9784405499640366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PON1,Serum paraoxonase/arylesterase 1,17683,68,0.36 [0.24-0.56],3.011092355334124e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PON2,Serum paraoxonase/arylesterase 2,19892,84,2.01 [1.19-3.39],0.0088552600100053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PON3,Serum paraoxonase/lactonase 3,20361,84,0.45 [0.32-0.62],1.780120088753348e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,POSTN,Periostin,17688,69,0.73 [0.40-1.33],0.2971020456141721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPBP,Platelet basic protein,17587,68,0.98 [0.74-1.30],0.8802747844312604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPCDC,Phosphopantothenoylcysteine decarboxylase,20440,87,0.85 [0.56-1.29],0.4470124092401648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPIB,Peptidyl-prolyl cis-trans isomerase B,20324,86,1.16 [0.95-1.42],0.1555826867292388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPIE,Peptidyl-prolyl cis-trans isomerase E,17353,70,0.74 [0.47-1.17],0.2020364685750463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",17688,69,0.95 [0.65-1.38],0.7832342127884075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPL,Periplakin,17153,67,2.06 [1.34-3.18],0.0010869310412482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPM1A,Protein phosphatase 1A,19826,80,0.64 [0.31-1.33],0.233894742627035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPM1B,Protein phosphatase 1B,17153,67,1.36 [1.04-1.78],0.0225720141829695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPM1F,Protein phosphatase 1F,17683,70,1.25 [0.81-1.92],0.3097151815068703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPME1,Protein phosphatase methylesterase 1,20178,85,0.78 [0.57-1.08],0.1365009099599447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,17598,68,1.09 [0.82-1.44],0.5537450545619653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,20360,87,1.11 [0.91-1.34],0.3067829307669003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,17353,70,1.34 [1.05-1.71],0.0192019458152801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,17643,68,1.13 [0.85-1.50],0.3973149491968777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,17643,68,2.08 [1.43-3.03],0.0001226167544618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R2,Protein phosphatase inhibitor 2,20278,85,1.18 [0.94-1.50],0.1609421185574696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP1R9B,Neurabin-2,20478,85,1.22 [0.99-1.49],0.0566530673970186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,17593,70,1.20 [1.00-1.44],0.0456883020430302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPP3R1,Calcineurin subunit B type 1,20091,84,1.60 [0.99-2.58],0.0535733129849881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPT1,Palmitoyl-protein thioesterase 1,17188,68,1.30 [1.03-1.64],0.0262557297370704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PPY,Pancreatic prohormone,20280,87,1.49 [1.25-1.77],5.756022112328449e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PQBP1,Polyglutamine-binding protein 1,19826,80,0.93 [0.64-1.34],0.6798143089918507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRAME,Melanoma antigen preferentially expressed in tumors,17033,67,0.76 [0.30-1.91],0.5622860220952275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRAP1,Proline-rich acidic protein 1,17688,69,20.17 [11.32-35.95],2.1209360801191973e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRC1,Protein regulator of cytokinesis 1,17598,68,0.92 [0.51-1.64],0.7683250506124252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRCP,Lysosomal Pro-X carboxypeptidase,20417,88,3.72 [2.75-5.03],1.5202061802800258e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX1,Peroxiredoxin-1,19681,81,0.98 [0.78-1.22],0.8345998126305383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX2,Peroxiredoxin-2,17363,67,0.54 [0.36-0.82],0.0038666032670279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",19903,84,1.67 [1.30-2.16],7.048274261375258e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX5,"Peroxiredoxin-5, mitochondrial",20478,85,0.97 [0.72-1.30],0.8357149969594284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRDX6,Peroxiredoxin-6,20442,86,0.55 [0.39-0.77],0.0005427020014683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PREB,Prolactin regulatory element-binding protein,19903,84,2.72 [1.85-4.00],3.525369527661543e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRELP,Prolargin,20270,84,4.04 [2.43-6.73],8.103885110810561e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRG2,Bone marrow proteoglycan,17688,69,2.94 [1.99-4.33],5.2763844762086864e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRG3,Proteoglycan 3,17688,69,1.05 [0.65-1.69],0.8534367530635129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,19903,84,1.54 [1.13-2.11],0.0067029105877043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,17188,68,1.41 [0.72-2.74],0.3179894304672553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,20278,85,1.18 [0.93-1.50],0.1664938345239616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,17616,71,1.29 [0.95-1.74],0.1021502417304572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKCQ,Protein kinase C theta type,19903,84,0.92 [0.57-1.51],0.7469567872773684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKD2,Serine/threonine-protein kinase D2,17070,67,1.03 [0.61-1.73],0.9146640027104644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKG1,cGMP-dependent protein kinase 1,17300,68,1.06 [0.88-1.28],0.5561570756484189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,19826,80,1.35 [1.03-1.76],0.0270218430673657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRL,Prolactin,20440,87,1.33 [1.06-1.67],0.0142983579118451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRND,Prion-like protein doppel,17647,71,1.70 [1.22-2.36],0.0015825466442498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PROC,Vitamin K-dependent protein C,20356,85,0.43 [0.21-0.90],0.0254218808877241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PROCR,Endothelial protein C receptor,17070,67,1.57 [0.94-2.63],0.0862074770721814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PROK1,Prokineticin-1,20224,82,1.11 [0.77-1.60],0.5642381155907966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PROS1,Vitamin K-dependent protein S,17711,69,0.32 [0.15-0.67],0.0026759430843637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRR4,Proline-rich protein 4,17166,68,1.63 [1.23-2.16],0.0006538306157015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRR5,Proline-rich protein 5,17153,67,1.26 [0.79-1.98],0.3313413931163321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRRT3,Proline-rich transmembrane protein 3,17228,69,2.89 [1.71-4.87],7.124939447822154e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS2,Trypsin-2,20401,85,1.45 [1.07-1.97],0.015872654285113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS22,Brain-specific serine protease 4,17153,67,2.11 [1.72-2.60],1.1680809787615519e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS27,Serine protease 27,20221,85,2.01 [1.26-3.23],0.0035651977151117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS53,Serine protease 53,17647,71,0.96 [0.53-1.73],0.886523900421291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRSS8,Prostasin,20196,84,7.30 [5.09-10.47],3.841547018828941e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,19826,83,1.05 [0.88-1.26],0.5654227029752614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRTG,Protogenin,20442,86,5.71 [2.89-11.27],5.190367939432669e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRTN3,Myeloblastin,19765,86,1.42 [1.04-1.95],0.0264850975822717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PRUNE2,Protein prune homolog 2,17353,70,2.36 [1.45-3.86],0.0005792210296034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSAP,Prosaposin,17513,69,2.91 [2.16-3.92],1.971896184257384e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSAPL1,Proactivator polypeptide-like 1,17593,70,1.24 [0.81-1.90],0.3292830201833154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSCA,Prostate stem cell antigen,17593,70,1.04 [0.95-1.14],0.4016038803909807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,20091,84,2.04 [1.64-2.53],1.9163532509773987e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSIP1,PC4 and SFRS1-interacting protein,20224,82,1.25 [0.98-1.60],0.073912360046112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMA1,Proteasome subunit alpha type-1,19826,80,0.98 [0.62-1.54],0.936336810160222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMC3,26S proteasome regulatory subunit 6A,17033,67,0.77 [0.34-1.72],0.5252333543851502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMD1,26S proteasome non-ATPase regulatory subunit 1,17643,68,1.01 [0.64-1.60],0.965623116453409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMD5,26S proteasome non-ATPase regulatory subunit 5,17188,68,1.24 [0.88-1.74],0.2192735189155559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMD9,26S proteasome non-ATPase regulatory subunit 9,20178,85,0.64 [0.44-0.94],0.0243855315602533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSME1,Proteasome activator complex subunit 1,20043,84,0.95 [0.56-1.60],0.8456468954880194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSME2,Proteasome activator complex subunit 2,19990,83,0.95 [0.55-1.64],0.848708853003291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMG3,Proteasome assembly chaperone 3,20224,82,0.66 [0.44-0.98],0.0399409539195781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSMG4,Proteasome assembly chaperone 4,17153,67,0.72 [0.45-1.13],0.1499290557677837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSPN,Persephin,20224,82,1.08 [0.88-1.34],0.4643061774273521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSRC1,Proline/serine-rich coiled-coil protein 1,19826,80,1.44 [1.08-1.91],0.011940196501878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,16710,66,0.99 [0.79-1.25],0.9617599224703232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",19826,83,0.71 [0.36-1.39],0.3216659387467933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTGDS,Prostaglandin-H2 D-isomerase,20154,84,5.85 [4.22-8.11],2.4909291459678623e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTGES2,Prostaglandin E synthase 2,17028,66,1.51 [1.01-2.26],0.0425207400127368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTGR1,Prostaglandin reductase 1,17683,70,1.14 [0.89-1.48],0.3026318428262946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTH,Parathyroid hormone,17188,68,1.10 [0.85-1.44],0.4681318284330543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,20224,82,1.77 [1.33-2.37],0.0001023902313504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTK7,Inactive tyrosine-protein kinase 7,19826,83,2.72 [1.82-4.06],1.0048187671936022e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTN,Pleiotrophin,19892,84,1.56 [1.12-2.18],0.0092008908104054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTP4A3,Protein tyrosine phosphatase type IVA 3,17153,67,1.54 [1.09-2.18],0.0149179736292954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,20091,84,1.27 [1.02-1.59],0.0323622960804176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,20325,84,1.05 [0.84-1.32],0.6491259367567123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,17124,67,1.34 [0.84-2.12],0.2156449411357975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRB,Receptor-type tyrosine-protein phosphatase beta,17683,70,2.37 [1.09-5.18],0.0297698478372124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRC,Receptor-type tyrosine-protein phosphatase C,17688,69,3.40 [1.87-6.15],5.51561428356257e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRF,Receptor-type tyrosine-protein phosphatase F,20528,88,1.38 [0.73-2.61],0.3270665049618245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,17593,70,2.05 [1.32-3.20],0.0014074361790989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,17593,70,2.49 [1.63-3.81],2.5731292289340007e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRM,Receptor-type tyrosine-protein phosphatase mu,20199,82,2.29 [1.02-5.17],0.0454664524706885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,20029,83,3.09 [1.93-4.96],2.7584206596668324e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRR,Receptor-type tyrosine-protein phosphatase R,17647,71,1.11 [0.61-2.02],0.7385267753141208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRS,Receptor-type tyrosine-protein phosphatase S,20528,88,1.24 [0.59-2.61],0.5676064051218894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,17683,70,1.08 [0.52-2.25],0.8420802788531413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,17300,68,0.80 [0.54-1.20],0.2806601879107619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTS,6-pyruvoyl tetrahydrobiopterin synthase,19729,82,1.53 [1.15-2.04],0.0039803074619396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTTG1,Securin,17353,70,0.89 [0.49-1.61],0.6946353970623234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PTX3,Pentraxin-related protein PTX3,20224,82,2.51 [1.49-4.23],0.000579046275444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PVALB,Parvalbumin alpha,20330,86,1.11 [0.92-1.33],0.2676012601646794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PVR,Poliovirus receptor,20440,87,4.36 [2.98-6.36],2.4234198639038552e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PXDNL,Peroxidasin-like protein,17598,68,0.82 [0.50-1.34],0.4290997306906876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PXN,Paxillin,19826,83,1.29 [0.95-1.76],0.1018122160701588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PYDC1,Pyrin domain-containing protein 1,17228,69,0.90 [0.51-1.59],0.7237991142104158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PYY,Peptide YY,17070,67,2.40 [1.99-2.90],4.199162342180455e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,PZP,Pregnancy zone protein,17711,69,0.46 [0.26-0.81],0.0071090284151975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,QDPR,Dihydropteridine reductase,20179,85,1.04 [0.66-1.64],0.8544130516084828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,QPCT,Glutaminyl-peptide cyclotransferase,20328,88,5.08 [3.12-8.27],5.878405176968993e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,QSOX1,Sulfhydryl oxidase 1,17371,68,1.71 [1.31-2.23],8.51419417680274e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB10,Ras-related protein Rab-10,17683,70,1.09 [0.71-1.66],0.7014135917246952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB11FIP3,Rab11 family-interacting protein 3,17683,70,1.11 [0.89-1.37],0.3560968562591813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB27B,Ras-related protein Rab-27B,17683,70,1.18 [0.88-1.58],0.2635167572135921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB2B,Ras-related protein Rab-2B,17598,68,1.10 [0.74-1.61],0.6412678196071138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB33A,Ras-related protein Rab-33A,17070,67,1.07 [0.76-1.50],0.7082514746878761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB37,Ras-related protein Rab-37,19903,84,1.16 [0.93-1.44],0.1887781498228521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB39B,Ras-related protein Rab-39B,17070,67,0.86 [0.63-1.19],0.3672679391937712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,17100,68,0.99 [0.68-1.44],0.9513139407370862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB44,Ras-related protein Rab-44,17598,68,1.25 [0.80-1.94],0.3279743782234101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB6A,Ras-related protein Rab-6A,20224,82,0.46 [0.30-0.69],0.0002335371834237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAB6B,Ras-related protein Rab-6B,19826,83,1.10 [0.75-1.61],0.6144469716209598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RABEP1,Rab GTPase-binding effector protein 1,17300,68,1.11 [0.82-1.50],0.5052888606613548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RABEPK,Rab9 effector protein with kelch motifs,19826,80,1.18 [0.85-1.64],0.3298462680785189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RABGAP1L,Rab GTPase-activating protein 1-like,19903,84,0.93 [0.67-1.29],0.6679401492447863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAC3,Ras-related C3 botulinum toxin substrate 3,17188,68,0.84 [0.56-1.25],0.3959563136845766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAD23B,UV excision repair protein RAD23 homolog B,19826,80,0.98 [0.63-1.51],0.9152854744623986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAD51,DNA repair protein RAD51 homolog 1,17353,70,1.32 [0.99-1.77],0.0603854417535901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RALB,Ras-related protein Ral-B,17153,67,2.46 [1.14-5.31],0.0221129895999458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RALY,RNA-binding protein Raly,17598,68,1.21 [0.79-1.85],0.3875257205818893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RANBP1,Ran-specific GTPase-activating protein,17228,69,0.72 [0.46-1.13],0.1548290595331195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RANBP2,E3 SUMO-protein ligase RanBP2,17100,68,0.72 [0.34-1.54],0.3949077929737566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RANGAP1,Ran GTPase-activating protein 1,19826,80,1.02 [0.66-1.57],0.925049264536408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAP1A,Ras-related protein Rap-1A,17153,67,1.14 [0.87-1.49],0.3502617096701564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RAPGEF2,Rap guanine nucleotide exchange factor 2,17353,70,1.25 [0.83-1.87],0.2802152126763218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RARRES1,Retinoic acid receptor responder protein 1,19826,80,1.67 [1.20-2.32],0.0024363486785357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RARRES2,Retinoic acid receptor responder protein 2,20427,85,2.04 [1.55-2.68],3.725593751603618e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RASA1,Ras GTPase-activating protein 1,19826,83,1.06 [0.58-1.94],0.84854554074566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,17033,67,1.27 [0.77-2.11],0.3491256229608426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RASSF2,Ras association domain-containing protein 2,19826,80,1.28 [1.00-1.64],0.0518982812172537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBFOX3,RNA binding protein fox-1 homolog 3,17643,68,2.68 [2.18-3.29],3.5414629865909336e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBKS,Ribokinase,19773,80,0.67 [0.48-0.92],0.0146315556009481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBM17,Splicing factor 45,17643,68,1.07 [0.79-1.44],0.657822244604504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBM19,Probable RNA-binding protein 19,17070,67,0.90 [0.51-1.61],0.731862494073983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBM25,RNA-binding protein 25,17033,67,0.98 [0.59-1.64],0.9487752261101792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP1,Retinol-binding protein 1,17188,68,1.24 [0.95-1.62],0.1218546806671349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP2,Retinol-binding protein 2,20178,85,1.72 [1.37-2.15],2.5548441393783114e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP5,Retinol-binding protein 5,20178,85,2.72 [2.10-3.52],3.9446118032049996e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBP7,Retinoid-binding protein 7,17593,70,1.69 [1.26-2.27],0.0004414066316991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBPMS,RNA-binding protein with multiple splicing,17153,67,1.08 [0.75-1.54],0.693360209574021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RBPMS2,RNA-binding protein with multiple splicing 2,17228,69,1.15 [0.92-1.45],0.2091136504952601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RCC1,Regulator of chromosome condensation,17598,68,1.16 [0.76-1.76],0.4932850763149343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RCOR1,REST corepressor 1,19892,84,0.97 [0.63-1.49],0.880929097492492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,17228,69,1.89 [0.62-5.79],0.2649118286030205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REEP4,Receptor expression-enhancing protein 4,17643,68,1.23 [0.86-1.75],0.2519221785006083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG1A,Lithostathine-1-alpha,20175,83,3.23 [2.62-3.98],6.094561784171232e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG1B,Lithostathine-1-beta,20528,88,2.47 [1.99-3.07],2.8636893887142463e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG3A,Regenerating islet-derived protein 3-alpha,20528,88,2.24 [1.79-2.79],8.134851744317368e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG3G,Regenerating islet-derived protein 3-gamma,17598,68,1.22 [0.71-2.08],0.4725718016030824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REG4,Regenerating islet-derived protein 4,20297,84,4.92 [3.74-6.48],6.835492881136845e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RELB,Transcription factor RelB,17153,67,0.93 [0.57-1.52],0.7680760959162993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RELT,Tumor necrosis factor receptor superfamily member 19L,20294,86,4.87 [3.46-6.87],1.6540002310501634e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REN,Renin,20278,85,2.82 [2.42-3.29],1.76489959164487e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REPS1,RalBP1-associated Eps domain-containing protein 1,17153,67,0.99 [0.53-1.83],0.9672608240678878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REST,RE1-silencing transcription factor,17033,67,0.92 [0.46-1.82],0.8079318863125913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,20178,85,2.27 [1.39-3.71],0.0009979130824866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RETN,Resistin,20236,86,2.42 [1.77-3.31],2.6900830511015823e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,REXO2,"Oligoribonuclease, mitochondrial",17070,67,0.86 [0.50-1.49],0.5928029109733977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RFC4,Replication factor C subunit 4,17598,68,1.78 [0.68-4.68],0.2397025580691135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGCC,Regulator of cell cycle RGCC,17643,68,1.12 [0.83-1.53],0.4547344209652411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,17353,70,1.24 [0.92-1.66],0.158077771764581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGMA,Repulsive guidance molecule A,20440,87,2.10 [1.15-3.82],0.0151462516116362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGMB,RGM domain family member B,20440,87,4.06 [2.30-7.17],1.422398979019747e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGS10,Regulator of G-protein signaling 10,17643,68,1.07 [0.72-1.58],0.7367194762207117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RGS8,Regulator of G-protein signaling 8,19903,84,0.82 [0.57-1.16],0.2538048179695832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RHOC,Rho-related GTP-binding protein RhoC,19964,83,1.19 [1.00-1.42],0.0530293817930038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RICTOR,Rapamycin-insensitive companion of mTOR,17153,67,0.81 [0.46-1.42],0.4592863510700996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,17300,68,1.56 [1.04-2.33],0.0314794906799789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RILP,Rab-interacting lysosomal protein,20372,86,0.95 [0.69-1.31],0.7676105543911794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RILPL2,RILP-like protein 2,17683,70,1.05 [0.83-1.33],0.6892330699528098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,17070,67,0.95 [0.65-1.39],0.8019496049612399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RLN1,Prorelaxin H1,17643,68,1.08 [0.73-1.61],0.6876771013334937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RLN2,Prorelaxin H2,17267,68,1.50 [1.06-2.12],0.0219598345981748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE1,Ribonuclease pancreatic,17683,68,4.24 [3.22-5.58],6.7739652884344525e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE10,Inactive ribonuclease-like protein 10,17228,69,2.07 [1.62-2.66],8.658975399496762e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE3,Eosinophil cationic protein,20185,85,1.05 [0.89-1.23],0.5600063939027609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE4,Ribonuclease 4,17082,67,4.44 [2.86-6.90],3.420515907078049e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASE6,Ribonuclease K6,17554,68,2.36 [1.92-2.89],2.3313992768258126e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASEH2A,Ribonuclease H2 subunit A,17643,68,1.38 [0.91-2.09],0.1335332819258458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNASET2,Ribonuclease T2,20441,88,7.41 [5.30-10.37],1.2017051919845367e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF149,E3 ubiquitin-protein ligase RNF149,17228,69,1.29 [0.56-3.00],0.5491117506298705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF168,E3 ubiquitin-protein ligase RNF168,17153,67,1.45 [0.89-2.35],0.1363318231560288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF31,E3 ubiquitin-protein ligase RNF31,17153,67,1.31 [0.72-2.38],0.3775428284100384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF4,E3 ubiquitin-protein ligase RNF4,17353,70,0.94 [0.64-1.36],0.7346355195960395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF41,E3 ubiquitin-protein ligase NRDP1,19826,80,1.26 [0.93-1.69],0.1299594799649881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF43,E3 ubiquitin-protein ligase RNF43,17353,70,1.26 [0.95-1.66],0.1072223173354241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RNF5,E3 ubiquitin-protein ligase RNF5,17228,69,0.94 [0.68-1.29],0.6932823870763611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROBO1,Roundabout homolog 1,20297,84,4.98 [3.11-7.97],2.1577095229948954e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROBO2,Roundabout homolog 2,20440,87,2.80 [1.36-5.77],0.0051493655358154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROBO4,Roundabout homolog 4,17228,69,3.90 [1.06-14.31],0.0402783064325424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,20278,85,3.71 [2.16-6.39],2.059735040865789e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RP2,Protein XRP2,20178,85,1.09 [0.69-1.70],0.7199043130832757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RPA2,Replication protein A 32 kDa subunit,17153,67,1.15 [0.55-2.40],0.7179997197747766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RPE,Ribulose-phosphate 3-epimerase,17353,70,0.99 [0.70-1.39],0.9504049694476536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RPGR,X-linked retinitis pigmentosa GTPase regulator,17188,68,0.78 [0.43-1.41],0.4017472407661011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RPL14,60S ribosomal protein L14,17228,69,1.08 [0.65-1.82],0.7596633323121988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RPS10,40S ribosomal protein S10,17070,67,1.19 [0.72-1.98],0.499911054548638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RRAS,Ras-related protein R-Ras,17188,68,1.08 [0.91-1.29],0.3787266868748764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RRM2,Ribonucleoside-diphosphate reductase subunit M2,19826,80,1.51 [1.16-1.97],0.0019948991363025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,19826,80,1.27 [0.95-1.71],0.1093840295987885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RRP15,RRP15-like protein,17100,68,1.02 [0.78-1.34],0.8630763221578375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RSPO1,R-spondin-1,20091,84,2.11 [1.30-3.41],0.0025110907129806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RSPO3,R-spondin-3,20442,86,4.82 [3.22-7.21],1.9143582703130982e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RTBDN,Retbindin,20178,85,1.90 [1.26-2.86],0.002196819725437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RTKN2,Rhotekin-2,17070,67,1.03 [0.65-1.63],0.9086976702595572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",17643,68,1.09 [0.84-1.40],0.5231510785306048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RTN4R,Reticulon-4 receptor,20442,86,4.49 [3.38-5.97],4.415938880626822e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RUVBL1,RuvB-like 1,19826,80,0.86 [0.69-1.08],0.1995259093534766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RWDD1,RWD domain-containing protein 1,20440,87,1.04 [0.77-1.40],0.8185973086134779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,RYR1,Ryanodine receptor 1,17070,67,1.26 [0.73-2.16],0.4041387241111865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A11,Protein S100-A11,20130,85,1.22 [0.86-1.73],0.2635273929488704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A12,Protein S100-A12,19989,84,0.98 [0.75-1.28],0.8690886837304805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A13,Protein S100-A13,17153,67,1.73 [1.05-2.85],0.0329513202606226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A14,Protein S100-A14,17643,68,0.64 [0.39-1.04],0.0742493426840298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A16,Protein S100-A16,19797,83,1.08 [0.78-1.50],0.6468913498760409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A3,Protein S100-A3,17598,68,1.40 [1.03-1.91],0.0327339965778479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100A4,Protein S100-A4,20360,87,0.81 [0.58-1.13],0.2172277571104844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100G,Protein S100-G,17643,68,0.87 [0.53-1.43],0.5885866179630408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,S100P,Protein S100-P,19892,84,1.54 [1.18-2.01],0.0015292142204801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAA4,Serum amyloid A-4 protein,17711,69,0.74 [0.25-2.18],0.5835575322429709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAFB2,Scaffold attachment factor B2,17643,68,1.54 [0.74-3.19],0.2494131093333159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAG,S-arrestin,17100,68,1.36 [0.92-2.00],0.124436469009039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAMD9L,Sterile alpha motif domain-containing protein 9-like,20224,82,1.27 [0.97-1.65],0.0820610049069719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAP18,Histone deacetylase complex subunit SAP18,17353,70,1.10 [0.84-1.45],0.4736646233182831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SARG,Specifically androgen-regulated gene protein,17601,70,1.20 [0.97-1.48],0.0977209787483378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SART1,U4/U6.U5 tri-snRNP-associated protein 1,17070,67,1.56 [1.04-2.33],0.0312170003562853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAT1,Diamine acetyltransferase 1,17070,67,1.12 [0.74-1.69],0.5958977241336327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SAT2,Thialysine N-epsilon-acetyltransferase,17353,70,1.30 [0.96-1.77],0.0931938947562808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SATB1,DNA-binding protein SATB1,17643,68,1.10 [0.52-2.35],0.7980725690028283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SBSN,Suprabasin,17657,69,1.08 [0.57-2.03],0.8150575939629942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCAMP3,Secretory carrier-associated membrane protein 3,20178,85,1.55 [1.25-1.94],7.85566396144258e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARA5,Scavenger receptor class A member 5,20440,87,10.05 [6.72-15.03],2.43996212193269e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARB1,Scavenger receptor class B member 1,19826,83,1.38 [1.09-1.74],0.0072206636631331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARB2,Lysosome membrane protein 2,19717,83,4.65 [3.64-5.94],6.352777167278186e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARF1,Scavenger receptor class F member 1,20528,88,2.60 [1.72-3.94],6.024708615500328e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCARF2,Scavenger receptor class F member 2,20440,87,8.45 [5.43-13.14],2.6560962138657747e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCG2,Secretogranin-2,20330,86,9.77 [6.10-15.66],2.690714373257197e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCG3,Secretogranin-3,20297,84,1.05 [0.59-1.86],0.8650339809222669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGB1A1,Uteroglobin,20280,84,1.87 [1.29-2.71],0.0010222494693987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGB2A2,Mammaglobin-A,17070,67,1.11 [0.52-2.36],0.7821369316986596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGB3A1,Secretoglobin family 3A member 1,17300,68,2.23 [0.91-5.45],0.0785625709719189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGB3A2,Secretoglobin family 3A member 2,20325,84,1.23 [1.04-1.46],0.0159125746423884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCGN,Secretagogin,19903,84,3.40 [2.52-4.59],1.0596892740498164e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCIN,Adseverin,17100,68,1.28 [0.99-1.66],0.0617367920360993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCLY,Selenocysteine lyase,20372,86,1.78 [1.22-2.58],0.0026830112817929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCN2A,Sodium channel protein type 2 subunit alpha,17100,68,0.96 [0.59-1.55],0.8604984452725633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCN2B,Sodium channel subunit beta-2,17188,68,0.45 [0.17-1.15],0.0934160994592255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCN3A,Sodium channel protein type 3 subunit alpha,17188,68,0.75 [0.35-1.60],0.4572029932379563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCN3B,Sodium channel subunit beta-3,17100,68,0.67 [0.37-1.22],0.1943601286846656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCN4B,Sodium channel subunit beta-4,17228,69,2.78 [1.76-4.41],1.278979511414731e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCP2,Non-specific lipid-transfer protein,19826,80,1.09 [0.84-1.40],0.521063409759749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCPEP1,Retinoid-inducible serine carboxypeptidase,17158,69,1.74 [1.13-2.67],0.0117098294039934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCRG1,Scrapie-responsive protein 1,17683,70,2.89 [1.81-4.61],8.228506354083735e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCRIB,Protein scribble homolog,17228,69,1.18 [0.95-1.45],0.1346509394745249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCRN1,Secernin-1,20224,82,0.96 [0.67-1.38],0.8206405924037935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SCT,Secretin,17188,68,1.24 [0.79-1.94],0.3563986841287959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDC1,Syndecan-1,20278,85,3.27 [2.28-4.70],1.17049851883517e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDC4,Syndecan-4,20278,85,0.48 [0.33-0.70],0.0001501172731921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDCCAG8,Serologically defined colon cancer antigen 8,17598,68,1.20 [0.98-1.47],0.0851878227648307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDHB,Succinate dehydrogenase,17593,70,1.39 [1.04-1.86],0.0240563235204967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SDK2,Protein sidekick-2,17300,68,1.25 [0.74-2.11],0.414425052363498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEC31A,Protein transport protein Sec31A,17228,69,1.08 [0.80-1.47],0.6083353722756624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEL1L,Protein sel-1 homolog 1,17228,69,0.43 [0.16-1.19],0.1033939324317845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELE,E-selectin,20528,88,2.40 [1.64-3.50],5.55823847267436e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELENOP,Selenoprotein P,17711,69,1.21 [0.44-3.34],0.709053876925263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELL,L-selectin,17711,69,0.80 [0.31-2.08],0.647272590042177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELP,P-selectin,20401,85,1.31 [0.93-1.83],0.1176822681190363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SELPLG,P-selectin glycoprotein ligand 1,20224,82,1.87 [0.86-4.06],0.1114394877553952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA3F,Semaphorin-3F,20278,85,6.07 [3.14-11.73],8.29543195575231e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA3G,Semaphorin-3G,17300,68,1.07 [0.63-1.82],0.8032705941546295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA4C,Semaphorin-4C,20178,85,1.17 [0.60-2.27],0.6430382151036331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA4D,Semaphorin-4D,20440,87,1.02 [0.53-1.93],0.9603761265580324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA6C,Semaphorin-6C,17153,67,2.74 [1.75-4.28],1.0004467511207376e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEMA7A,Semaphorin-7A,20470,88,3.45 [2.60-4.56],5.5858650002313456e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEPTIN3,Neuronal-specific septin-3,17643,68,1.04 [0.77-1.40],0.8171858325074055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEPTIN7,Septin-7,17353,70,1.27 [0.92-1.76],0.1394845273123243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEPTIN8,Septin-8,17620,71,3.45 [2.53-4.72],6.010248185144612e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEPTIN9,Septin-9,20178,85,1.26 [0.65-2.43],0.4934068993053674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA1,Alpha-1-antitrypsin,17352,69,8.51 [2.13-33.99],0.0024435343996179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA11,Serpin A11,20528,88,1.67 [1.05-2.65],0.0313112623607586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA12,Serpin A12,19659,82,1.08 [0.89-1.30],0.4363450475694662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA3,Alpha-1-antichymotrypsin,17637,69,2.64 [0.86-8.15],0.0907034437184509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA4,Kallistatin,17389,69,1.20 [0.44-3.30],0.7253226004796529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA5,Plasma serine protease inhibitor,17449,69,1.38 [0.70-2.71],0.3520756854672413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA6,Corticosteroid-binding globulin,17711,69,5.37 [1.36-21.18],0.0162502071267534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA7,Thyroxine-binding globulin,17711,69,1.10 [0.32-3.81],0.8745470798559307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINA9,Serpin A9,20074,84,1.78 [1.43-2.20],1.9261755252965185e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINB1,Leukocyte elastase inhibitor,20222,86,1.10 [0.89-1.36],0.3696904247417144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINB5,Serpin B5,19892,84,1.26 [0.83-1.90],0.2744386424051327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINB6,Serpin B6,20375,87,1.34 [0.97-1.85],0.0739914450526443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINB8,Serpin B8,20478,85,1.31 [1.02-1.68],0.0328731960175076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINB9,Serpin B9,20091,84,1.84 [1.01-3.37],0.0460148579565593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINC1,Antithrombin-III,17681,69,1.27 [0.27-6.03],0.7602999936185689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPIND1,Heparin cofactor 2,17681,69,2.96 [1.33-6.56],0.0076478829419739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINE1,Plasminogen activator inhibitor 1,20528,88,1.04 [0.77-1.39],0.8094179836810387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINE2,Glia-derived nexin,17683,70,0.88 [0.61-1.25],0.4723456946118803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINF1,Pigment epithelium-derived factor,17432,69,5.10 [2.64-9.86],1.3034538642399424e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINF2,Alpha-2-antiplasmin,17368,69,0.60 [0.10-3.57],0.5731040979501838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPING1,Plasma protease C1 inhibitor,17681,69,0.77 [0.22-2.64],0.6718731633787747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINH1,Serpin H1,17353,70,1.13 [0.94-1.34],0.190865995650896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINI1,Neuroserpin,17273,68,1.09 [0.51-2.36],0.8183997357892778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SERPINI2,Serpin I2,17593,70,0.98 [0.66-1.46],0.9338213579367404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,19826,83,1.04 [0.76-1.41],0.8026122661864932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SETMAR,Histone-lysine N-methyltransferase SETMAR,20021,84,0.74 [0.38-1.43],0.3722341972515729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEZ6,Seizure protein 6 homolog,17188,68,1.74 [0.88-3.41],0.1090100019179531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEZ6L,Seizure 6-like protein,20360,87,2.90 [1.58-5.34],0.0005916330621808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SEZ6L2,Seizure 6-like protein 2,20178,85,3.18 [1.84-5.50],3.420296062057286e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SF3B4,Splicing factor 3B subunit 4,20178,85,0.74 [0.56-0.97],0.0311130603607521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFRP1,Secreted frizzled-related protein 1,20027,84,2.21 [1.63-3.01],3.861295162452403e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFRP4,Secreted frizzled-related protein 4,17300,68,2.15 [1.21-3.81],0.008620849179928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFTPA1,Pulmonary surfactant-associated protein A1,19826,80,1.09 [0.77-1.54],0.627378976353398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFTPA2,Pulmonary surfactant-associated protein A2,19826,80,0.99 [0.69-1.43],0.9658303897829604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SFTPD,Pulmonary surfactant-associated protein D,20278,85,1.40 [1.06-1.86],0.019514049294165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SGSH,N-sulphoglucosamine sulphohydrolase,17357,69,1.36 [0.92-2.01],0.1254822957322046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH2B3,SH2B adapter protein 3,19826,80,1.19 [0.97-1.47],0.0911934393467177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH2D1A,SH2 domain-containing protein 1A,20224,82,1.18 [0.89-1.58],0.2565265829435058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,17100,68,1.42 [1.11-1.81],0.0047470820398498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH3BP1,SH3 domain-binding protein 1,17593,70,1.51 [1.04-2.21],0.0318579927846138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH3GL3,Endophilin-A3,17273,70,1.24 [0.94-1.64],0.1250479320720025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SH3GLB2,Endophilin-B2,17647,71,0.94 [0.67-1.32],0.7238103719209954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHBG,Sex hormone-binding globulin,17683,68,0.63 [0.41-0.96],0.0319255946677307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHC1,SHC-transforming protein 1,17033,67,1.01 [0.83-1.24],0.903953693050013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHD,SH2 domain-containing adapter protein D,17031,67,0.94 [0.71-1.24],0.6678662555474953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHH,Sonic hedgehog protein,17153,67,1.13 [0.67-1.90],0.6502963437149634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHISA5,Protein shisa-5,17688,69,3.03 [2.38-3.87],5.754184771997573e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHMT1,"Serine hydroxymethyltransferase, cytosolic",20325,84,0.99 [0.78-1.25],0.9239288462079488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SHPK,Sedoheptulokinase,17353,70,1.07 [0.64-1.78],0.7893160575426983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIAE,Sialate O-acetylesterase,20325,87,1.74 [1.16-2.61],0.0070120545824589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC1,Sialoadhesin,20361,84,3.98 [2.92-5.42],1.877178827873361e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,20224,82,2.80 [2.24-3.50],1.3602302962811891e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC15,Sialic acid-binding Ig-like lectin 15,19826,83,0.94 [0.71-1.24],0.64061723107116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC5,Sialic acid-binding Ig-like lectin 5,20294,86,1.42 [1.14-1.77],0.0016056351856375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,20442,86,3.61 [2.52-5.16],2.1579106046204507e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,20278,85,4.01 [2.26-7.13],2.162355247069163e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC8,Sialic acid-binding Ig-like lectin 8,17228,69,3.10 [1.94-4.93],2.038320038852434e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIGLEC9,Sialic acid-binding Ig-like lectin 9,20406,86,2.12 [1.13-3.97],0.0192548726531021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIL1,Nucleotide exchange factor SIL1,17228,69,1.34 [0.72-2.51],0.3530685244916324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,20344,87,2.67 [1.75-4.09],5.873453376724819e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRPB1,Signal-regulatory protein beta-1,20244,84,3.47 [2.49-4.84],1.8266605469273477e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRT1,NAD-dependent protein deacetylase sirtuin-1,17153,67,1.20 [0.95-1.52],0.1253255594856525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRT2,NAD-dependent protein deacetylase sirtuin-2,20178,85,1.06 [0.85-1.33],0.5900755031871814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",19826,83,0.73 [0.47-1.12],0.147292590878585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,19903,84,1.86 [1.34-2.58],0.0002113853119092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SKAP1,Src kinase-associated phosphoprotein 1,20058,83,0.89 [0.68-1.17],0.4108073865227714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SKAP2,Src kinase-associated phosphoprotein 2,20361,84,1.06 [0.88-1.28],0.5426341400501518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SKIV2L,Helicase SKI2W,17070,67,0.81 [0.42-1.55],0.518285143580649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLA2,Src-like-adapter 2,17643,68,1.13 [0.90-1.41],0.282955769687731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF1,Signaling lymphocytic activation molecule,19903,84,2.49 [1.94-3.19],4.967273076432639e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF6,SLAM family member 6,19826,80,2.73 [2.01-3.71],1.393718803616508e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF7,SLAM family member 7,20224,82,2.06 [1.60-2.67],3.244291778507278e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLAMF8,SLAM family member 8,19826,80,3.50 [2.53-4.83],3.5618381042897636e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC12A2,Solute carrier family 12 member 2,17070,67,1.62 [0.99-2.63],0.054012055682895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC13A1,Solute carrier family 13 member 1,17598,68,1.09 [0.75-1.57],0.6551352707258941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC16A1,Monocarboxylate transporter 1,19826,83,1.51 [1.19-1.92],0.0007619069705392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC1A4,Neutral amino acid transporter A,17188,68,1.37 [0.94-2.02],0.1040517541076161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC27A4,Long-chain fatty acid transport protein 4,19826,83,1.20 [0.93-1.55],0.1700369765315531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC28A1,Sodium/nucleoside cotransporter 1,17033,67,1.28 [0.93-1.74],0.1250027075355703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC34A3,Sodium-dependent phosphate transport protein 2C,17033,67,1.04 [0.65-1.66],0.8758635728229386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC39A14,Zinc transporter ZIP14,19826,83,2.03 [1.44-2.87],5.510824039562109e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC39A5,Zinc transporter ZIP5,20224,82,1.75 [1.39-2.21],2.332333709848017e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC44A4,Choline transporter-like protein 4,17188,68,1.15 [0.87-1.53],0.3317549221511393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC4A1,Band 3 anion transport protein,17688,69,0.72 [0.43-1.21],0.2148163512492863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC51B,Organic solute transporter subunit beta,17070,67,1.11 [0.81-1.50],0.5184009810198418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,17300,68,1.13 [0.86-1.48],0.3949321156184675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,17593,70,1.60 [1.21-2.11],0.0008174054745548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",17033,67,1.10 [0.76-1.59],0.6046654861633616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLIT2,Slit homolog 2 protein,19826,83,1.45 [1.12-1.88],0.0052163794835723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLITRK1,SLIT and NTRK-like protein 1,17153,67,1.15 [0.56-2.39],0.7039776131420026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLITRK2,SLIT and NTRK-like protein 2,20442,86,2.63 [1.68-4.12],2.392464207383388e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLITRK6,SLIT and NTRK-like protein 6,19892,84,2.30 [1.52-3.47],7.158195824534602e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLK,STE20-like serine/threonine-protein kinase,17353,70,1.18 [0.93-1.50],0.1721672653587085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLMAP,Sarcolemmal membrane-associated protein,17593,70,1.66 [1.30-2.12],5.559756690631954e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SLURP1,Secreted Ly-6/uPAR-related protein 1,17559,68,1.59 [1.13-2.24],0.0082531474159178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMAD1,Mothers against decapentaplegic homolog 1,19826,80,1.18 [0.94-1.48],0.1648848858038422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMAD2,Mothers against decapentaplegic homolog 2,17598,68,1.20 [0.87-1.65],0.2698563585680775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMAD3,Mothers against decapentaplegic homolog 3,17598,68,1.01 [0.65-1.58],0.968292435825984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMAD5,Mothers against decapentaplegic homolog 5,20178,85,0.64 [0.25-1.65],0.3597391359776142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMARCA2,Probable global transcription activator SNF2L2,19826,83,0.91 [0.68-1.20],0.5000272209564424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMC3,Structural maintenance of chromosomes protein 3,17033,67,0.96 [0.62-1.50],0.8603698697037623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMNDC1,Survival of motor neuron-related-splicing factor 30,17593,70,1.12 [0.78-1.61],0.5478585495743283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMOC1,SPARC-related modular calcium-binding protein 1,20442,86,3.02 [2.07-4.41],9.427263771489968e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMOC2,SPARC-related modular calcium-binding protein 2,20361,84,3.56 [2.50-5.07],1.959341346161918e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMPD1,Sphingomyelin phosphodiesterase,20334,86,2.33 [1.65-3.28],1.5223269401894316e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMPD3,Sphingomyelin phosphodiesterase 3,17153,67,1.58 [1.21-2.06],0.0007463204097339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,20335,84,0.96 [0.72-1.27],0.7720428877338399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,17598,68,0.70 [0.45-1.08],0.1080987039868899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMS,Spermine synthase,17100,68,0.79 [0.51-1.22],0.2889079767225342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SMTN,Smoothelin,17622,71,1.47 [1.19-1.83],0.0004045466651734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNAP23,Synaptosomal-associated protein 23,20278,85,1.14 [0.90-1.43],0.2698619401765593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNAP25,Synaptosomal-associated protein 25,17100,68,0.83 [0.50-1.37],0.4591116135423808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNAP29,Synaptosomal-associated protein 29,20360,87,1.11 [0.90-1.37],0.3178330881758098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNAPIN,SNARE-associated protein Snapin,17643,68,0.82 [0.55-1.25],0.3598447547913989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNCA,Alpha-synuclein,17300,68,0.92 [0.75-1.12],0.405551093214073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNCG,Gamma-synuclein,20091,84,2.75 [2.13-3.54],4.304061387525706e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",17228,69,2.39 [1.66-3.45],2.7254710637896183e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNRPB2,U2 small nuclear ribonucleoprotein B'',17647,71,1.62 [1.22-2.16],0.000996634384676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNU13,NHP2-like protein 1,17070,67,0.77 [0.48-1.26],0.2990722505813062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNX15,Sorting nexin-15,17300,68,0.82 [0.52-1.27],0.3666481627398749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNX18,Sorting nexin-18,17593,70,1.35 [0.85-2.13],0.1977612338532758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNX2,Sorting nexin-2,17598,68,1.33 [1.05-1.68],0.017113394052239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNX5,Sorting nexin-5,17228,69,1.15 [0.51-2.59],0.7373362543172703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SNX9,Sorting nexin-9,20278,85,1.25 [0.95-1.64],0.1075907733526343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOD1,Superoxide dismutase [Cu-Zn],19917,83,0.82 [0.54-1.25],0.3509280870574542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOD2,"Superoxide dismutase [Mn], mitochondrial",20294,86,1.57 [1.02-2.42],0.0400470209470713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOD3,Extracellular superoxide dismutase,17683,68,0.47 [0.24-0.91],0.0251751911054576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORBS1,Sorbin and SH3 domain-containing protein 1,17643,68,1.79 [1.40-2.28],3.2589195243983896e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORCS2,VPS10 domain-containing receptor SorCS2,19826,80,4.71 [3.28-6.77],4.571488779281612e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORD,Sorbitol dehydrogenase,20346,86,0.95 [0.72-1.25],0.7156884794517353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SORT1,Sortilin,20237,85,1.57 [0.95-2.61],0.0785701176934769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOST,Sclerostin,20237,85,1.63 [1.00-2.66],0.0517806451735517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,17188,68,0.88 [0.53-1.48],0.6331698972374104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOX2,Transcription factor SOX-2,17606,68,1.48 [0.62-3.52],0.3740006174858039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SOX9,Transcription factor SOX-9,17188,68,5.58 [2.46-12.63],3.767924255862199e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,17643,68,1.89 [1.20-3.00],0.0064997666086162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPAG1,Sperm-associated antigen 1,17643,68,1.17 [0.81-1.70],0.4038662991530911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPARC,SPARC,20360,87,0.95 [0.72-1.25],0.7065203459211645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPARCL1,SPARC-like protein 1,20335,85,1.77 [1.10-2.84],0.0176431569229014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPART,Spartin,17300,68,1.21 [0.89-1.64],0.2278691187085249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPESP1,Sperm equatorial segment protein 1,17683,70,1.43 [0.75-2.73],0.2800213460259151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK1,Serine protease inhibitor Kazal-type 1,20294,86,2.96 [2.34-3.74],7.865767832658037e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK2,Serine protease inhibitor Kazal-type 2,17300,68,2.01 [1.13-3.58],0.0181369708141246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK4,Serine protease inhibitor Kazal-type 4,20224,82,2.65 [2.20-3.19],4.9704635686535e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK5,Serine protease inhibitor Kazal-type 5,20294,86,1.79 [1.07-3.00],0.0277666650876675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK6,Serine protease inhibitor Kazal-type 6,20442,86,1.56 [1.06-2.28],0.0230869963459461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINK8,Serine protease inhibitor Kazal-type 8,17070,67,1.22 [0.70-2.15],0.4822513184039252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINT1,Kunitz-type protease inhibitor 1,20231,85,3.84 [2.60-5.66],1.1627587576272456e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINT2,Kunitz-type protease inhibitor 2,20361,84,3.61 [2.29-5.70],3.714474644701695e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPINT3,Kunitz-type protease inhibitor 3,17593,70,0.98 [0.84-1.13],0.7448045665857141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPOCK1,Testican-1,20091,84,0.46 [0.27-0.76],0.0025577827655186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPON1,Spondin-1,20297,84,2.36 [1.84-3.02],1.1648120972658303e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPON2,Spondin-2,20178,85,9.56 [6.27-14.57],9.675315410783606e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPP1,Osteopontin,20505,88,1.87 [1.30-2.71],0.0008539939870293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",17153,67,1.71 [1.05-2.77],0.0297698255575462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPRING1,SREBP regulating gene protein,17033,67,1.35 [1.00-1.83],0.0478324066577286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPRR1B,Cornifin-B,17353,70,1.11 [0.85-1.44],0.4484680578036363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPRR3,Small proline-rich protein 3,17647,71,1.56 [1.13-2.15],0.0073274662899221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPRY2,Protein sprouty homolog 2,19903,84,1.07 [0.87-1.32],0.5268880529299027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",17100,68,0.88 [0.40-1.93],0.7558602254709719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SPTLC1,Serine palmitoyltransferase 1,17647,71,1.54 [1.06-2.22],0.0218908311499987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SRC,Proto-oncogene tyrosine-protein kinase Src,20323,87,1.05 [0.89-1.23],0.5501800102358705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SRP14,Signal recognition particle 14 kDa protein,20178,85,1.33 [1.00-1.79],0.0539814504446851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SRPK2,SRSF protein kinase 2,20224,82,1.21 [0.98-1.50],0.0799135219445724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SRPX,Sushi repeat-containing protein SRPX,17683,70,3.39 [1.99-5.79],7.308551252592752e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSB,Lupus La protein,19826,83,0.78 [0.52-1.18],0.247261614847569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",17153,67,1.87 [1.21-2.89],0.0050997660287842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,20237,85,0.87 [0.75-1.02],0.0892735840513523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,20401,85,1.86 [1.19-2.89],0.0063679623959983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSH3,Protein phosphatase Slingshot homolog 3,17033,67,1.12 [0.52-2.41],0.7694816456828092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SSNA1,Sjoegren syndrome nuclear autoantigen 1,17593,70,1.25 [0.83-1.89],0.2929776727143321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ST13,Hsc70-interacting protein,17300,68,0.75 [0.49-1.15],0.1857261865119828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",20178,85,2.02 [1.51-2.71],2.212338830085132e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",20528,88,2.56 [1.85-3.52],1.0487091503206552e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",17153,67,1.30 [0.88-1.93],0.1857854561900074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAB2,Stabilin-2,17688,69,3.31 [1.49-7.37],0.0033316877762105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAM,Signal transducing adapter molecule 1,17598,68,0.91 [0.46-1.80],0.7968154829138422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAMBP,STAM-binding protein,20058,83,1.05 [0.77-1.43],0.7650022064146511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAT2,Signal transducer and activator of transcription 2,17153,67,1.37 [1.02-1.82],0.0349694369833414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAT5B,Signal transducer and activator of transcription 5B,20178,85,1.10 [0.96-1.27],0.1747098651701002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,17033,67,1.09 [0.76-1.57],0.6259136603331844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STC1,Stanniocalcin-1,20440,87,2.89 [2.14-3.91],5.704334530009443e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STC2,Stanniocalcin-2,20270,86,6.45 [3.12-13.37],5.173486753567359e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STEAP4,Metalloreductase STEAP4,17100,68,1.09 [0.82-1.46],0.5483401641084487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STIP1,Stress-induced-phosphoprotein 1,20263,86,0.96 [0.71-1.30],0.8000968105631068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STK11,Serine/threonine-protein kinase STK11,19892,84,1.18 [0.91-1.54],0.2048626519033571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STK24,Serine/threonine-protein kinase 24,19826,83,1.28 [0.93-1.76],0.1233998139610583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STK4,Serine/threonine-protein kinase 4,20278,85,1.09 [0.88-1.36],0.4345332124300758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STOML2,"Stomatin-like protein 2, mitochondrial",17033,67,1.07 [0.83-1.39],0.5828415643719576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX16,Syntaxin-16,19826,80,1.48 [1.13-1.95],0.0049149560273968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX1B,Syntaxin-1B,17188,68,0.86 [0.47-1.58],0.6203195028659255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX3,Syntaxin-3,17647,71,1.14 [0.66-1.97],0.6404571053267123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX4,Syntaxin-4,20178,85,1.61 [1.29-2.00],2.415046998473232e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX5,Syntaxin-5,17153,67,1.17 [0.71-1.93],0.5394833254874756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX6,Syntaxin-6,19826,80,1.44 [1.11-1.87],0.0063008880858161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX7,Syntaxin-7,17153,67,2.30 [1.44-3.69],0.0005276871754255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STX8,Syntaxin-8,20224,82,1.73 [1.21-2.48],0.002584378701611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STXBP1,Syntaxin-binding protein 1,17643,68,1.15 [0.84-1.56],0.3797096571029741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,STXBP3,Syntaxin-binding protein 3,19826,80,1.13 [0.73-1.75],0.5912677644554769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUGP1,SURP and G-patch domain-containing protein 1,17593,70,1.20 [0.68-2.12],0.5257779094602526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUGT1,Protein SGT1 homolog,19826,80,1.08 [0.84-1.39],0.5522593613129346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SULT1A1,Sulfotransferase 1A1,20440,87,1.08 [0.93-1.26],0.319488452205603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SULT2A1,Bile salt sulfotransferase,20224,82,1.60 [1.26-2.02],0.0001054515619086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUMF1,Formylglycine-generating enzyme,17153,67,1.25 [0.95-1.65],0.1120965564098581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,20440,87,1.71 [1.15-2.53],0.0074895791672445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUOX,"Sulfite oxidase, mitochondrial",17643,68,1.60 [1.17-2.19],0.0033807039661418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUSD1,Sushi domain-containing protein 1,19892,84,1.02 [0.68-1.51],0.9286541012094311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUSD2,Sushi domain-containing protein 2,20294,86,3.07 [1.86-5.08],1.2611619448620206e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUSD4,Sushi domain-containing protein 4,17598,68,2.05 [1.42-2.97],0.000139942143226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SUSD5,Sushi domain-containing protein 5,17197,68,1.23 [0.62-2.42],0.551050211213532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SV2A,Synaptic vesicle glycoprotein 2A,17188,68,1.33 [1.00-1.78],0.0539084609379368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SWAP70,Switch-associated protein 70,17593,70,1.64 [0.94-2.86],0.0829906236511396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SYAP1,Synapse-associated protein 1,17300,68,0.99 [0.66-1.49],0.9796767727295728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,17100,68,1.25 [0.90-1.74],0.1861761320897084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SYT1,Synaptotagmin-1,17647,71,0.98 [0.56-1.71],0.9541209904964164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,SYTL4,Synaptotagmin-like protein 4,17683,70,1.27 [0.95-1.70],0.101199340349112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,17353,70,1.14 [0.91-1.43],0.2405330392825067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TACC3,Transforming acidic coiled-coil-containing protein 3,20178,85,1.09 [0.92-1.28],0.3321801667014025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TACSTD2,Tumor-associated calcium signal transducer 2,17909,75,2.51 [1.75-3.60],5.732891861578731e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TADA3,Transcriptional adapter 3,17598,68,1.47 [0.84-2.55],0.1759758649136807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAFA5,Chemokine-like protein TAFA-5,20178,85,3.63 [2.60-5.07],4.561373353217735e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAGLN3,Transgelin-3,17033,67,1.10 [0.75-1.63],0.6129972092289502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TALDO1,Transaldolase,17608,69,1.37 [0.83-2.28],0.2217437643802035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TANK,TRAF family member-associated NF-kappa-B activator,19903,84,1.25 [0.95-1.65],0.1053860387294365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAP1,Antigen peptide transporter 1,17353,70,0.88 [0.58-1.34],0.5511311161614503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TARBP2,RISC-loading complex subunit TARBP2,19826,83,1.22 [0.95-1.56],0.1153896138504445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",17188,68,1.12 [0.88-1.43],0.3660680973439025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",17598,68,1.01 [0.54-1.91],0.9703077760601004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TAX1BP1,Tax1-binding protein 1,17647,71,1.51 [1.08-2.10],0.0151570430350123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBC1D17,TBC1 domain family member 17,19826,83,0.86 [0.54-1.37],0.518067849217637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBC1D23,TBC1 domain family member 23,20178,85,1.22 [0.99-1.51],0.0658088816954573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBC1D5,TBC1 domain family member 5,20224,82,1.15 [0.92-1.45],0.2211103726241241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBCA,Tubulin-specific chaperone A,17300,68,1.04 [0.78-1.37],0.8041052930182125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBCB,Tubulin-folding cofactor B,20091,84,1.11 [0.91-1.36],0.3046864289713637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBCC,Tubulin-specific chaperone C,20091,84,1.18 [0.92-1.50],0.1830699176160697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBL1X,F-box-like/WD repeat-containing protein TBL1X,19826,80,1.19 [0.94-1.51],0.1514781947349158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TBR1,T-box brain protein 1,17188,68,0.78 [0.43-1.41],0.4170923603940925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCL1A,T-cell leukemia/lymphoma protein 1A,20071,84,0.72 [0.60-0.87],0.0005287073247027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCL1B,T-cell leukemia/lymphoma protein 1B,19892,84,1.10 [0.89-1.35],0.3957914804595066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCN1,Transcobalamin-1,17326,67,1.15 [0.69-1.92],0.5865047277542363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCN2,Transcobalamin-2,20505,88,4.15 [3.04-5.67],4.550387824107632e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCOF1,Treacle protein,17683,70,2.52 [1.67-3.79],9.953561601966916e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCP11,T-complex protein 11 homolog,17353,70,0.68 [0.38-1.20],0.1815784808197559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TCTN3,Tectonic-3,17683,70,1.36 [0.65-2.85],0.4113071012739023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TDGF1,Teratocarcinoma-derived growth factor 1,19826,83,0.99 [0.87-1.13],0.9157148211550236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TDO2,"Tryptophan 2,3-dioxygenase",17188,68,0.70 [0.35-1.42],0.3275605410151162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TDP1,Tyrosyl-DNA phosphodiesterase 1,17598,68,1.11 [0.81-1.54],0.5109812500928979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TDRKH,Tudor and KH domain-containing protein,19826,83,1.28 [1.03-1.59],0.0262970880468941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TEF,Thyrotroph embryonic factor,17070,67,1.29 [0.83-2.00],0.2565305294038292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TEK,Angiopoietin-1 receptor,20360,87,3.91 [1.72-8.92],0.0011642601657335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TERF1,Telomeric repeat-binding factor 1,17153,67,1.85 [0.90-3.79],0.0939482314641063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TET2,Methylcytosine dioxygenase TET2,17313,69,1.19 [1.00-1.42],0.0443029127332077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TEX101,Testis-expressed protein 101,17188,68,1.42 [0.98-2.04],0.0636718396610159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TEX33,Testis-expressed protein 33,17353,70,1.07 [0.59-1.94],0.8356693742060983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TF,Serotransferrin,17711,69,3.18 [1.10-9.17],0.0320965488525615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFAP2A,Transcription factor AP-2-alpha,17100,68,0.81 [0.52-1.25],0.332559034072908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF1,Trefoil factor 1,20187,86,2.10 [1.76-2.51],1.8670492732475941e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF2,Trefoil factor 2,20325,84,3.47 [2.68-4.50],6.977584628228199e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFF3,Trefoil factor 3,20294,85,2.00 [1.67-2.39],4.736944549143052e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFPI,Tissue factor pathway inhibitor,20261,85,0.68 [0.35-1.31],0.2520258688854587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFPI2,Tissue factor pathway inhibitor 2,20306,87,1.48 [1.14-1.92],0.0029211164910447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TFRC,Transferrin receptor protein 1,20390,85,2.38 [1.58-3.60],3.633349232072309e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TG,Thyroglobulin,17598,68,1.06 [0.87-1.30],0.567485042605489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFA,Protransforming growth factor alpha,20224,82,3.18 [2.36-4.28],2.1623037311415422e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFB1,Transforming growth factor beta-1 proprotein,20449,85,2.80 [2.06-3.81],4.6414568095665556e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFB2,Transforming growth factor beta-2 proprotein,17598,68,1.16 [0.76-1.78],0.4968744799245677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBI,Transforming growth factor-beta-induced protein ig-h3,20196,84,0.66 [0.32-1.38],0.2720288730953821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBR1,TGF-beta receptor type-1,17153,67,3.93 [2.40-6.45],5.8955992918276425e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBR2,TGF-beta receptor type-2,20360,87,4.10 [3.15-5.32],3.951146286964273e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGFBR3,Transforming growth factor beta receptor type 3,20528,88,2.67 [1.47-4.85],0.0013306221328001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGM2,Protein-glutamine gamma-glutamyltransferase 2,20254,85,0.74 [0.58-0.95],0.0171546073890264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TGOLN2,Trans-Golgi network integral membrane protein 2,17683,68,6.47 [3.49-11.97],2.7891428286619743e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THAP12,52 kDa repressor of the inhibitor of the protein kinase,17007,67,0.89 [0.65-1.21],0.4406468061225281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THBD,Thrombomodulin,20278,85,4.34 [2.97-6.37],4.7652067491523993e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THBS2,Thrombospondin-2,20294,86,4.33 [3.33-5.64],1.5577082182025516e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THBS4,Thrombospondin-4,20319,85,1.91 [1.29-2.83],0.0011974671024475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THOP1,Thimet oligopeptidase,20162,85,0.72 [0.38-1.37],0.3239057994396241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THPO,Thrombopoietin,19892,84,0.99 [0.61-1.63],0.9811572034480408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THRAP3,Thyroid hormone receptor-associated protein 3,17070,67,0.91 [0.70-1.18],0.4741429100167947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THSD1,Thrombospondin type-1 domain-containing protein 1,17022,66,0.96 [0.47-1.96],0.9086841882377532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THTPA,Thiamine-triphosphatase,17571,68,0.93 [0.71-1.22],0.6091800056623491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,THY1,Thy-1 membrane glycoprotein,20440,87,4.76 [2.98-7.61],7.204677075344215e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIA1,Nucleolysin TIA-1 isoform p40,19658,83,1.10 [0.94-1.28],0.2400404909892505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIE1,Tyrosine-protein kinase receptor Tie-1,20528,88,1.97 [1.10-3.54],0.0228810654546534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",19793,82,1.15 [0.77-1.72],0.4859079497032109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,17353,70,2.70 [1.91-3.82],1.9209683376269303e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,20401,85,1.48 [0.97-2.26],0.0707145834410073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,17683,70,1.57 [0.92-2.68],0.094792170563061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,17647,71,1.07 [0.82-1.40],0.6241711545648537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMP1,Metalloproteinase inhibitor 1,20105,85,6.08 [4.47-8.28],1.7729121322666453e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMP2,Metalloproteinase inhibitor 2,17683,70,0.39 [0.10-1.58],0.1886302619195184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMP3,Metalloproteinase inhibitor 3,20361,84,1.06 [0.92-1.23],0.3930336187815516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TIMP4,Metalloproteinase inhibitor 4,20294,86,1.90 [1.28-2.83],0.0014745479874029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TINAGL1,Tubulointerstitial nephritis antigen-like,20207,85,7.07 [3.10-16.14],3.32523064447458e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TJAP1,Tight junction-associated protein 1,20360,87,1.17 [0.93-1.47],0.1798032942674874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TJP3,Tight junction protein ZO-3,17100,68,1.13 [0.70-1.83],0.6214172663868576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TK1,"Thymidine kinase, cytosolic",17353,70,1.56 [1.08-2.24],0.0180328940792007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TLR1,Toll-like receptor 1,17153,67,3.55 [1.88-6.71],9.741456316054957e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TLR2,Toll-like receptor 2,17353,70,2.51 [1.00-6.30],0.0498604613054026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TLR3,Toll-like receptor 3,20478,85,1.27 [0.92-1.77],0.1481102301326673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TLR4,Toll-like receptor 4,17153,67,1.92 [0.94-3.91],0.071518828844983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,17188,68,0.94 [0.59-1.49],0.7827580480525954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMED1,Transmembrane emp24 domain-containing protein 1,17353,70,1.23 [0.85-1.77],0.2801693546161221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMED10,Transmembrane emp24 domain-containing protein 10,17070,67,0.97 [0.60-1.58],0.9013877343340796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMED4,Transmembrane emp24 domain-containing protein 4,17070,67,0.84 [0.55-1.30],0.4332597117307296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMED8,Protein TMED8,17593,70,1.13 [0.90-1.42],0.2878647349952127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMEM106A,Transmembrane protein 106A,17598,68,1.18 [0.87-1.61],0.2831736102719687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMEM132A,Transmembrane protein 132A,17228,69,1.06 [0.73-1.53],0.7705390366007739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMEM25,Transmembrane protein 25,17643,68,1.28 [0.90-1.84],0.1745161930597722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMOD4,Tropomodulin-4,17033,67,1.94 [1.21-3.09],0.0056350059618041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS11B,Transmembrane protease serine 11B,17100,68,0.74 [0.50-1.09],0.1242166416671175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS11D,Transmembrane protease serine 11D,17620,71,1.91 [1.26-2.89],0.0022071344934029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS15,Enteropeptidase,20178,85,1.85 [1.50-2.28],8.205421300563818e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMPRSS5,Transmembrane protease serine 5,20001,84,0.72 [0.44-1.17],0.1857016664096776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TMSB10,Thymosin beta-10,20294,86,1.59 [1.23-2.05],0.0003497325381722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNC,Tenascin,20401,85,1.47 [1.00-2.15],0.0473027908687822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNF,Tumor necrosis factor,19865,83,1.88 [1.49-2.36],7.925973937676743e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,17593,70,1.73 [1.17-2.57],0.0064744940168989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,19903,84,1.11 [0.66-1.87],0.6904747936607531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,17300,68,0.96 [0.65-1.41],0.8308155539354534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,20091,84,3.70 [2.93-4.66],3.1713424972512003e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,20091,84,1.73 [1.53-1.96],5.290919872076077e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,20351,87,1.56 [1.03-2.35],0.0342480059858041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,20478,85,5.48 [4.13-7.28],7.04679269629803e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,20270,84,7.98 [5.01-12.71],2.0885992087533527e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,20360,87,5.70 [4.40-7.38],7.501725685120204e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,20297,84,2.27 [1.83-2.82],8.409072835674257e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,19903,84,1.54 [1.06-2.24],0.0218995696863725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,20297,84,6.91 [4.81-9.91],1.1342459839805603e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,17300,68,1.98 [1.17-3.36],0.0113260966881145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,20442,86,4.16 [3.01-5.75],6.276249376404304e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,20294,86,7.31 [5.40-9.89],4.500343161310112e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,20294,86,1.97 [1.66-2.34],7.762301818802328e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,20440,87,4.65 [3.07-7.05],4.1327817824184854e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,20449,85,4.30 [3.22-5.75],4.3596027051541683e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,20091,84,2.19 [1.78-2.68],4.299020336051753e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,20440,87,2.78 [2.05-3.76],4.590907514986285e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,20091,84,2.42 [2.04-2.87],1.8053095560550903e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF10,Tumor necrosis factor ligand superfamily member 10,20478,85,0.34 [0.17-0.71],0.0037014980447101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF11,Tumor necrosis factor ligand superfamily member 11,20224,82,0.75 [0.54-1.03],0.0782172563873599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF12,Tumor necrosis factor ligand superfamily member 12,20478,85,0.49 [0.31-0.77],0.0019392270330648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,20361,84,6.69 [3.97-11.27],1.008666786600462e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,20501,88,2.95 [1.83-4.77],9.42301604165824e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF14,Tumor necrosis factor ligand superfamily member 14,20091,84,1.17 [0.85-1.62],0.3388414491791176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,17688,69,3.86 [2.58-5.79],6.148466864716875e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNIP1,TNFAIP3-interacting protein 1,17647,71,1.21 [0.93-1.56],0.1528148232613994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNN,Tenascin-N,17688,69,2.40 [1.42-4.06],0.0011165842379188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNNI3,"Troponin I, cardiac muscle",19892,84,1.42 [1.11-1.81],0.0052210448971537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNPO1,Transportin-1,17353,70,0.89 [0.45-1.74],0.7275906593391859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNR,Tenascin-R,20091,84,1.34 [0.87-2.08],0.1839694803461916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TNXB,Tenascin-X,20294,86,0.41 [0.21-0.79],0.007819059778418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,17683,70,1.50 [1.15-1.97],0.0026996695582486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOP1,DNA topoisomerase 1,17593,70,1.02 [0.84-1.25],0.81586402629241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOP1MT,"DNA topoisomerase I, mitochondrial",17033,67,0.92 [0.54-1.56],0.7609074974475988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOP2B,DNA topoisomerase 2-beta,17153,67,1.30 [0.98-1.72],0.068489138557546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TOR1AIP1,Torsin-1A-interacting protein 1,17228,69,1.32 [0.89-1.96],0.171413654672283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TP53,Cellular tumor antigen p53,19826,80,1.12 [0.70-1.78],0.6353144445745008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TP53BP1,TP53-binding protein 1,17153,67,1.52 [1.17-1.97],0.0018533881759748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TP53I3,Quinone oxidoreductase PIG3,16937,68,1.24 [0.81-1.91],0.3237044431642336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TP53INP1,Tumor protein p53-inducible nuclear protein 1,19892,84,1.48 [0.89-2.48],0.1317944010474976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TP73,Tumor protein p73,17188,68,0.63 [0.33-1.23],0.1787943317896397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPBGL,Trophoblast glycoprotein-like,17188,68,0.88 [0.50-1.54],0.6484719464519422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPD52L2,Tumor protein D54,17300,68,1.03 [0.83-1.28],0.7924683136627236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPK1,Thiamin pyrophosphokinase 1,17683,70,0.69 [0.30-1.63],0.3998360125443043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPM3,Tropomyosin alpha-3 chain,17070,67,1.51 [1.01-2.24],0.0425632143103953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPMT,Thiopurine S-methyltransferase,19826,80,0.72 [0.54-0.98],0.035452252769725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPP1,Tripeptidyl-peptidase 1,20128,84,1.96 [1.45-2.66],1.400496096656268e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPPP2,Tubulin polymerization-promoting protein family member 2,17353,70,0.96 [0.71-1.30],0.7765687629006607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPPP3,Tubulin polymerization-promoting protein family member 3,19826,83,0.52 [0.28-0.96],0.0375326050755044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPR,Nucleoprotein TPR,17070,67,1.54 [1.13-2.09],0.0057714343451741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPRKB,EKC/KEOPS complex subunit TPRKB,17033,67,1.05 [0.75-1.47],0.7780272438676035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPSAB1,Tryptase alpha/beta-1,20446,85,1.61 [1.11-2.33],0.0122320060142374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPSD1,Tryptase delta,17643,68,1.66 [1.14-2.41],0.0082440986672643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPSG1,Tryptase gamma,17153,67,1.39 [0.58-3.36],0.4593302241648574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TPT1,Translationally-controlled tumor protein,19903,84,0.90 [0.64-1.26],0.5314817485717662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRAF2,TNF receptor-associated factor 2,20224,82,1.06 [0.80-1.41],0.6713992256349048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRAF3,"TNF receptor-associated factor 3, Isoform 2",17153,67,0.93 [0.48-1.83],0.8411167158573389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,17070,67,1.37 [0.97-1.95],0.0763060926665735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,17353,70,1.11 [0.87-1.40],0.4019828045027492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TREH,Trehalase,17688,69,1.93 [1.37-2.70],0.0001378934453023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TREM2,Triggering receptor expressed on myeloid cells 2,20270,84,1.99 [1.45-2.74],1.927403473461851e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TREML1,Trem-like transcript 1 protein,17683,68,1.09 [0.71-1.69],0.6839746283673435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TREML2,Trem-like transcript 2 protein,20294,86,1.78 [1.15-2.78],0.0104792274000753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIAP1,TP53-regulated inhibitor of apoptosis 1,20442,86,1.60 [1.19-2.15],0.0020037034214323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM21,E3 ubiquitin-protein ligase TRIM21,20224,82,1.04 [0.79-1.35],0.796790569139461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM24,Transcription intermediary factor 1-alpha,17325,70,1.01 [0.70-1.45],0.975030583725714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,17593,70,1.17 [0.94-1.45],0.1597516571833376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM26,Tripartite motif-containing protein 26,17033,67,1.03 [0.67-1.59],0.881733386661141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM40,E3 ubiquitin ligase TRIM40,17188,68,1.27 [0.92-1.76],0.1401697000472024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM5,Tripartite motif-containing protein 5,20224,82,1.10 [0.88-1.39],0.4039711322447026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRIM58,E3 ubiquitin-protein ligase TRIM58,17598,68,1.25 [0.96-1.62],0.1012868401472004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TRPV3,Transient receptor potential cation channel subfamily V member 3,17070,67,0.70 [0.40-1.23],0.213475331583184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSC1,Hamartin,17153,67,1.34 [1.05-1.72],0.0195075362801869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSC22D1,TSC22 domain family protein 1,17643,68,1.37 [1.00-1.87],0.0507591742670297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSHB,Thyrotropin subunit beta,20278,85,0.75 [0.58-0.97],0.0275867113199179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSLP,Thymic stromal lymphopoietin,19892,84,1.06 [0.80-1.41],0.6724112866547992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSNAX,Translin-associated protein X,17070,67,0.85 [0.46-1.59],0.6157312733331324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSPAN1,Tetraspanin-1,19892,84,0.85 [0.66-1.10],0.2112536526320682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSPAN15,Tetraspanin-15,17070,67,1.29 [0.91-1.83],0.1590377955707606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSPAN7,Tetraspanin-7,17100,68,0.85 [0.63-1.15],0.3058599638407459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSPAN8,Tetraspanin-8,17593,70,1.36 [1.08-1.72],0.0088492865329831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TSPYL1,Testis-specific Y-encoded-like protein 1,17153,67,1.00 [0.55-1.81],0.9983512224137616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TST,Thiosulfate sulfurtransferase,19784,83,1.21 [0.93-1.57],0.1518601847056251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TTF2,Transcription termination factor 2,17188,68,1.25 [0.84-1.86],0.2708221284762753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TTN,Titin,17070,67,1.70 [1.33-2.17],2.3548340837226263e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TTR,Transthyretin,17519,69,0.56 [0.31-1.01],0.0536074801312445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TUBB3,Tubulin beta-3 chain,17100,68,1.07 [0.46-2.53],0.8715265221077728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TWF2,Twinfilin-2,17688,69,1.18 [0.90-1.55],0.2316103148058817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXK,Tyrosine-protein kinase TXK,17353,70,1.08 [0.80-1.46],0.5950863329456255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXLNA,Alpha-taxilin,20091,84,1.30 [1.04-1.62],0.0206615990024399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXN,Thioredoxin,17385,67,0.83 [0.46-1.47],0.5122647851509818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNDC15,Thioredoxin domain-containing protein 15,20360,87,2.06 [1.06-4.01],0.0324554347403223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNDC5,Thioredoxin domain-containing protein 5,20440,87,1.73 [1.34-2.23],2.9330704339599545e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNDC9,Thioredoxin domain-containing protein 9,17647,71,1.20 [0.79-1.81],0.3881518417845224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNL1,Thioredoxin-like protein 1,17065,68,1.07 [0.85-1.35],0.5763113026393785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",20294,86,1.31 [0.88-1.96],0.1809589064682036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TYMP,Thymidine phosphorylase,20146,85,1.34 [1.00-1.79],0.0530201246227071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TYRO3,Tyrosine-protein kinase receptor TYRO3,20278,85,2.90 [1.47-5.70],0.0020884227231124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",17153,67,1.53 [1.05-2.23],0.0254224138345838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBAC1,Ubiquitin-associated domain-containing protein 1,20178,85,0.53 [0.30-0.94],0.0299686850086157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBE2B,Ubiquitin-conjugating enzyme E2 B,17598,68,1.10 [0.49-2.45],0.8173967460888117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,17683,70,1.47 [1.02-2.11],0.0375367582504602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,17153,67,1.11 [0.75-1.66],0.5927851603264342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBQLN3,Ubiquilin-3,17070,67,1.16 [0.84-1.61],0.3633735220056805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UBXN1,UBX domain-containing protein 1,17300,68,1.01 [0.71-1.44],0.9379178841132108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,17593,70,1.07 [0.91-1.25],0.4337340079747929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UGDH,UDP-glucose 6-dehydrogenase,17070,67,1.31 [1.09-1.56],0.0030794974870345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UHRF2,E3 ubiquitin-protein ligase UHRF2,17070,67,0.76 [0.36-1.60],0.4728427388639715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ULBP2,UL16-binding protein 2,20091,84,5.06 [3.73-6.86],1.3843767169072698e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UMOD,Uromodulin,20478,88,0.34 [0.27-0.44],9.670277635628864e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UNC5D,Netrin receptor UNC5D,17153,67,3.19 [1.81-5.62],5.911508000213692e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UNC79,Protein unc-79 homolog,17033,67,1.20 [0.79-1.82],0.3869321659196146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UNG,Uracil-DNA glycosylase,17598,68,1.61 [0.95-2.72],0.0785648938843527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UPB1,Beta-ureidopropionase,17683,70,1.33 [1.07-1.67],0.011835717752764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UPK3A,Uroplakin-3a,17100,68,0.67 [0.41-1.12],0.1263207738302569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UPK3BL1,Uroplakin-3b-like protein 1,17315,70,1.07 [0.72-1.58],0.7437879222561323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UROD,Uroporphyrinogen decarboxylase,17300,68,0.96 [0.68-1.36],0.8134209001461055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UROS,Uroporphyrinogen-III synthase,17188,68,0.83 [0.57-1.22],0.3524047939366121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USO1,General vesicular transport factor p115,20178,85,1.25 [1.01-1.55],0.0446865131549735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USP25,Ubiquitin carboxyl-terminal hydrolase 25,17598,68,1.32 [0.96-1.82],0.0909709594660488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USP28,Ubiquitin carboxyl-terminal hydrolase 28,17647,71,2.13 [1.58-2.87],6.070842414579907e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USP47,Ubiquitin carboxyl-terminal hydrolase 47,17070,67,1.04 [0.79-1.36],0.8042733311948742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,USP8,Ubiquitin carboxyl-terminal hydrolase 8,19892,84,1.16 [0.95-1.42],0.1340371732932078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,UXS1,UDP-glucuronic acid decarboxylase 1,19826,80,1.20 [0.83-1.73],0.3436849816639885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VAMP5,Vesicle-associated membrane protein 5,19892,84,1.58 [1.27-1.95],2.944029084569363e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VAMP8,Vesicle-associated membrane protein 8,17153,67,1.23 [0.94-1.61],0.1252127653798703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VASH1,Tubulinyl-Tyr carboxypeptidase 1,20224,82,1.09 [0.86-1.38],0.482264309173807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VASN,Vasorin,19990,84,3.83 [1.94-7.56],0.0001047767563379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VASP,Vasodilator-stimulated phosphoprotein,17683,68,1.15 [0.84-1.58],0.3807386107278475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,20178,85,0.30 [0.11-0.84],0.0223368466888119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VAV3,Guanine nucleotide exchange factor VAV3,17100,68,1.04 [0.82-1.33],0.7280338606797825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VCAM1,Vascular cell adhesion protein 1,20356,85,7.94 [5.29-11.90],1.3640275948659424e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VCAN,Versican core protein,20440,87,2.14 [1.15-3.99],0.0167498587762085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VCPKMT,Protein-lysine methyltransferase METTL21D,17033,67,0.95 [0.70-1.29],0.7428577137234343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFA,Vascular endothelial growth factor A,20415,85,1.73 [1.27-2.35],0.0004370346686542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFB,Vascular endothelial growth factor B,17153,67,4.64 [2.30-9.38],1.8340681916187777e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFC,Vascular endothelial growth factor C,20360,87,0.96 [0.68-1.35],0.8179427938745156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VEGFD,Vascular endothelial growth factor D,20446,85,5.49 [3.44-8.74],7.585078030748868e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VGF,Neurosecretory protein VGF,17643,68,2.33 [1.19-4.54],0.0131307521895433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VIM,Vimentin,19892,84,1.01 [0.85-1.21],0.904620995413212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VIPR1,Vasoactive intestinal polypeptide receptor 1,17228,69,1.05 [0.39-2.84],0.9196183377766444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VIT,Vitrin,17683,70,1.52 [0.84-2.74],0.1659936427249189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VMO1,Vitelline membrane outer layer protein 1 homolog,20178,85,2.19 [1.64-2.93],1.0779757137067808e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VNN1,Pantetheinase,17683,68,0.98 [0.72-1.34],0.8895857037669581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VNN2,Vascular non-inflammatory molecule 2,20178,85,1.68 [1.06-2.67],0.0272105041844365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VPS28,Vacuolar protein sorting-associated protein 28 homolog,17353,70,1.27 [0.91-1.77],0.153110025341359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VPS37A,Vacuolar protein sorting-associated protein 37A,20178,85,1.24 [0.98-1.56],0.072014235956898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VPS4B,Vacuolar protein sorting-associated protein 4B,17598,68,1.02 [0.80-1.30],0.8962533035963086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VPS53,Vacuolar protein sorting-associated protein 53 homolog,20178,85,1.22 [0.96-1.55],0.1083307310231015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG10,V-set and immunoglobulin domain-containing protein 10,17598,68,1.59 [0.92-2.74],0.0959609558796747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,17070,67,1.89 [1.18-3.03],0.0080265105839039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,17598,68,2.47 [1.94-3.15],1.8103010357405294e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,20270,86,5.58 [4.13-7.53],3.25741009704322e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,20242,85,1.34 [1.01-1.78],0.0441642000063734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSNL1,Visinin-like protein 1,17647,71,0.63 [0.33-1.20],0.163514010992922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSTM1,V-set and transmembrane domain-containing protein 1,19826,83,1.57 [1.18-2.09],0.0020735321881548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSTM2B,V-set and transmembrane domain-containing protein 2B,17353,70,0.79 [0.40-1.56],0.4919387491085096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,19892,84,1.54 [1.25-1.89],5.057905074381045e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,20440,87,0.94 [0.72-1.22],0.6326777042877358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VTCN1,V-set domain-containing T-cell activation inhibitor 1,19826,80,1.98 [1.24-3.17],0.0044544900029868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,17300,68,1.52 [1.04-2.24],0.0318442346102617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWA1,von Willebrand factor A domain-containing protein 1,20408,86,1.83 [1.17-2.86],0.0078725225949679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWA5A,von Willebrand factor A domain-containing protein 5A,17033,67,1.17 [0.91-1.51],0.2228357109242226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWC2,Brorin,20023,83,3.42 [2.22-5.28],2.8488819971786964e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWC2L,von Willebrand factor C domain-containing protein 2-like,17643,68,1.17 [0.76-1.82],0.4744314915624251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,VWF,von Willebrand factor,20528,88,1.56 [1.21-2.02],0.0006902012142778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WARS,"Tryptophan--tRNA ligase, cytoplasmic",20294,86,1.24 [0.75-2.05],0.3946606368247989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WAS,Wiskott-Aldrich syndrome protein,19903,84,0.96 [0.71-1.31],0.8163881295431585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WASF1,Wiskott-Aldrich syndrome protein family member 1,19892,84,1.25 [1.02-1.53],0.0305842748863921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WASF3,Wiskott-Aldrich syndrome protein family member 3,19826,83,1.04 [0.82-1.31],0.7706918732936796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WASHC3,WASH complex subunit 3,17647,71,1.43 [1.08-1.88],0.0116551106507852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WASL,Neural Wiskott-Aldrich syndrome protein,17153,67,1.07 [0.74-1.54],0.7226348281476105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WDR46,WD repeat-containing protein 46,17598,68,0.75 [0.37-1.53],0.4252193207965588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFDC1,WAP four-disulfide core domain protein 1,17237,68,1.70 [1.39-2.08],2.008881194324996e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFDC12,WAP four-disulfide core domain protein 12,20413,86,1.62 [1.24-2.12],0.0004178366343243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFDC2,WAP four-disulfide core domain protein 2,19276,82,3.60 [2.81-4.62],5.03578470108146e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",20021,84,0.35 [0.22-0.54],3.677108257416335e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",20297,84,1.44 [0.81-2.57],0.2185545418292879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WIF1,Wnt inhibitory factor 1,20442,86,0.34 [0.19-0.62],0.0003463595381721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WNT9A,Protein Wnt-9a,19903,84,4.72 [3.38-6.59],6.843439269847347e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,20091,84,1.03 [0.71-1.48],0.8746860798787407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XCL1,Lymphotactin,20442,86,1.66 [1.30-2.13],5.773915385495782e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XG,Glycoprotein Xg,20441,88,3.77 [2.74-5.20],5.3808705448886445e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XIAP,E3 ubiquitin-protein ligase XIAP,17153,67,1.45 [0.99-2.13],0.0596794434632524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XPNPEP2,Xaa-Pro aminopeptidase 2,20360,87,0.65 [0.56-0.77],2.1132241841863002e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,XRCC4,DNA repair protein XRCC4,19826,83,1.14 [0.69-1.88],0.6217657490229351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YAP1,Transcriptional coactivator YAP1,17647,71,3.24 [2.32-4.54],6.702862171730304e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",17593,70,1.11 [0.94-1.30],0.2233588983766524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YES1,Tyrosine-protein kinase Yes,20178,85,1.24 [1.05-1.47],0.0126655187493132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YJU2,Splicing factor YJU2,17598,68,1.09 [0.53-2.22],0.8198263047942328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YOD1,Ubiquitin thioesterase OTU1,17070,67,0.68 [0.46-1.00],0.0503050383976933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YTHDF3,YTH domain-containing family protein 3,19903,84,1.14 [0.91-1.42],0.2480324471518634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YWHAQ,14-3-3 protein theta,17300,68,1.12 [0.81-1.53],0.4927746876402304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,YY1,Transcriptional repressor protein YY1,17153,67,1.90 [0.92-3.91],0.0821242330661306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZBP1,Z-DNA-binding protein 1,17153,67,1.37 [0.81-2.32],0.2458858253408525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZBTB16,Zinc finger and BTB domain-containing protein 16,19826,80,1.44 [1.14-1.82],0.0021081745375201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZBTB17,Zinc finger and BTB domain-containing protein 17,19892,84,1.54 [1.19-2.00],0.0010743783108392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZCCHC8,Zinc finger CCHC domain-containing protein 8,17070,67,0.90 [0.58-1.39],0.6353106606242869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZFYVE19,Abscission/NoCut checkpoint regulator,17593,70,1.07 [0.82-1.38],0.6308988225060692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZHX2,Zinc fingers and homeoboxes protein 2,17647,71,1.77 [1.14-2.76],0.0108868198315784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNF174,Zinc finger protein 174,17153,67,1.12 [0.62-2.03],0.7175193511617068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNF75D,Zinc finger protein 75D,17353,70,0.86 [0.57-1.30],0.4809147312471611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNF830,Zinc finger protein 830,17598,68,0.95 [0.69-1.31],0.754716337027205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNRD2,Protein ZNRD2,17593,70,1.83 [1.38-2.44],3.0598956184074506e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,17598,68,1.01 [0.65-1.56],0.9708378636187398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZP3,Zona pellucida sperm-binding protein 3,17228,69,1.12 [1.01-1.25],0.0254750657822483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZP4,Zona pellucida sperm-binding protein 4,17033,67,0.67 [0.27-1.63],0.3726353962588307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,ZPR1,Zinc finger protein ZPR1,17100,68,0.96 [0.74-1.23],0.7459474134686672
